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The human cornea is one of the most transplanted tissues in the world due to corneal 
blindness. Corneal blindness is usually caused by corneal endothelium dysfunction due 
to Fuchs endothelial dystrophy (FED) or other diseases. Transplantation of donor 
corneal tissue is the only available solution for endothelium dysfunction patients. Donor 
cornea shortage presents huge challenges for the ever-growing patients in need of donor 
corneal transplants. Consequently, alternative treatments such as cell regenerative 
therapies and tissue-engineered monolayer transplantation by using in vitro cultivated 
primary human corneal endothelial cells are being investigated. Extracellular 
topographical cues have shown promising results to direct the essential cellular 
processes in several cell types. However, little is known on how the extracellular 
topographical cues could modulate the behavior of HCEC cells and the essential 
processes in corneal cell regenerative therapies and tissue engineering. This thesis was 
set out to investigate the role of extracellular topographical cues in the field of corneal 
endothelial tissue engineering and regenerative medicine. 
In the first part of the thesis, the effect of extracellular topography on the proliferation 
and functional markers of primary HCECs was studied. The results of the study 
demonstrated that the isotropic micro and nano-extracellular topographical cues could 
increase the proliferation rate, the expression of cell-cell tight junction protein ZO1, 
and cell morphology of primary HCECs. This led to the high quality in vitro growth of 
cells and formation of cell monolayer. The results also showed that even after the 
primary HCECs were detached from the topographically patterned substrates, they 
were able to maintain the topography-mediated cell functions. This suggests that the 
primary HCECs cultured on topography would acquire epigenetic memory of the 
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topography-induced functions, leading to formation of functionally enhanced in situ 
monolayer even upon transplantation to a non-patterned cell-carrier or in vivo surfaces. 
Corneal cell injection therapy and pharmacotherapy for in situ monolayer regeneration 
are promising alternative techniques. However, the effectiveness of such therapies in 
the presence of pathological micro-topography (corneal guttata), which is characteristic 
of FED, is not known. No adequate in vitro or in vivo disease model is available for 
understanding FED. In the next part of the thesis, an FED disease model was developed 
by fabricating pathological guttata-like micro-topography. The effect of guttata 
dimensions and density (which are related with the progression of the FED disease) was 
investigated on the primary HCEC monolayer regeneration. The primary HCECs were 
unable to form a monolayer in cell injection approach or in pharmacotherapy approach 
on densely-packed synthetic guttata, which mimicked the late stage FED. However, the 
cells could form a monolayer and express ZO1 on sparsely-spaced synthetic guttata 
micro-structures of a lower height, mimicking the early stage FED. Overall, the findings 
suggested that the severity of the FED, as determined by height and density of existing 
guttata, can potentially attenuate corneal endothelial monolayer formation of cell 
injection therapy and pharmacotherapy. 
The transplantation of tissue engineered primary HCEC monolayer is another 
alternative option to treat endothelium dysfunction. Current material cell carrier films 
for corneal endothelial monolayer regeneration and transplantation only serve as 
mechanical support and lack specifically tailored properties such as mechanical 
strength and biodegradation. In the last part of the thesis work, gelatin methacrylate 
hydrogel cell carrier film was designed which not only acts as robust mechanical 
support, but also modulated the cellular functions by using patterned topographical 
cues. Hybrid GelMA+ hydrogel was designed where the presence of physical network 
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of gelatin triple helices improved the subsequent UV covalent crosslinking efficiency, 
which imparted excellent strength to hydrogels. A new generic micro- and nano-
molding method was developed for the pattering of UV-crosslinkable hydrogels. The 
primary HCEC monolayers grown on 1 µm pillars of square-array GelMA+ films 
demonstrated improved ZO1 expression, while monolayers on 1 µm pillar of 
hexagonal-array GelMA+ exhibited higher cell density and homogeneity of cell size, 
which are indications of functionally-superior monolayer.  
Overall, this PhD thesis has attempted to take a holistic approach to look at the field of 
corneal endothelial tissue engineering and regenerative medicine. The findings of the 
research work suggest that the topographical cues can benefit the corneal endothelial 
tissue engineering and regenerative medicine field by directing cellular proliferation, 
functional markers and regeneration of monolayer, whether in-situ in case of cell 
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Chapter 1. Introduction 
 
 Background definition and scope of the thesis 
 Corneal dysfunction and the unmet need of treatment 
The human cornea is one of the most transplanted tissues in the world. In 2014 alone, 
Eye Banking Association of America reported 76,431 corneal transplants in only USA 
[2]. Over 40 percent of the corneal transplants were performed solely due to the failure 
of corneal endothelium [2]. The other indications for corneal transplantations that 
account for the rest of the corneal transplants include diseases such as keratoconus, 
trauma, post-cataract-surgery edema, and other causes of corneal dysfunction or 
distortion. 
Cornea, the front section of the eye, is a 5-layered tissue [3]. Of these five layers, 
corneal endothelium is the posterior and the inner most layer of the cornea. As the 
cornea is an avascular tissue, it receives the nutrient supply from aqueous humor, which 
passes through the leaky barrier provided by the corneal endothelial monolayer [4]. 
However, the influx of aqueous humor to the corneal stroma could lead to the stroma 
swelling [5]. This is where the pump function of the corneal endothelium comes into 
the action [4]. Corneal endothelial cells have transport protein called Na/+K+-ATPase, 
which pump excessive fluids out of stroma, thus maintaining the relative dehydration 
of stroma [4]. This relative dehydration of stroma is a prerequisite for the maintenance 
of corneal transparency [6]. In short, the principal physiological function of the corneal 
endothelium is to provide nutrients to the rest of the cornea and maintain the corneal 
transparency by its ‘pump-leak’ process.  
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Corneal blindness is caused by damages to corneal endothelium due to trauma or 
diseases such as Fuchs’ Endothelial Dystrophy (FED) and Bullous Keratoplasty [7]. 
The corneal endothelial cells do not divide in vivo, which means that the corneal 
endothelial cells are unable to repair the endothelium [8]. The cell death due to these 
damages leads towards an impaired corneal endothelium. While modern science offers 
various means to cope with the symptoms, transplantation of the donor tissue remains 
the only long-term solution to treat corneal endothelium dysfunction and the resulting 
corneal blindness  to restore vision [9]. However, the donor cornea shortage presents 
huge challenges for the ever-growing patients in need of donor corneal transplants. 
Diseases of corneal endothelium are degenerative in nature, which means that the aging 
populations will lead to higher incidence of age-related endothelium dysfunction 
patients. Therefore, the demand for donor tissue demand will potentially increase [10]. 
On the other hand, 30% of the donor tissues for transplantation are rejected due to strict 
criteria for tissue acceptability such as the endothelial cell count and cell morphology 
[2]. Additionally, most eye banks do not collect corneas from donors above 75 years of 
age [11]. Therefore, the donor corneal tissue shortage is likely to further aggravate in 
the future. 
 Innovative treatments for the corneal endothelium dysfunction: Recent 
progress and shortcomings 
Alternative treatments for the corneal endothelial dysfunctional patients, which does 
not rely on the availability of donor tissue, are needed. In the last two decades, several 
research groups have shown that the primary human corneal endothelial cells (HCECs) 
could proliferate in vitro in the presence of soluble cues such as growth factors and on 
proper extracellular matrix proteins for cell adhesion [12]. However, the field of 
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HCECs proliferation still faces challenges in terms of the quality (cell morphology and 
functional markers) of the in vitro grown cells and the slow proliferation rate of HCECs 
[12].  
Nonetheless, the fact that HCECs can be converted into a proliferative phenotype in 
vitro was exciting and it laid the groundwork for the development of tissue engineering 
and regenerative medicine based methods to treat corneal endothelial dysfunction. In 
the last decade, three themes evolved significantly for the treatment of corneal 
endothelium dysfunction, which are: 
(1) The injection of in vitro grown HCECs in the anterior chamber of the eye followed 
by in-situ monolayer reconstruction by the injected cells [13]. 
(2) The use of small molecule drugs such Rock inhibitor drops, to stimulate the 
proliferation and migration of remaining healthy cells of corneal endothelium so that 
they can repair the corneal endothelium [14]. 
(3) The formation of an HCECs monolayer in vitro on an implantable cell carrier thin 
film device followed by the transplantation of tissue engineered monolayer into patient 
eye [15]. 
However, the development of such techniques faces major challenges. Corneal 
dystrophies include the Fuchs endothelial dystrophy (FED), which account for the 
majority of cases of endothelium dysfunction [2]. Studies have revealed that the 
posterior FED corneal surfaces are laden with bump or pillar like micro-structures of 
different dimensions [16]. Such micro-structures, corneal guttata, are resulted from the 
thickening of the Descemet membrane [16]. Therefore, the FED not only causes the 
cell death, but also leaves behind a heavily-altered guttata-laden surface of extracellular 
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matrix. The first two treatment methods, which aim to regenerate the corneal 
endothelial monolayer in situ, seem to overlook this important aspect of the endothelial 
dystrophies. It is yet to be tested if the injected cells or the remaining healthy cells of 
the corneal endothelium would be able to migrate or would be able to form a monolayer 
in the presence of such guttata micro-structures due to the lack of adequate in vitro or 
in vivo model.  
The third approach, which aims to replace the dysfunction endothelium with the in vitro 
cultivated primary HCEC monolayer, requires a strong cell-carrier device due to the 
fragility of the cell monolayer. The minimum key properties required for an ideal cell 
carrier device are the optical transparency, cellular adhesion, mechanical strength, and 
bio-degradation. Previous studies have proposed hydrogel materials such as silk fibroin, 
chitosan, gelatin, and collagen among others which are capable of acting as a cell carrier 
device [15]. However, the proposed materials are passive in nature and primarily act as 
a mechanical support only.  
Signaling cues present on the basement membranes of cells in form of topographical 
features at micro- to nano- length scales are called extracellular topographical cues. 
They are a subset of biophysical cues and they form an important component of cell–
matrix signaling to direct essential cellular processes. They can be readily found in-
vivo and can be fabricated in-vitro (Detailed review in chapter 2). Extracellular 
topographical cues have shown promising results to direct the essential cellular 
processes. Previous studies on other cell types such as neurons, vascular cells, 
osteoblasts, cardiac cells, muscle cells, adult and pluripotent stem cells have shown that 
the patterned extracellular cues may significantly modulate the cellular behavior of the 
cells such as proliferation, morphology and expression of functional markers [17, 18]. 
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While the effect of soluble studies has been studied considerably on the proliferation of 
primary HCECs, little is known on how the extracellular topographical cues will 
modulate the behavior of HCEC cells.    
The extracellular topographical cues will be applicable in testing and enhancing the 
above-mentioned alternative therapies for corneal endothelium dysfunctions. To 
validate the first two treatments for FED, the success of both of these therapies can be 
evaluated in an in vitro module with the presence of a topographical micro-
environment, which mimic the actual diseased-like corneal surface.  In the third 
treatment model, the use of a material gives us an opportunity to modulate the cellular 
behavior by using the topographical cues on the surface of the material. The 
intelligently designed ‘active’ cell carrier materials could not only provide material 
support to counter for the fragility of the monolayer, but could also take part in 
improving the functional properties of in vitro grown cell monolayer. In addition, the 
currently proposed materials lack in-depth biodegradation studies and mechanical 
strength when fabricated into the form of a thin film. 
In summary, this chapter has so far introduced the major causes of corneal 
transplantation (corneal endothelial dystrophies) and the currently available treatment 
in form of donor corneal graft transplantation. Further, an overview of the current 
researches on the in vitro endothelial cell culture and the alternative treatment methods 
was presented. With the unmet needs and challenges of the next generation treatments, 
in-depth studies are lacking in three areas of research in the corneal endothelial cell 
culture and regenerative medicine approaches:  
(i) the effect of extracellular topographical cues on the in vitro primary HCECs 
proliferation and other cellular behaviors,  
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(ii) the effect of pathological topography in form of corneal guttata on the regeneration 
of corneal endothelial monolayer and  
(iii) the lack of intelligent design of the cell carrier monolayer for tissue engineered 
primary HCEC monolayer transplantation. This thesis focuses on understanding the 
role of extracellular topographical cues in improving above-mentioned areas in the field 
of corneal endothelial tissue engineering and regenerative medicine. 
 Thesis hypothesis and aims 
 Hypothesis 
To address the research areas of the unmet needs in corneal endothelial tissue engineering and 
regenerative medicine it is hypothesized that the extracellular topographical cues could play an 
important role in corneal endothelial tissue engineering and regenerative medicine.  
Sub-hypotheses: (i) Periodic extracellular topographical cues could enhance the primary 
HCECs proliferation rate and functional markers, (ii) Corneal guttata-like pathological 
extracellular micro-topography could affect the regeneration of primary HCEC monolayer and 
the effectiveness of regenerative therapies (iii) Micro- and nano-topographical cues on hydrogel 
cell carrier films could modulate the cellular behavior and improve the primary HCEC 
monolayer functions. 
 Specific aims 
The following aims were designed to test the hypotheses. 
Aim 1. Identification of optimal micro/nano features for enhancing the 




Various topographies were fabricated using soft lithography and hot embossing on 
polydimethylsiloxane (PDMS) and polystyrene (PS). These micro- and nano-
extracellular topographies were used to investigate the effect of topographical cues on 
primary HCECs proliferation, cell morphology and functional marker expression. The 
data were analyzed by using proliferation assays, immuno-fluorescence staining and 
quantification of functional markers and cell morphology. 
Aim 2. Development of a micro-fabricated in vitro disease model simulating the 
topographical microenvironment of FED-affected corneal surface to study the cell 
monolayer regeneration 
Firstly, the dimensions of pathological topography (corneal guttata) were quantified by 
using the data from published studies and by analyzing an FED patient’s cornea. 
Microfabrication methods were used to fabricate guttata topography of similar 
dimensions on cell culture substrates. The cellular migration and tight junction protein 
expression was studied on these substrates with guttata-mimicking surface 
topographical environment, which are important parameters for monolayer 
reformation. The effect of guttata dimensions and spacing was quantified on the 
formation of monolayer by measuring the expression of tight-junction protein and cell 
migration by measuring the migration speeds and directionality.  
Aim 3.  Designing of gelatin methacrylate hydrogel film carrier with micro- and 
nano-topographical cues for the formation of functionally-enhanced primary 
HCEC monolayer  
Modification of hydrogel was designed to enhance mechanical strength in form of a 
free-standing membrane which would be suitable for cell-carrier device. Further, a new 
nano-molding method was developed, which was capable of patterning UV-
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crosslinkable hydrogel films with high resolution topographical cues. The bulk 
properties of hydrogels such as mechanical strength, permeability, optical transmittance 
and biodegradation were studied. Next, the primary HCEC monolayer was formed on 
hydrogel membranes and the effect of topography on the expression of functional 
markers and primary HCECs cell morphology was studied. Finally, the implantability 
of the monolayers was characterized by inserting the monolayers in a clinically-used 
corneal endothelial transplantation device and the damage to the cells is characterized.  
 Significance of the thesis 
This PhD thesis is motivated by the clinical need for innovative treatment methods of 
corneal endothelium dysfunction and by the shortcomings in the current field of 
primary HCEC proliferation and the tissue engineering based solutions.  The research 
work done in this PhD project will expand the knowledge by three major contributions. 
Firstly, this work has demonstrated that the extracellular micro- and nano-topographical 
cues could be incorporated in the cell culture materials, which could direct the 
proliferation and functional markers of primary HCECs. As such, the overall 
proliferation rate and the quality of the cultivated HCECs were significantly improved. 
Additionally, the cells could achieve topographic memory and could sustain improved 
cellular functions after passaging. This is of tremendous importance in the applications 
that require primary HCECs, such as research and development of alternative treatment 
methods and drug discovery. Secondly, this work developed a synthetic micro-
fabricated FED disease model, which can now be used to test the applicability of cell 
regenerative therapies for corneal endothelial dysfunction patients. Currently, there is 
no in vitro or in vivo disease model to study FED disease. This work provides a platform 
to study the cell regenerative therapies in a clinically-relevant environment, which 
could propel the future investigations.   
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This thesis designed a new hybrid crosslinked hydrogel material, which could 
demonstrate up to 9-fold improved mechanical strength without the incorporation of 
additional components in the hydrogel system. The extracellular topographic cues 
patterning of hydrogels in the nano-scale range is challenging. This work also 
developed a new method of nano-molding, which enables the fabrication of high 
resolution patterns on hydrogels. The hybrid crosslinked and nano-patterned hydrogel 
films not only provide mechanical support to the primary HCEC monolayer, but also 
improve the functionality of the monolayer by exploiting the interaction of primary 
HCECs with patterned topographies. The improved cellular morphology and functional 
marker expression could result in decreased cell loss after the transplantation of 
monolayer, which has been implicated as one of the major reasons for graft failure in 
patients [19]. The materials used in this thesis is fully biodegradable and biocompatible 
as tested in animal model. Therefore, they can be used as implantable cell carrier deice 
to transplant the tissue-engineered monolayer for human cornel endothelial patients. 
Although the materials used in this study are specifically tailored for corneal tissue 
engineering, the methods used to fabricate the biomaterial films and the nano molding 
methods are generic and applicable to other fields of tissue engineering. Overall, this 
thesis will be an important step to further the ongoing research on finding alternative 
treatments for patients with corneal endothelial dysfunctional and will expand our 
knowledge of the field.  
 Organization of the thesis 
This thesis is composed into 6 chapters. Chapter 1 presents an overview of the thesis 
project and introduces the thesis hypothesis, specific aims and significance of the study. 
Chapter 2 will focus on the literature review pertinent to corneal endothelium function, 
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pathology, biophysical cues and corneal endothelium tissue engineering. Chapter 3 will 
present research study to modulate the primary HCECs proliferation and functional 
characteristics by using appropriate extracellular topographical cues. Chapter 4 will 
present the effect of synthetic micro-fabricated guttata disease model on the cell 
migration and monolayer formation potential. Chapter 5 will present the development 
of gelatin methacrylate hydrogel based thin film carrier with extracellular topographical 
cues for cornel endothelial tissue engineering.  The final chapter of this thesis, chapter 
6, will summarize the major research findings and their impact on the field of corneal 
endothelial tissue engineering. It will also outline future work for the progress of 





Chapter 2. Literature Review 
The cornea is one of the most transplanted tissues. The majority of the cornea 
transplants are caused by corneal endothelial dysfunction, which is also the major cause 
of corneal blindness. Due to donor cornea shortage, we need to develop new methods 
for the treatment of endothelial dysfunction patients. In this chapter, I shall introduce 
anatomy of cornea, function and pathology of corneal endothelium and the currently 
available treatments. Further, the progress in the field of corneal endothelial tissue 
engineering spanning over past two decades will be discussed and research gaps in the 
previous work will be focused. An introduction to the extracellular topographical cue 
will be presented and their importance in context of corneal endothelial tissue 
engineering will be highlighted. Subsequently, the fabrication methods of extracellular 
topographical cues will be introduced. Finally, a brief introduction of the hydrogels will 
be presented along with its possible uses in corneal endothelial tissue engineering as 
cell carrier membrane.  
 Anatomy and physiology of the cornea 
The cornea is the transparent, curved structure that covers the front of the eye. It 
comprises of five distinct layers, which are epithelium, Bowman’s layer, stroma, 
Descemet’s membrane, and endothelium from the anterior to posterior cornea 
respectively; each layer performs a specific function to maintain a healthy cornea 
(Figure 2.1) [20]. Overall, the cornea is approximately 520 µm thick where the bulk of 
the cornea is stromal tissue made of aligned collagen fibers stroma that is approximately 
450 µm thick. 
The corneal tissue is a delicate example of natural tissue engineering.  The requirement 
for a living, optically clear structure on the surface of the eye was resolved by packing 
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cells and collagen in an ordered lamellar arrangement without the presence of blood 
vessels. The critical spacing of collagen fibrils and the crystalline arrangement imparts 
the optical transparency to the cornea [7]. Any accumulation of fluid in the cornea 
would disturb this spacing and reduce the transparency. 
 
 Corneal endothelium 
 Function of corneal endothelium 
Corneal endothelium comprises of a monolayer of endothelial cells, which are derived 
from the neural crest [21]. The corneal endothelium covers the posterior surface of the 
cornea where the cells are well-arranged in a mosaic pattern. Of the five corneal layers, 
the corneal endothelium performs two crucial physiological functions. The first 
function is to provide nutrients from aqueous humor to the rest of the cornea to maintain 
corneal health. The second function of the corneal endothelium is to  maintain the 
corneal transparency by keeping the stroma in a dehydrated state by pumping excess 
fluids out of stroma via the dynamic balance between ionic pump and barrier functions 
[22].  
Figure 2.1 The anatomical layers of the cornea. 
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Corneal endothelial cells contain several junctions such as macula occludens, tight 
junctions, macula adherens and gap junctions [23]. The corneal endothelium produces 
a state of relative stromal dehydration, which maintains cornea transparent. The corneal 
epithelial cell layer forms a barrier to reduce the flow of tear film water into the stroma. 
However, a continuous tight junction barrier between endothelial cells is absent, which 
leaves a leaky barrier for aqueous humor from the anterior chamber. Therefore, the 
corneal endothelial cells actively transport ions by using Na+/K+-ATPase pumps from 
cornea towards anterior chamber, which helps to maintain a dynamic equilibrium 
between the tendency of the stroma to swell and the deturgescence [24]. 
Corneal endothelial cell density is inversely proportional to age [25]. The cell density 
of corneal endothelium of 2-month-old infants has been reported to be a mean value of 
4252 cells/mm2 [26]. The cell density drops to approximately 3500 cells/mm2 by the 
age of 5. The drop in cell density is largely associated with the corneal growth and 
development [27]. Overall, the cells density drops at the rate of 0.3-0.6% per year 
throughout adulthood [28]. The corneal endothelial cells do not proliferate in vivo to 
account for the loss of cells [8]. Therefore, decrease in cell density is critical as it leads 
towards a dysfunctional corneal endothelium. The pathology of the endothelium will 
be discussed in detail later.  
The corneal endothelium secretes collagen, which forms a basement membrane called 
Descemet's membrane. The thickness of the Descemet's membrane is approximately 
3 µm at the time of birth and it consists of banded collagen with a periodicity of about 
110 nm [29]. Throughout adulthood, corneal endothelial cells secrete Descemet's 
membrane continually. However, the collagen contributed after birth is not in a banded 
form [7]. The average Descemet's membrane could be as thick as 13 µm by the age of 
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70 including the original 3 µm of anterior banded (foetal) Descemet's membrane and 
an additional 10 µm of posterior non-banded Descemet's membrane [7]. Studies have 
shown that the collagen IV is the main type of collagen produced by normal corneal 
endothelial cells. Collagen IV is also the major component of Descemet’s membrane 
[30].  
 Pathology of corneal endothelium 
To perform its functions and maintain corneal transparency, corneal endothelium must 
have endothelial cell density of 400-1000 cells/mm2 [31-34]. Despite the gradual 0.3-
0.6% per year decrease in the cell density in normal eyes, the corneal endothelium is 
normally able to maintain its function throughout the adulthood. This indicates that the 
HCECs have large adaptive capacity of the endothelial pump, which could 
physiologically overcome for the decrease in cell density and could maintain the cornea 
healthy. Unfortunately, the cell loss from the corneal endothelium could be significantly 
accelerated in some cases due to several conditions such as refractive surgery, 
accidental or surgical trauma, stress induced by diseases such as diabetes or glaucoma, 
previously performed endothelial or penetrating keratoplasty or endothelial 
dystrophies. If the density of corneal endothelial cells drops below the minimum 
required functioning CE cell density, the dynamic balance between the barrier and 
pump functions is lost, which leads to uncontrolled fluid entry into the cornea [7]. The 
uncontrolled fluid in the cornea disrupts the delicate organization of collagen fibers, 
which results in corneal edema, bullous keratopathy, and loss of visual acuity. Corneal 
blindness, the condition where the retina is functioning but the cornea becomes opaque, 




 Fuchs Endothelial Dystrophy (FED) 
Of particular note among the corneal dystrophies is the Fuchs Endothelial Dystrophy 
(FED), which exclusively affects the corneal endothelial cells. Fuchs endothelial 
dystrophy is a degenerative disorder. It is the primary disease of the corneal 
endothelium, which, if left untreated, results in corneal blindness [16, 35]. FED is an 
age-related disorder, which usually shows clinical signs during the fifth or sixth decade 
of life. A diagnostic clinical sign and hallmark of FED, is the presence of discrete 
abnormal collagen excrescences, called corneal guttata found on the posterior surface 
of the cornea (Figure 2.2) [16, 36, 37]. In FED, the guttata are typically more confluent 
and more centrally located than the guttata of normal aging, which are predominantly 
present at the peripheral cornea. The guttata appear centrally on the Descemet’s 
membrane (DM), at the onset of the disease. As the guttata become larger, they 
attenuate the cell cytoplasm on the apical side of the endothelium, which leads to cell 
death and progressive deterioration of endothelial function and subsequent corneal 
blindness [1]. Previous studies using transmission electron microscopy (TEM), have 
reported that guttata lesions appear as convex micro-dome like or micro-pillar like 
structures with different diameters, heights and spacing. These factors all depend on the 
stage to which the FED had progressed [1]. 
 
Figure 2.2 (a) The schematic diagram of the development of guttata micro-structures 




 Current treatments for corneal endothelial dysfunctions 
Currently the only treatment for corneal blindness caused by endothelium dysfunction 
is corneal transplantation. No pharmaceutically treatment can promote wound healing 
or regeneration of the corneal endothelium. The symptoms of endothelium dysfunction 
can be managed to a certain extent by treatments such as the use of dehydrating agents, 
lowering the intraocular pressure and topical nonsteroidal anti-inflammatory drugs. 
However, the ultimate treatment option is a corneal transplantation. Therefore, patients 
with endothelium dysfunction have largely relied on cadaveric donor corneal 
transplants. The first surgical technique for corneal endothelial replacement for over 80 
years has been a full-thickness penetrating keratoplasty (PK), where the whole cornea 
graft is trephined and replaced with a donor corneal tissue. Generally, PK is considered 
to be a successful surgical method for FED patients and it is the predominant technique 
of corneal transplantation [38]. However, it results in several post-surgical 
complications. The vertical wound in corneal stroma during PK leads to delayed wound 
healing, which not only creates unpredictable refractive error, but also puts the patient 
in substantial risk of late incision rupture and loss of the eye [39, 40]. Another major 
issue with PK is the poor long-term tissue survival, which is mainly due to the continual 
cell loss of donor corneal endothelial cells leading to graft failure. The cell loss after 
PK follows a bi-exponential decay [41]. This earlier observation was also substantiated 
by the Cornea Donor study group and Bertelmann et al., where both studies showed a 
70% corneal endothelial cell loss in the 5 years following PK [42, 43]. According to 
the Australian Corneal Graft Registry (ACGR), the graft survival rate following PK 
drops from 90 % at 1-year post surgery to 59 %  at 10-years [44]. 
The above challenges in PK as well as the development of modern micro-surgical tools 
and microkeratome devices led to the development of new surgical procedures for FED 
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patients in the form of endothelia keratoplasty (EK) [9], which is gradually replacing 
PK in recent years as reported by Eye Banking association of America [45]. As opposed 
to PK, where the full thickness cornea is replaced with donor tissue, EK aims to achieve 
targeted lamellar replacement in corneal transplantation surgery either by only 
replacing the damaged corneal endothelium or the corneal endothelium along with 
some stromal tissue (Figure 2.3). The donor tissue is inserted by using a small 4-5 mm 
corneoscleral or limbal incision. There are two predominant forms of EK procedures as 
follows. 
Descemet stripping endothelial keratoplasty (DSEK): DSEK was first introduced by 
Price et al. in 2005 [46]. DSEK is an endothelial keratoplasty procedure in which the 
partial corneal tissue of 150–200 μm in thickness (endothelium + part of stroma) is 
inserted into the patient [47]. The patient’s endothelium and Descemet membrane are 
removed and replaced with the donor tissue. The donor tissue is generally prepared by 
using a microkeratome or a femtosecond laser. Another variant of DSEK is called 
Descemet stripping automated endothelial keratoplasty (DSAEK) where the donor 
tissue is prepared by using automated tools for better consistency. DSEK or DASEK 
have been shown to perform better as compared to PK in terms of visual recovery, 
refractive outcomes, and healing due to absence of deep wound and sutures [48]. 
However, DSEK is similar to PK in terms of long term graft survival and endothelial 
cell loss [48]. DSEK also comes with its own set of challenges. The most common 
complications from DSEK include posterior tissue dislocations due to delicate method 
of tissue insertion. 
Descemet membrane endothelial keratoplasty (DMEK): The second method of 
endothelial keratoplasty is called the Descemet membrane endothelial keratoplasty, 
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which was first demonstrated by Melles et al. in 2006 [49]. DMEK is the transplantation 
of Descemet membrane and corneal endothelium (without stroma). Sophisticated 
methods, such as the use of femtosecond laser, are increasingly being used to produce 
donor tissue for DMEK [50]. DMEK aims at pursuing the ideal goal of only replacing 
the damaged corneal endothelium without affecting the remaining healthy layers of 
patient cornea such as stroma and epithelium. DMEK has been shown to present better 
outcomes as compared to PK and DSEK. DMEK is a more anatomically accurate 
procedure that only replaces DM and endothelium [51], which could lead to a rapid 
visual recovery with minimal refractive change.[52-56] However, the surgical 
technique requires rigorous training of the surgeons to achieve consistent results. As 
one could expect, the major challenge for DMEK is the preparation of donor tissue [57]. 
Another issue is the fragility of the donor tissue and its susceptibility to break during 
insertion procedure. The detachment of the graft following surgery is another challenge 
associated with DMEK [58].  
Figure 2.3 The section of donor cornea tissue prepared to replace the patient’s 
defective corneal endothelium in different forms of keratoplasty procedure. 
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 Shortage of donor corneas and growing demand for corneal transplants 
Worldwide, there is a global shortage of donor corneas for transplantation [59]. 
Although more than 100,000 corneal transplants have been performed worldwide, the 
global shortage of available donor cornea remains an issue. In USA alone, over 76,000 
corneal transplants were performed for corneal endothelium dysfunction patients [2]. 
According to the Eye Bank Association of America Report published in 2014, over 
70% of the donor tissue comes from patients of age 50 years or older, and that as high 
as 30% of the tissues are rejected for transplantation due to strict criteria for tissue 
acceptability such as the endothelial cell count and cell morphology. The shortage of 
donor tissue is further worsened by potential cultural, logistical and technical 
difficulties [60], and can render transplant-grade donor tissue unusable due to long post-
mortem storage time or damage that may have occurred during shipping and handling 
of the fragile donor corneas [12, 61]. 
The majority of corneal transplants performed in the developed world are for diseases 
affecting the corneal endothelium, and the leading indication for endothelial failure is 
FED disease [2]. In the USA alone, 4% of the population over the age of 40 is believed 
to have a compromised corneal endothelium due to FED. As the FED is a degenerative 
disorder, it is likely to affect even larger segment of the population due to increasing 
life expectancy and a rapidly ageing population [62].  
The donor cornea shortage has expedited the efforts to find alternative treatments for 
corneal endothelial dysfunction patients. Tissue engineering and regenerative medicine 
techniques are potential methods that can provide solution to corneal endothelial 
dysfunction. However, such methods largely depend on the availability of a large 
supply of HCECs. A continuous supply of HCECs can be used for the research and 
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development purpose of tissue engineering methods to treat for corneal endothelium 
dysfunction patients. The HCECs are not known to proliferate in vivo. The next section 
provides an overview of the efforts to proliferate HCECs in vitro for the purpose of 
finding alternative treatment methods. 
 Efforts to induce proliferation of human corneal endothelial 
cells 
Human corneal endothelial cells (HCECs) are not known to proliferate in vivo to 
account for the loss of cells [8]. Joyce et al. showed that HCECs are arrested in the G1-
phase of the cell cycle in vivo, where contact-dependent inhibition plays a major role in 
the induction of cell-cycle arrest [63].  The HCECs have limited capacity to repair the 
HCEC monolayer in vivo due to their inability to proliferate. Hence, cell enlargement 
and migration to some extent are the major means of monolayer repair [64]. However, 
the cell enlargement results in the deviation of cell morphology from a hexagonal cell 
to enlarged and spindle cell shapes, which compromises the function of cells. 
Furthermore, there is a limit to this type of wound healing. After the cells loss has 
proceeded significantly, the remaining cells are not able to heal the cell monolayer, 
which results in the bare posterior cornea and loss of function.  
The HCECs are arrested at different points within G1-phase of the cell cycle and 
therefore do not proliferate in vivo [65]. The cell cycle is an orderly sequence of events 
divided into phases, namely G1, S, G2, and M phase. The stage of the cell cycle can be 
determined by using the temporal order of cyclin synthesis. Cyclins D and E are 
observed at the early and late G1-phase. However, cyclin A is present during late G1/S-
phase. Joyce et al. demonstrated that HCECs express proteins which are associated with 
cell cycle such as cyclin A, D and E, but lack the expression of Ki67, which is the 
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marker for active cell proliferation [66]. Cyclin D and E are contained in the cytoplasm 
of HCECs while cyclin A is localized in the nucleus. The authors speculated that the 
cytoplasmic expression of cyclin D and E render the HCEC to be prepared for external 
stimuli, which will translocate cyclin D and E back into the nucleus (nuclear-
cytoplasmic translocation). This could allow the proliferation of HCECs in the presence 
of appropriate stimuli. The methods to induce proliferation in HCECs can be broadly 
categorized in two categories as follows.  
 Proliferation of primary HCECs in vitro by using immortalization 
Several research groups have tried to transfect and immortalize HCECs derived from 
donor corneas to increase the cell proliferation capacity and population doublings. 
Wilson et al. first demonstrated that the HCECs can be successfully transfected with 
the SV40 large T antigen, which could extend the proliferative capacity [67]. The 
transfected cells continued to proliferate to 38 passages with more than 120 population 
doublings in culture as compared to control cells with merely 8 population doublings 
before achieving cell senescence. The same group further demonstrated that the onco-
proteins E6 and E7 could better regulate the proliferation of corneal endothelial cells 
by diminishing the activity of retinoblastoma (RB) and p53 tumor suppressing proteins 
[68]. Valtink et al. developed a stable corneal endothelial cell line (B4G12) by 
using immortalized corneal endothelial cells cultured in serum-free culture medium 
and repeated cloning [30]. The generation of the B4G12 cell line helped to 
circumvent the issue of heterogeneous cell populations in transformed cells derived 
from whole corneal endothelium. 
Deriving primary cells from donor corneas is challenging, time consuming as well as 
cost intensive. Establishing a cell line provides several benefits. Corneal endothelial 
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cell lines can provide a model system with easy accessibility to cells for studies in 
order to understand the underlying cellular mechanisms.  Cell lines can provide 
sufficient numbers of homogenous cells for multiple experiments, which is difficult 
to obtain from donor corneas due to the difference in cell proliferation potential 
obtained from central versus the peripheral region of endothelium as will be 
discussed later. However, studies on human corneal endothelial cells lines, even 
though being useful for research [69, 70], provide little translatability and benefits with 
respect to primary HCECs [12] in terms of their applications for endothelial 
dysfunctions patients. Immortalized HCECs and primary HCECs are different in their 
cellular behaviors and gene expression [71]. Cell lines remain a valuable source in the 
absence of good primary cell culturing techniques, but should be used by keeping their 
limitations in mind.  The indefinite growth potential of cell lines could also result in 
multi-layering of the cells on top of each other. If used for FED patients to regenerate 
the corneal endothelium, the proliferation of immortalized cells due to absence of cell-
cell contact inhibition could interfere with the aqueous outflow pathway by covering 
the trabecular meshwork of the eye. 
 Proliferation of primary HCECs in vitro without immortalization 
 The HCECs are maintained in G1-phase primarily by 3 different mechanisms, 
which are cell-cell contact dependent inhibition, absence of growth factors, and TGF-
β2 suppression of S-phase entry [72]. Together, they contribute to maintain HCECs in 
a non-proliferative state in aqueous humor environment [65, 73, 74]. It has been 
reported that cell division does not appear in vivo, even if the cell-cell contacts are 
disrupted following wounding, which may suggest the lack of sufficient paracrine or 
autocrine growth factor stimulation to induce cells to divide [32]. Cellular senescence 
is the loss of cell’s ability to undergo mitotic division. Replicative senescence is a result 
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of successive shortening of telomeres, which occurs as a result of DNA replication. 
Once telomeres have eroded to a threshold value, the cellular senesce is activated, 
which inhibits cells from further dividing [75]. Corneal endothelial cells from younger 
as well as older donor corneas have been shown to have telomere restriction fragment 
(TRF) length of 12.2 kb, which is sufficient to support multiple rounds of cell division 
if proper cellular proliferation stimuli is provided [76].  Ex vivo studies of HCECs using 
EDTA showed that the HCECs retain the capacity to proliferate in vitro [77].  
 Isolation of HCECs and effect of media composition on HCECs 
proliferation  
The first part of establishing the in vitro culture is the harvesting of cells from the donor 
corneas. Protocols to isolate and cultivate primary HCECs are continuously evolving. 
Isolation of HCECs from donor cornea has initially moved from explant culture method 
to scraping method. Currently, the isolation of HCECs from posterior cornea uses a 
two-step peel-and-digest technique by which the Descemet’s membrane and the corneal 
endothelium are first peeled off from the cornea and then subjected to enzymatic 
digestion, which releases the HCECs from the Descemet’s membrane [78]. 
The efforts to proliferate HCECs in vitro largely take advantage of the existing hidden 
proliferative capacity of HCECs by using the release of cell-cell contacts, providing 
growth factor driven stimulatory environment and/or by overcoming the G1-phase 
inhibition by lowering the level of cyclin-dependent kinase inhibitors [79]. Engelmann 
et al. presented one of the earliest optimization of in vitro culture systems where they 
studied 25 different nutrient media, different sera, 6 mitogens, and numerous substrates 
[80]. In the later years, several protocols have been used by different groups to induce 
cellular proliferation in HCECs. However, the protocols involved in the culture of 
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primary HCECs varies greatly between laboratories in terms of extracellular matrix 
(ECM) coatings and culture media used in HCECs culture and propagation. Previous 
research studies on the proliferation of corneal endothelial cells have used ECM derived 
for bovine corneal endothelial cells [81], collagen type I and type IV [82, 83], a mixture 
of fibronectin and collagen [84, 85], laminin and chondroitin sulphate [85-87] and 
commercially available FNC coatings mix [85] with varying degree of success. As far 
the culture media is concerned, several types of complex culture media exists, which 
were developed from different basal media such as Minimum Essential Medium 
(MEM), Dulbecco's Modified Eagle Medium (DMEM), Medium 199, Ham’s F12 and 
Medium 199, endothelial growth medium (EGM-2) and supplements such as basic 
fibroblast growth factor (bFGF), epidermal growth factor (EGF), glutamine, minimum 
essential amino acids, nonessential amino acids, Insulin-transferrin-selenium, foetal 
bovine serum, ascorbic acid and antibiotics etc [81, 88-93]. However, no standard 
practice for the efficient expansion of HCECs exists and many groups have found it 
challenging to establish consistent long-term propagation of HCECs [32, 94]. Despite 
all these efforts to proliferate HCECs, the methods are still not reliable to generate 
sufficient HCECs in an efficient manner for the purpose of tissue-engineered corneal 
endothelium monolayer graft fabrication. This is due to the following two major 
reasons: The proliferation rate is still inherently slower and the HCEC cultures tend to 
become heterogeneous, by showing a fibroblastic morphology over each passage [32, 
33, 94]. In addition, the HCECs tend to lose characteristic Na+/K+–ATPase pump and 
Zona Occludens-1 (ZO-1) markers expression [95]. 
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 Effect of donor age and the location of cells in endothelium on HCECs 
proliferation 
Studies have also shown that the proliferation of HCECs is highly dependent on 
donor age [96]. The cells harvested from young donor corneas demonstrated higher 
capacity to proliferate in vitro in the presence of growth stimulating agents as compared 
to the cells harvested from older donors [96]. Log phase of HCECs growth indicate that 
the average doubling time for HCECs cultured from older donors was 90.25 hours as 
compared to 46.25 hours for cells cultured from young donors [96]. Beta-galactosidase 
(SA-β-Gal), which is a marker of cell senescence, was detected in older donor cells, 
however, it was not detected in cells from younger donors [97]. However, recent studies 
have also shown that the G1-phase inhibition in older donor HCECs can be overcome 
to some extent by siRNA (small interfering RNA)-mediated down-regulation of the 
expression of cyclin-dependent kinase inhibitors, p21Cip1 (p21 cyclin-dependent 
kinase-interacting protein 1) and p16INK4a (p16 cyclin-dependent kinase inhibitor 1A) 
[98]. Besides donor age, location of cells within the corneal endothelium also affects 
the proliferative capacity of HCECs. The HCECs cultured from central region of 
endothelium had severely limited proliferative capacity, while the cells from the 
peripheral rim exhibited higher proliferative capacity [97, 99]. Interestingly, the central 
region of endothelium tends to have larger number of senescent cells in older donors as 
compared to younger donors [97]. Another important consideration is that some of the 
studies on the cultivation of corneal endothelial cells have been performed on non-
human primary corneal endothelial cells, which may not extrapolate to the HCECs in 
terms of growth potential, cell attachment and morphometric characteristics [100, 101]. 
In the next section, an overview of the recent efforts to develop next generation 
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treatments for corneal endothelium dysfunctions is presented along with the challenges 
involved. 
 Innovative treatments for corneal endothelium dysfunction 
Due to donor cornea shortage, corneal endothelial tissue engineering and regenerative 
medicine could potentially be used to prepare corneal tissues for patients in need of 
cornea transplant. There are three approaches to apply corneal endothelial tissue 
engineering for treat endothelium dysfunctions patients. The following sub-sections 
will provide an overview of the three different approaches along with the research 
progress and limitations. 
 Cell injection therapy 
In this approach, cultured corneal endothelial cells are injected directly into the anterior 
chamber of patients to form a monolayer in-situ [13, 102]. The attachment of cells 
following injection has been shown to be facilitated by the addition of the Rho-
associated kinase (ROCK) inhibitor, Y-27632 [103], the use of magnetic nanoparticles 
[104, 105] and posturing face down postoperatively [106]. Experiments in monkey and 
rabbit models have demonstrated the recovery of corneal transparency with high CEC 
density after cell injection therapy, attesting to the potential of this approach in restoring 
function to an otherwise compromised endothelium [103]. 
Cell injection therapy comes with several advantages.  It involves less surgical 
complications. Patient recovery time is shorter as full incision of the cornea is not 
required. The costs involved in cell therapy approach are also minimized as no cell 
carrier (to be discussed in detail in section 2.5.3) is needed. Overall, the cell injection 
therapy is a creative and conceptually appealing approach for corneal patients. 
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Current published studies on the cell injection therapy have been performed in animal 
models by physically removing the corneal endothelial cells with a spatula and retaining 
an intact Descemet’s membrane [13, 102-104]. As such, the injected cells have been 
shown to attach, spread, migrate and form a monolayer on a smooth continuous planar 
DM, which does not have corneal guttata and hence, does not represent the diseased 
DM surface. The spatula is able to remove diseased corneal endothelial cells but is 
unable to remove corneal guttata. Micro-structural guttata may be able to exert 
topographical influence on the injected HCECs, and it is unclear if the injected cells 
can establish a functional monolayer on DM that are populated with guttata of different 
dimensions as seen on patient cornea suffering from FED.  
In summary, cell therapy is a low cost, simple treatment solution with short patient 
recovery times. However, the feasibility of cell injection therapy still needs to be 
researched for diseased corneal surfaces. 
 In-situ cell monolayer reconstruction by using pharmacotherapy 
The second cell regenerative therapy involves the use of a small molecule-based 
pharmacotherapy, which can regenerate the damaged corneal endothelial monolayer in 
vivo by stimulation of the remaining native cells [107-111]. In a study by Okumura et 
al., topical treatment with the ROCK inhibitor has been shown to improve cellular 
migration and proliferation, as well as the cellular morphology of corneal endothelial 
cells for faster wound closure in vitro and in animal models [108], possibly via the 
activation of cyclin D and p27 via PI 3-kinase signaling [112]. Paparelli et al. also 
demonstrated the positive effect of ROCK inhibitor on the migration of corneal 
endothelial cells, but they showed that the ROCK inhibitor does not influence the 
proliferation of cells, which contradicts the earlier findings by Okumura et al. [109]. 
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Pharmacotherapy is extremely simple as the rock inhibitor can be applied topically to 
convert the endothelial tissue into a phenotype that can regenerate the monolayer. 
However, this technique also suffers with the same limitations, which were discussed 
in previous section. The studies of cell migration have only been conducted on flat 
substrates, which do not represent the topographical environment of the patient cornea. 
It is not yet known if the injected cells could form a monolayer in a topographical micro-
environment created by the presence of guttata as seen in clinical cases of FED. 
Besides, cell migration may not be enough to ‘stitch’ the HCEC monolayer together. 
Cells will also need to proliferate to cover for the loss of cells and decrease in cell 
density as a result of FED disease. However, the effect of ROCK inhibitor on cell 
proliferation is still debatable [109]. 
 Transplantation of tissue engineered corneal endothelial monolayer 
Another treatment option for endothelial dysfunctions is the regeneration of a cell 
monolayer in vitro followed by transplantation of the monolayer. The transplantation 
of the monolayer could be performed similar to endothelial keratoplasty procedure 
where the only difference is that the tissue to be transplanted is tissue-engineered 
instead of taken from donor cornea. Based on how the transplantation is performed, this 
strategy can be further divided into two categories.  
 Carrier-free approach for transplantation 
The first strategy to generate a free standing HCEC monolayer is based upon the use of 
thermo-responsive surfaces. Poly(N-isopropylacrylamide) (PNIPAAm) is a well-
known thermo-sensitive material, which shifts from a hydrophobic state to hydrophilic 
state at 32ºC upon lowering the temperature [113]. Researchers have used this property 
of PNIPAAm to generate a free standing HCEC monolayer. Several studies have 
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demonstrated that the HCECs can be successfully expanded on PNIPAAm-grafted 
surface and once the cells achieve confluency, they can be detached in the form of an 
intact monolayer [114-117]. This technique is promising as it can generate an intact 
HCEC monolayer. However, the technique is inherently imperfect as the cell sheet 
produced in this fashion is very fragile and difficult to handle during transplantation, 
which is similar to the challenge faced by endothelial keratoplasty procedures [12, 15]. 
Due to the fragility of the monolayer, the carrier-free approach has garnered less 
attention in the later years for corneal tissue engineering. 
 Carrier-based approach for cell monolayer transplantation 
The second strategy is the use of cell-carrier device in the form of a thin membrane that 
can support adhesion and proliferation of HCECs as well as the formation of a confluent 
corneal endothelium monolayer and the transplantation of the monolayer in vivo. This 
strategy has the potential to realize the goal of tissue-engineered corneal endothelial 
grafts to treat FED. The design of material that can be used as a cell-carrier device is 
crucial for the successful implementation of this technique. Ideally, the implantable 
film should be biocompatible and support HCECs adhesion, be optically transparent, 
permit diffusion of aqueous humor nutrient molecules and should be mechanically 
strong for easy handling. It should also be foldable to suit the surgical procedure and 
preferably demonstrate slow biodegradation after implantation. Based on these criteria, 
several materials have been used in literature as a cell-carrier device (Table 2.1). Hsiue 
et al. first reported a study on carrier-based approach by using a gelatin material film 
as a cell transporter [118]. Biodegradability of the gelatin film was also studied and 
found to be suitable for this application. However, the films were thicker than the 
normal thickness required for cornea transplant. The study also lacked the 
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characterization of mechanical properties of the gelatin films. Subsequently, some other 
studies also showed the use of gelatin films with different crosslinking methods as a 
cell carrier for HCEC monolayer transplantation [117, 119]. Chitosan is another 
material that has been researched as a cell-carrier due to its ease of crosslinking and 
biocompatibility [120, 121]. However, chitosan also lacks the mechanical strength in 
hydrated thin film form, which is needed for cell carrier films. Moreover, the studies 
also did not examine the biodegradability of chitosan-based films. In a study by Madden 
et al, silk ﬁbroin coated with collagen protein was demonstrated to support the 
formation of corneal endothelium monolayer [122].  Lastly, collagen type I was also 
reported as a potential material for cell monolayer translation [123]. In summary, 
several materials have been tested for the formation of an HCEC monolayer for 
transplantation. However, there is a lack of characterization in terms of the design rules 
that are necessary for the cell-carrier material such as nutrient transport rates through 
the cell-carrier, biodegradation kinetics in relevant media, and cell phenotype analysis. 
Additionally, the currently used cell-carriers are “passive” as they act merely as a 
transfer support for transplantation of monolayer and do not participate in enhancing 
the functional markers and phenotype of the regenerated monolayer. Almost 1 in 4 
corneal transplants fail at 5-10 years after transplantation [124], and when they fail it is 
usually due to loss of the donor HCECs from the transplanted HCEC monolayer [19]. 
Studies show that 30% HCECs are lost within the ﬁrst 6 months of transplantation [125, 
126]. It necessitates that, to improve the long term survival of the graft, the implantable 
film should not only act as a transporter, but should also enhance the cell functions and 






Material Biodegradable Thickness Cells used Ref 
Gelatin NA 50 µm HCECs [119] 
Gelatin yes ~700 µm Non-human [127] 
Gelatin Yes 700-800 µm HCECs [117] 
Collagen I NA 40-50 µm HCECs [128] 
Collagen I NA 74 µm B4G12; HCECs [123] 
chitosan-based Yes NA HCECs [121] 
Chitosan-PEG Yes <1 µm Non-human [120] 
silk ﬁbroin Yes 5 µm B4G12 [122] 
Hydrogel Lens NA 100 µm HCECs [129] 
Table 2.1 hydrogel films used as a cell carrier device for the transplantation of a 
corneal endothelial monolayer 
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From section 2.5, it can be seen that the alternative treatment of corneal dysfunction 
can be based on either cell regenerative therapies or in vitro monolayer based 
approaches. While both options have merits and could potentially solve the issue of 
cornea shortage for patients, there exist some limitations, which need to be studied. For 
the cell therapy approach, there is lack of data on the formation of a cell monolayer in 
a topographical environment similar to FED patient cornea.  For in vitro grown 
monolayer transplantation approach, there is a lack of a single material that combines 
enhanced strength, nutrient permeability, and bioactivity with slow degradation rates.  
 Extracellular matrix topographical cues 
This section provides an overview of the extracellular matrix (ECM) topographical cues 
and their application to control cellular function. Topographical cues will also be 
discussed in the context of corneal cells.  
One of the key elements in tissue engineering and regenerative medicine is to 
understand the interaction of cells with the substrates on which they adhere and grow 
and use this understanding to manipulate cellular functions. Several aspects of the 
substrate material design, collectively termed as biophysical cues, could affect cellular 
function. Biophysical cues include the stiffness of substrate material, viscoelasticity and 
surface topography. Cells are extraordinary sensors, which can detect and respond to 
numerous extracellular signals. In vivo, the biophysical cues are provided by the 
extracellular matrix on which cells reside [130]. The extracellular matrix is composed 
of diverse proteins, glycosaminoglycans and polysaccharides, which self-assemble into 
nano and micro fibrils and fibers of hierarchical order [131]. Various native tissues such 
as bone, cartilage, nerves, bladder, or blood vessels, consist of ECMs with micro- and 
nanoscale topographical cues. In depth understanding of cellular response to various 
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configurations of surface topographical features is a critical component of biomaterial 
design. Over the past decade numerous studies have been published to bring forth the 
importance of topographical cues to control cellular adhesion, proliferation, 
morphology and alignment, and differentiation of stem cells into cells belonging to all 
different types of tissues [132-135].  
The human cornea has three different extracellular matrixes, namely the epithelial 
basement membrane, the stromal extracellular matrix and the basement membrane of 
corneal endothelium called the Descemet membrane. The corneal epithelial and 
endothelial cells reside on top of their respective basement membranes. However, the 
corneal stromal cells (keratocytes) reside inside the stroma, which is a layered 
extracellular matrix of highly organized and aligned collagen fibers. Each of the three 
extracellular matrices present a different kind of topographical cue to the cells. Corneal 
basement membranes have been studied by Abrams et al. for their topographical 
features by using scanning electron micrography and it was determined that the surface 
features of the basement membrane and Descemet membrane are in the nanometer size 
range and have periodic surface topography [136]. Both of these matrices contain 
isotropic topography in the form of pores. Isotropic topography is surface topographic 
patterns that are independent of xy direction such as pillars or wells as opposed to 
anisotropic topography that is different in different xy directions such as gratings. The 
endothelial surface of Descemet’s membrane of corneal endothelium contain finer 
features and are less porous compared to the epithelial basement membrane. On the 
other hand, stroma is a network of aligned fibers which can be taken as an example of 
anisotropic topography cues. 
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The effects of topographical cues on corneal epithelial cells have been studied 
extensively in terms of cell migration and tissue growth [137-141].  In a study by Diehl 
et al, corneal epithelial cells frequently aligned along the surface and migrated almost 
exclusively along grooves and ridges of all pitches in the 400 to 4000 nm range, which 
could potentially be important findings for the maintenance of corneal homeostasis and 
wound healing [142]. In another study, the rate of corneal epithelial wound healing was 
shown to improve significantly on hydrogel surfaces patterned with topographical 
features [143]. Surface texture also modulated the adhesion and growth of epithelial 
cells on implanted membranes where the adhesion was improved on a surface with 
surface roughness of 150 nm root mean square (RMS). However, the tissue growth and 
cell adhesion were disrupted when the RMS values went up to 300 nm. The cellular 
functions of corneal keratocytes have also been demonstrated to be modulated by nano 
and microscale surface topography [144-146], although to a lesser extent. 
While the role of soluble biochemical cues has been extensively studied to improve the 
proliferation of corneal endothelial cells, there is very limited literature on the use of 
ECM topographical cues in corneal tissue engineering in the literature. For example, 
primary and immortalized HCECs were aligned along the direction of collagen fibers 
when seeded on aligned collagen I fibrils [147]. In vivo, HCECs are hexagonal and 
polygonal in shape. Thus, the elongation of HCECs may not be a desired feature to 
induce in HCECs. Teo et al. showed that the bovine corneal endothelial cells could 
form improved monolayer on micro- and nano-scaled pillars and wells, in terms of 
microvilli density, lower coefficient of variation of cell area, as well as enhanced 
expression of Na+/K+-ATPase [148]. However, animal corneal cells behave differently 
compared to primary HCECs. Thus these results may not translate when the primary 
HCECs are used. Besides, the tissue engineering or regenerative therapies for corneal 
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endothelium demands for high quality human cells for treatment of patients. Therefore, 
the studies should be conducted using human cells, which can be cultivated to produce 
cells for therapies and treatments. There is greater need to explore surface topographical 
cues to induce the proliferation of corneal endothelial cells. The topographical cues 
could also be fabricated on cell carrier devices. Such devices with the help of proper 
topography could lead to the formation of functionally improved HCEC monolayers 
for transplantation. The following section will provide a brief introduction of the micro- 
and nano-fabrication techniques which have been employed to fabricate topographical 
cues to on various materials including hydrogels to study cell-substrate interaction. 
 Fabrication of extracellular matrix topographical cues  
 Fabrication of master molds 
The most common methods to fabricate patterned master molds are photolithography, 
electroforming and electron beam lithography [149]. Nanoimprint lithography in 
conjunction with photolithographic techniques could also be used to fabricate master 
molds. The main patterning technique in microfabrication is optical lithography, also 
known as photolithography [150]. In its simple form, the substrate, usually silicon, is 
spin coated with a photoresist and exposed to UV light through a mask containing the 
desired features. Upon exposure, the exposed areas of the photoresist either become 
insoluble in the solvent solution or become soluble. Subsequently, a spin coated layer 
or developed in the solvent to dissolve the soluble areas of photoresist film and the 
silicon wafer is etched through the patterned photoresist layer to create permanent 
patterns in the silicon. Photolithography remains the most widely used method to 
pattern surface topographical features in the micron range. 
 36 
 
For the fabrication of nanometer scale features, electron beam lithography (EBL) is the 
most widely used technique [151]. EBL is a direct writing technique, which uses a 
focused beam of electrons to modify the chemical structure of electron-sensitive resists, 
thus enabling the selective removal of unexposed or exposed areas of resist upon 
immersion in a solvent. EBL is advantageous in that it can fabricate features as low as 
10 nm in size. However, EBL is a low throughput technique.  
 Fabrication of patterned cell culture substrates 
Master mold by lithography are tedious to fabricate and are expensive. Methods 
to fabricate topographically-patterned cell culture substrates should be high throughout 
and should allow rapid and cost-effective fabrication of multiple replicas from one 
master mold. Therefore, soft lithography, micro-molding, hot embossing and 
nanoimprint lithography remain the methods of choice. Among these patterning 
techniques, soft lithography is the most common technique embraced by the researcher 
in regenerative medicine due to its low cost, simplicity, and versatility [152]. Soft 
lithography refers to a set of fabrication techniques based on printing and molding using 
elastomeric stamps with the patterns of interest to carry out micron and sub-micron 
fabrication. Micro-molding, a subtype of soft lithography, is the process of curing a 
liquid precursor on a substrate and thereby replicating the topographic information. The 
Polydimethylsiloxane (PDMS) solution is poured onto the master mold, degassed to 
remove entrapped air, and crosslinked for few hours at elevated temperature. 
Subsequently, the crosslinked PDMS containing the replicated features is detached 
from the master mold. PDMS is almost exclusively patterned by using soft lithography. 
On the other hand, hot embossing and nanoimprinting can be used to pattern a variety 
of cell culture substrates such has poly(methyl methacrylate) (PMMA), polystyrene 
(PS), polycarbonate (PC) and polyethylene terephthalate (PET)[153]. Both of these 
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techniques essentially use pressure to emboss or imprint the master mold features into 
the polymer substrate, while the substrate is at a temperature higher than the glass 
transition temperature of the polymer. Hot embossing differs from nanoimprint 
lithography in terms of the pressure used. Higher pressure is used in hot embossing as 
compared to nanoimprint lithography [154]. Generally, the resolution achieved in 
nanoimprint lithography is higher as compared to the hot embossing due to well 
controlled pressure and temperate values. Nanoimprint lithography can fabricate 
feature sizes of down to 10 nm resolution, which is similar to EBL. However, the 
nanoimprint lithography requires a master mold to start with, which is generally 
prepared by using photolithography or EBL.  
 Hydrogels in tissue engineering and regenerative medicine 
 Hydrogels 
Hydrogels are crosslinked polymer networks, which can absorb substantial amounts of 
water [155, 156]. Depending upon the nature of crosslinking, hydrogels can be divided 
into two categories: Chemically crosslinked hydrogels and physically crosslinked 
hydrogels. Chemical crosslinking can be achieved by using chemical cross-linkers such 
as glutaraldehyde or by using photo-initiators, which are activated upon UV light 
exposure.  Physical crosslinking is transient in nature, and it can be achieved by 
polymer chain entanglements, hydrogen bonds, ionic interactions or hydrophobic 
interactions. Hydrogels can also be classified based on the origin: natural hydrogels and 
synthetic hydrogels. Natural hydrogels are biopolymer hydrogels derived from natural 
sources [157]. Collagen, gelatin, silk, chitosan, alginates are some of the examples of 
natural biopolymer hydrogels. The major benefit of using natural hydrogels is that 
natural hydrogels with extracellular matrix cell adhesion motifs support cellular 
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adhesion. These hydrogels contain cell adhesion ligands in polymer chains. Another 
benefit of using natural hydrogels is that most of the natural hydrogels support 
biodegradation. Therefore, the cells are able to remodel their environment. However, 
the natural hydrogels suffer from batch to batch variation. Another major challenging 
of using natural hydrogels is, in general, their lack of strength.  
Synthetic hydrogels are fabricated by using synthetic molecules in polymer chemistry 
[158]. Poly hydroxyalkyl methacrylates, poly acrylamide, poly methacrylamide and 
poly vinyl alcohol are examples of synthetic hydrogels. In general, synthetic hydrogels 
do not support cell adhesion, unless chemically modified by grafting cell adhesion 
ligands. However, the synthetic hydrogels shave excellent reproducibility. 
Gelatin methacrylate (GelMA) is a hydrogel, which is fabricated by chemically 
modifying the gelatin chains [159]. The methacrylate groups are introduced in gelatin 
chains, which are then UV-crosslinked by using photo-initiators to make GelMA 
hydrogels.  GelMA is increasingly being used in tissue engineering and regenerative 
medicine for applications such as cell encapsulation, cardiac and cardiovascular tissue 
engineering, bone tissue engineering, cartilage tissues engineering, muscle tissue 
engineering, and as bioink for 3D printing [160]. The rise in popularity of GelMA is 
due to its proven biocompatibility, physico-chemical tailorability and the possibilities 
that it offers for patterning with spatio-temporal control of UV-crosslinkable hydrogels 
[160]. 
 Patterned topographical cues on hydrogels 
Hydrogels are the most commonly used material for many applications in tissue 
engineering and regenerative medicine due to biocompatibility, flexible synthesis, 
similarities with native tissues and desirable physical characteristics [161]. Therefore, 
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it is important to elucidate the cellular response on hydrogel topographical cues. 
However, pattering of topographical cues on hydrogels, especially on biopolymer 
hydrogels, is not trivial as compared to the above-mentioned polymer materials due to 
the high water content, fragility and swelling of the hydrogels. A survey of the 
topographical patterning of hydrogels to modulate cellular functions is presented in 
Table 2.2. Hydrogels are chemically-crosslinked or crosslinked by using UV 
irradiation. Patterning of the UV-crosslinkable hydrogels such as GelMA with 
topographical cues in the range of 1 µm or lower is challenging by using the 
conventional methods of soft lithography. Silicon master molds are expensive and 
cannot be used directly to mold hydrogels. PDMS micro-molding or photolithography 
are the most commonly used techniques for the patterning of topographical cues on 
hydrogels [162-164]. Hydrogels that are chemically-crosslinked, have been patterned 
with feature sizes of 10 µm to less than 500 nm (micro and nano-molding) by using 
PDMS working molds [165-167]. However, UV-crosslinkable hydrogels can only 
achieve feature sizes on the scale of tens of microns or higher (low resolution 
patterning) by using soft lithography and PDMS micro-molding [168-171]. PDMS 
master molds can only support low resolution pattering of UV-crosslinkable hydrogels, 
potentially due to the high oxygen diffusion coefficient of PDMS, which inhibits UV 
crosslinking at the hydrogel-PDMS mold interface [172, 173]. UV-crosslinking under 
N2 purging [174] or expensive quartz and silicon stamp-based nanoimprint lithography 
of hydrogels have been used to improve the patterning resolution of UV-crosslinkable 
hydrogels [175, 176]. In another study, the EBL method was used to directly write the 
topographical patterns in the range of 50 nm – 500 nm on the polyethylene glycol (PEG) 
based hydrogel. However, EBL, as mentioned earlier, is a slow, low throughput and 
cost-intensive method, which is not well suited to produce patterned substrates in large 
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numbers for cell seeding. Similar to what has been achieved for other hydrogels, there 
is a need to develop nano-molding methods to achieve high resolution pattering of UV-
crosslinkable hydrogels without the need of N2 purging or expensive molds and 
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In summary, this chapter presented a brief introduction of the function of corneal 
endothelial monolayer and highlighted pathology of the corneal endothelium and the 
current treatment methods by using donor corneal tissue. The current situation 
regarding donor cornea shortage was examined, which necessitates finding innovative 
treatments for corneal endothelium dysfunction patients by using tissue engineering 
methods. A survey of the literature related to the in vitro proliferation of the HCECs 
and corneal endothelial tissue engineering and therapies was presented and major issues 
were highlighted. Subsequently, the importance of topographical cues for HCECs, cell 
injection therapy, pharmacotherapy and corneal endothelial tissue engineering was 
demonstrated and the lack of studies on application of topography in this field was 
pointed out. The fabrication methods for topographical cues were introduced. Finally, 
an introduction to the hydrogels was presented along with the approaches for the 
fabrication of extracellular topographic cues on hydrogels.  
Due to the shortfalls in current research, this PhD thesis aims to investigate the 
importance of topographical cues in the field of HCECs proliferation, cell regenerative 
therapies and corneal endothelial tissue engineering. The methods and the results of the 





Chapter 3. Effect of micro- and nano-extracellular 
topographical cues on cellular functions of donor-derived 
human corneal endothelial cells 
Summary 
[Muhammad R, Peh GSL, Adnan K, Law JBK, Mehta JS, Yim EKF. Micro- and nano-
topography to enhance proliferation and sustain functional markers of donor-derived 
primary human corneal endothelial cells, Acta Biomater. 2015;19:138-48.] 
 
Corneal endothelium dysfunction is a major cause of corneal blindness, which can only 
be treated by using donor for corneal transplantation as of now. Due to donor cornea 
shortage, the development of new treatment strategies is being focused, which relies on 
the growth of primary human corneal endothelial cells (HCECs) in vitro. Primary 
HCECs do not proliferate in vivo and are difficult t to expand in vitro while maintaining 
their characteristic cell markers. This part of the thesis work studied the effect of 
isotropic extracellular topographical cues fabricated on tissue culture polystyrene (PS) 
on the proliferation and functional marker expression of primary HCECs. The 
proliferation of primary HCECs increased up to 2.9-fold, and the cell-cell tight junction 
protein ZO1 expression was significantly increased when grown on 1 µm PS pillars. In 
addition to increasing the proliferation, nano-sized 250 nm PS pillars also induced the 
hexagonal primary HCEC morphology. The results also showed that the topographical 
effect on functional markers could be sustained after passaging and was effectively 
retained by the cells. High expression of ZO1 was maintained when topographic cues 
were removed. The development of patterned PS culture platform could significantly 
benefit those researching primary HCEC cultivation for cell therapy for in situ HCEC 




Currently, transplantation of the donor cornea is the only available option for patients 
with endothelium dysfunction.  Due to the donor cornea shortage, alternative treatment 
methods are being investigated in the form of tissue-engineered grafts or cell therapy 
[103, 123]. A continuous supply of high quality primary HCECs is required for the 
research and development of alternative treatment methods. However, primary HCECs 
have limited proliferation in vitro [77]. Primary HCECs are difficult to culture because 
of their tendency to be heterogeneous, and spontaneous fibroblastic differentiation 
during the in vitro propagation [32, 33, 94]. Moreover, in vitro propagation of HCECs 
also leads to the progressive loss of functional markers such as Na+/K+–ATPase pumps 
and the Zona Occludens-1 tight junction protein (ZO1) [95]. The human corneal 
endothelial cell lines and animal corneal endothelial cells are useful for research. 
However, they cannot be used directly for therapeutics due to the difference in cell 
properties and genetic differences from primary HCECs [69, 70]. 
Primary HCECs formed a monolayer on the Descemet membrane in vivo, while 
the cellular processes are modulated by extracellular topography cues [191]. However, 
the in vitro effect of extracellular topographical cues on primary HCECs is largely 
unknown.  In this part of the thesis, I investigated the effect of micro and nano 
topographical cues on tissue culture polystyrene (PS) on primary HCECs cellular 
functions. 1 µm topography and 250 nm topography was selected for this study based 
on the previous evidence that these surface topographies could modulate the cellular 
response of cells from corneal endothelial cell line B4G12 [192]. Additionally, 
basement membranes of cells are known to have nano and micro-size topographic cues.  
Another aim of this work was to determine if the topographic influence on the 
primary HCECs could be retained over the subsequent passaging. This could sustain 
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their functional markers after passaging on unpatterned surfaces as well. Topographic 
memory could help the cells to recurrently express improved functional markers after 
they are seeded onto other surfaces.  
3.2 Material and methods 
3.2.1 Fabrication and ECM protein coating of patterned PS 
Soft lithography was used to fabricate PDMS master molds from a silicon (Si) master 
to pattern PS cell culture substrate with the following patterns: (i) 1 µm diameter pillars 
with 1 µm height and 9 µm spacing (referred to as 1 µm PS pillars (ii) 1 µm diameter 
wells with 1 µm depth and 9 µm spacing (referred to as 1 µm PS wells) (iii) 250 nm 
diameter pillars with 250 nm height and 150 nm spacing (referred to as 250 nm PS 
pillars). Prior to using, PDMS masters were cleaned and exposed to plasma for 60 
seconds at 60 Watts and 80 % O2 gas (FEMTO Science, Cute-B). Subsequently, the 
molds were treated with an anti-stiction layer (1H,1H,2H,2H)-perﬂuorodecyl 
trichlorosilane (FDTS, Sigma) to facilitate the demolding. PS pieces were cut from cell-
culture dishes (BD Falcon) and heat-embossed with patterned PDMS stamp with 0.3–
0.5 MPa pressure and 175°C for 90 s. The samples were then cooled to room 
temperature for another 90 s. For, PS samples were heat embossed with an unpatterned 
PDMS master mold topography to prepare control PS samples. The PS samples were 
then cleaned with absolute ethanol, dried and plasma-treated for 60 seconds to change 
the surface contact angle to improve the protein adsorption.  After sterilization, PS 
samples were coated overnight with either FNC Coating Mix® (a proprietary mixture 
of fibronectin and collagen, US Biological), or 10 mg/ml of chondroitin sulphate 
(Sigma) and 10 µg/ml of laminin (Gibco) mixture (which will be referred to as “LC” in 
this chapter) in phosphate buffer saline (PBS, 1st BASE) in 24 well plates. After 
coating, the samples were washed once with 1x PBS and seeded with cells. 
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Characterization of PS heat-embossing for micro- and nano-patterns was performed by 
using SEM and ImageJ. 
3.2.2 Primary HCECs isolation and cell culture 
Donor corneas were sourced from the Florida Lions Eye Bank (Miami, FL, USA). 
Primary HCECs were detached from donor corneas as described in a previous study 
[95]. The donor age was between 14-25 years (Table 1). The protocols conformed to 
the tenets of the Declaration of Helsinki, and the study was approved by the Institutional 
Review Board of the Singapore Eye Research Institute and Singapore National Eye 
Centre. Two different culture media were used for the culture of primary HCECs: s-
media and p-media as previously described [193]. The S-media composition was 
Human Endothelial-SFM supplemented with 5 % fetal bovine serum (Gibco) and 1 % 
penicillin-streptomycin (Gibco). P-Media composition was equal amounts of Ham’s 
F12 and M99 supplemented with 5 % fetal bovine serum (Gibco), 20 µg/ml of ascorbic 
acid (Sigma), Insulin, Transferrin, Selenium, Ethanolamine Solution (ITS-X, Gibco) 
diluted to a final concentration of 5 µg/ml of insulin, 2.75 µg/ml of transferrin, 2.5 
ng/ml of selenium, 1x Gibco Antibiotic-Antimycotic (Life Technologies, mixture of 
streptomycin, amphotericin B, penicillin), and 10 ng/ml of bFGF (Life Technologies). 
After passaging, the primary HCECs were incubated in s-media for 1 day and then the 
media was replaced with p-media. The HCECs were then cultured in p-media until 
confluency. Then the cells were switched back to s-media [194]. The HCECs 
confluency usually required 2 weeks. The media was changed with fresh media every 
second day. The cells were maintained in an incubator with 5 % CO2 on FNC coated 
tissue culture dishes. For experiments, the cells were detached by incubating them in 
TrypLETM Express solution (Gibco) for 10-15 min followed by gentle pipetting. After 
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Table 3.1 Donor information for corneas used in the current study. OD = Oculus 
Dexter, OS = Oculus Sinister. 
 
 
3.2.3 Proliferation assay of Primary HCECs 
To evaluate cell proliferation, I seeded primary HCECs on ECM-coated patterned PS 
samples at a seeding density of 30 and 50 cells/mmmm2 in s-media for one day followed 
by p-media for another day. After this, the cells were incubated with 10 µM 5-ethynyl-
2´-deoxyuridine (EdU) dye in p-media for 24 hrs (Figure 3.1). Primary HCECs 
proliferation was assessed after 3 days by using Alexa Fluor 488 Click-iT EdU cell 
proliferation assay kit (Invitrogen) according to the kit’s protocol. The samples were 
then counterstained with 40,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich) at a 
concentration of 2 ng/ml for 30 min. The EdU incorporation in proliferating HCECs 









Cell Count  
(OD) 
Cause of death 
01  14 F 5 3205     3115     Cerebral Edema 
02 10 M 6 3175 3030 Multiple Blunt Trauma 
03 29 M 7 2545 2545 Overdose 
04      66 M 8 2315 2315 Myocardial Infarction 
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least 500 cells were analyzed to calculate the proliferation rate. A schematic of the 






3.2.4 IF staining of functional markers of primary HCECs  
PS samples were coated overnight with either FNC Coating Mix®, or LC coating as 
mentioned before. Primary HCECs at Passage 3 (P3) were seeded on unpatterned and 
patterned PS samples at a density of at least 100 cells/mm2 and cultured in s-media for 
one day, followed by in p-media until the HCECs started to demonstrate cell-cell 
contacts. The media was switched from p-media to s-media and a confluent primary 
HCEC monolayer was maintained for 3 days in s-media to stabilize the cells before to 
fixing. The seeding density (at least 100 cells/mm2) and time point (3 days in s-media 
after confluency) for the fixing of primary HCECs was same for both ZO1ZO1 and 
Na+/K+-ATPase staining. For imaging of Na+/K+-ATPase and tight junction ZO1, 
HCECs were fixed with 4 % PFA in 1x PBS for 15 min and permeabilized in 50 mM 
Figure 3.1 Schematic diagram of the culture of primary HCECs culture in dual-media 
for proliferation and functional markers assays and morphometry analysis on patterned 
topographical cues.  
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glycine and 0.05 % of triton X-100 in 1x PBS for 15 min. Next, the cells were washed 
and blocked with 10 % goat serum and 1 % bovine serum albumin (BSA) in PBS for 1 
hr. The permeabilization step was excluded for Na+/K+-ATPase staining. ZO1 was 
labelled with mouse ZO1 monoclonal antibody (BD Transduction) that was diluted to 
5 µg/ml in 1 % goat serum in PBS, while Na+/K+-ATPase was labelled with mouse 
monoclonal IgG1 Na+/K+-ATPase α1 (Santa Cruz) diluted to 5 µg/ml in 1 % goat serum 
in PBS, overnight at 4ºC. The samples were then washed and incubated for 1 hr with 
2.67 µg/ml Alexa Fluor 488-conjugated goat anti-mouse antibody diluted in PBS, 
counterstained with 2 ng/ml DAPI in PBS for 30 minutes, and mounted onto 
microscope slides for analysis. To examine the effect of primary HCEC monolayer 
maintenance time in culture, the cells were maintained in s-media for an additional 7 
days before staining the cells for ZO1 protein. A schematic of the primary HCECs 
culture method for monolayer formation is shown in Figure 3.1. 
To investigate the effect of extracellular topography on the expression of ZO1 at 
passage 3 at a high seeding density, HCECs were seeded at 1500 cells/mm2 on FNC-
coated unpatterned and patterned PS and maintained for 7 days in s-media (to mimick 
the lower end of the HCEC density in an adult human eye that is 1500 cells to 2500 
cells per mm2). The ZO1 staining was performed as mentioned earlier. The was imaged 
by using a confocal microscope. Confocal microscopy (Zeiss LSM 710) images of the 
high density (HD) HCEC monolayer were taken at an interval of 2 µm in z-direction 
and the z-stack was merged using the “maximum intensity projection” in ImageJ. ZO1 
fluorescence was analyzed using ImageJ.  
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3.2.5 IF staining of primary HCEC monolayer after changing the 
topographical cues 
PS samples were coated with FNC Coating Mix® in 24 well plates as mentioned in 
section 3.2.1. P3 Primary HCECs were seeded at 100 cells/mm2 on FNC-coated 
unpatterned PS and 1 µm PS pillars. The cells were cultured for expansion until 
achieving confluency. Once the HCECs were confluent, they were passaged using 
TrypLE on unpatterned PS and 1 µm PS pillars at 1500 cells/mm2 and cultured in s-
media for 7 days. Then, the cells were fixed, permeabilized and stained for ZO1 and 
Na+/K+-ATPase cell markers as described earlier. 
3.2.6 Quantitative image analysis 
Immuno-fluorescence staining of ZO1 at cell-cell junctions was imaged and 
quantitatively measured by using ImageJ [195]. In brief, the total integrated density of 
the fluorescence image (ZO1 in cytoplasm + ZO1 at cell-cell junctions) was measured. 
Total integrated density is the product of mean grey value and the area of the image. 
Next, the integrated density of ZO1 fluorescence in the cells’ cytoplasm was assessed. 
For this purpose, mean grey value of randomly selected 9 different areas of the image 
were averaged and multiplied with the whole image area. The following rule was used 
to measure the ZO1 fluorescence at tight junctions only: 
ZO1 fluorescence at cell-cell junctions = Total integrated density (ZO1 in cytoplasm & 
ZO1 at cell-cell junctions) − (average mean grey value of 9 different areas) x (image 
area) 
The process was replicated for all images. The results were normalized with the cell 
number. ZO1 fluorescence at cell-cell junctions was shown in arbitrary units (A.U.). 
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3.2.7 SEM imaging of heat-embossed PS topography and primary HCECs 
FNC- and LC-coated unpatterned and patterned PS samples (1 µm pillars, wells and 
250 nm pillars) were analysed by using SEM. The samples were coated overnight with 
ECM proteins at 37°C, washed with PBS and then fixed with 2 % glutaraldehyde (GA) 
in 0.1 M sodium cacodylate and 3 mM calcium chloride dissolved in filtered deionized 
(DI) water. The fixed samples were serially dehydrated in an ethanol gradient and dried 
by using critical point dryer (Blazers CPD 030). To examine the shape of primary 
HCECs by using SEM, cells at P3 were cultured at a seeding density of at least 100 
cells/mm2 on 1 µm PS wells and unpatterned PS. The cells were fixed with 4 % PFA 
and 1 % GA (Sigma Aldrich) in 0.1M sodium cacodylate and 3 mM CaCl2 buffer at 
two different time points which are as follows: in p-media before switching to s-media, 
and after 3 days in s-media.  The fixed cells were serially dehydrated and dried by using 
CPD. Finally, the samples were sputtered with 10 nm platinum and imaged with JEOL 
JSM-6700F field-emission scanning electron microscope (FE-SEM). 
3.2.8 Primary HCEC cell morphology analysis 
Primary HCEC cell morphology analysis was performed to study the effect of 
extracellular topographical cues on the cell area, coefficient of variation (CV) of cell 
area, and circularity of the cells. CV is defined as the ratio of the SD to the mean cell 
area multiplied by 100. The circularity of the cells is defined as 4π×(A/P2) where A 
refers to the cell area and P refers to the cell perimeter. ZO1 stained cells were used to 
analyze the cell shape parameters by making use of ZO1, which outlined the cell 
boundary. Briefly the images were opened in ImageJ and the cell boundary was 




Each experiment was run in triplicate and three runs for each experiment were 
performed. Data are presented as arithmetic mean ± standard deviation (SD) unless 
stated otherwise. One-way ANOVA and student’s t-test were used to measure the 
statistical significance except for cell areas and CV where Kruskal-Wallis test followed 





3.3.1 Heat embossing and ECM coatings of PS 
In this work, the extracellular topographic cues on PS surfaces were fabricated by using 
heat embossing. Figure 3.2 shows the SEM images of the patterned PS with FNC and 
LC coating. Both nano- and micro-sized pillars and wells were replicated faithfully by 
heat embossing. The replicated patterns were bigger than the designed features on Si 
master mold that could be due to the expansion/contraction of the PDMS material 
during molding and hot-embossing. However, the coefficient of variation of feature 
sizes was low and features were highly reproducible. The selection of embossing 
temperature above the PS glass transition temperature ensured the flow of PS into the 
master mold micro- and nano-features. Cooling to room temperature before release of 
PDMS master from the heat-embossed PS was found to be the critical to obtain 
distortion free features. The SEM images suggested that the PS patterns were not 
Figure 3.2 (a) SEM microscopy images of heat-embossed PS patterns with FNC and 
LC coating. (b) The dimensions of heat-embossed PS micro- and nano-structures. CV 
= coefficient of variation. 
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obscured by ECM protein coatings (Figure 3.2(a)) and that the fabrication method for 
PS patterning was robust for both micro- and nano-scale features. Although the 
replicated structures were generally bigger than the designed structures, the value was 
repeatable and precise, with low SD and CV of replicated structures (Figure 3.2(b)). 
3.3.2 Effect of patterned PS topography on primary HCECs proliferation 
Proliferation of primary HCECs was measured by using EdU assay. Figure 3.3(a) 
shows the effect of patterned PS topography and ECM coating on the proliferation of 
primary HCECs at 30 cells/mm2, while the figure 3.3(b) shown the effect at 50 
cells/mm2 seeding density. As primary HCECs demonstrate strong cell-cell contact 
inhibition, two different seeding densities were used to validate the HCECs 
proliferation results. The proliferation rate of HCECs was found to be significantly 
higher on 1 µm FNC-coated pillars when compared to an unpatterned PS substrate 
(P<0.05 at 30 cells/mm2; P<0.001 at 50 cells/mm2). However, there was no significant 
difference in proliferation rate between cells grown on micro-wells and this was 
irrespective of ECM coating and seeding density.  
 
Figure 3.3 EdU cell proliferation assay of primary HCECs on ECM coated patterned 
topographies at (a) 30 cells/mm2 and (b) 50 cells/mm2 density. 500 cells from 3 
independent experiments were analysed (n=3). *P < 0.05; **P < 0.01; *** P < 0.001 
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At a 30 cells/mm2 seeding density, the HCEC proliferation rate was 18.0 % on FNC-
coated unpatterned PS and 34.8 % on FNC-coated 1 µm pillars. At a 50 cells/mm2 
seeding density, the proliferation rate of HCECs was 14.5 % on FNC-coated 
unpatterned PS and 41.2 % on FNC-coated 1 µm pillars. At 50 cells/mm2, 250 nm 
pillars with FNC coating showed significantly higher proliferation rate (P<0.05) than 
unpatterned PS. No significant difference in proliferation rate of HCECs was observed 
when cells were seeded on LC-coated patterned PS samples, irrespective of seeding 
density. 
3.3.3 Effect of patterned extracellular topographical cues on HCECs 
morphometry 
The area, CV, and circularity of primary HCECs are important parameters to consider 
when evaluating the quality of cultured HCECs. For this reason, primary HCECs cell 
shape parameters were examined by using ImageJ software. Figure 3.4 shows the effect 
of ECM-coated patterned PS topography on the morphometry of primary HCECs. Cell 
area is reported in form of a dot-plot where each dot corresponds to a cell (Figure 
3.4(a)). The lowest mean cell area was found on cells seeded onto FNC-coated 250 nm 
pillars (2873 µm2) and LC-coated unpatterned PS (2278 µm2). The fact that LC-coated 
patterned surfaces had higher cell areas compared to unpatterned surface shows that the 
topography plays a major role over the extracellular protein coating in modulating the 
cell areas. Cell area was significantly lower when cells were grown on 250 nm FNC-
coated pillars than all other patterned PS (P<0.005), except for FNC-coated 1 µm wells. 
Coefficient of variation (CV) in the area of primary HCECs (polymegethism) was also 
investigated. FNC-coated 250 nm pillars and 1 µm wells showed a lower CV, which 
means that the cells grown on these substrates were more uniform in terms of cell area 
(Figure 3.4(b)). However, FNC-coated 1 µm pillars showed higher CV, which indicates 
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a wider distribution of cell areas. The lowest CV was found on LC-coated 1 µm PS 
wells. Primary HCECs circularity was similar on all samples regardless of extracellular 
topography and ECM coating, which suggest that the underlying extracellular 
topography did not modulate cell circularity (Figure 3.4(c)). 
 
3.3.4 Effect of extracellular topographical cues on the expression of HCEC 
functional markers 
3.3.4.1 Low density primary HCEC monolayers 
Figure 3.5 shows IF staining images of ZO1 in HCECs cultured at a seeding 
density of at least 100 cells/mm2 on FNC-coated and LC-coated patterned PS. The 
effect of maintaining the primary HCEC monolayers in s-media for a longer time period 
is also shown.  
ZO1 was found to be dispersed in the cytoplasm, and was less concentrated at 
cell-cell tight junctions, when cells were maintained for 3 days in s-media (Figure 
Figure 3.4 Effect of ECM-coated patterned PS extracellular topographical cues on 
primary HCECs cell shape. (a) The distribution of primary HCEC cell area in dot-plot 
on various FNC- and LC-coated PS substrates where each dot indicates a cell. (b) 
Coefficient of Variation (CV) of cell area on FNC-coated and LC-coated PS substrates. 
(c) Cell circularity of primary HCECs on FNC- and LC-coated PS patterns. At least 
100 cells from 3 independent experiments (n=3) were analyzed. *P < 0.05; **P < 0.01; 
***P < 0.001; ****P < 0.0001 
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3.5(a)). No difference was observed between cells grown on different topographies, or 
ECM coatings, even after 3 days of maintenance in s-media. Interestingly, when the 
HCEC monolayer was maintained in s-media for an additional 7 days, the expression 
of ZO1 at cell-cell tight junctions improved significantly.  
ZO1 expression patterns were also modulated by patterned extracellular topography. 
On unpatterned PS, although the expression of ZO1 was increased at cell-cell junctions, 
it was less distinct (Figure 3.5(b)). In case of cells grown on LC-coated 250 nm pillars,  
 
Figure 3.5 IF staining images of ZO1 functional marker of HCECs on FNC and LC-
coated PS substrates. (a) ZO1 expression after maintaining the primary HCEC 
monolayer for 3 days in s-media. (b) ZO1 expression after maintaining the cells for 7 
days in s-media. Scale bar=100 µm 
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ZO1 expression was enhanced at cell-cell junctions as compared to the cells grown on 
FNC-coated 250 nm pillars. Cells grown on 1 µm pillars, coated with either LC or FNC 
coating, expressed ZO1 primarily at cell-cell junctions, with a more continuous pattern, 
which was evident compared to other PS topographies. Overall, the expression of ZO1 
was more distinct in primary HCECs grown on micron pillars. Furthermore, these cells 
had polygonal cell shapes, which resembled corneal endothelial cells in the human 
cornea [196].   
Na+/K+-ATPase, along with ZO1, are important cell markers whose expression asserts 
that HCECs have not undergone endothelial-to-mesenchymal transformation during in 
vitro expansion. The HCECs were stained for Na+/K+-ATPase pumps to verify the 
phenotype of the cells. Figure 3.6 shows primary HCECs at a seeding density of at least 
100 cells/mm2 on FNC-coated and LC-coated patterned PS and stained for Na+/K+-
ATPase. The expression of Na+/K+-ATPase was found to be similar on all surfaces 
regardless of ECM coating and extracellular topographies. This indicated that the 
primary HCECs were not de-differentiated to a fibroblastic phenotype during in vitro 
Figure 3.6 IF staining images of Na+/K+-ATPase of primary HCECs on FNC and LC-
coated PS substrates after maintaining the primary HCEC monolayer for 3 days in s-
media. Scale bar=100 µm 
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expansion. Additionally, the Na+/K+-ATPase was found to be uniformly dispersed in 
the cytoplasm at low seeding density. 
 
3.3.4.2 High density primary HCEC monolayers 
I also investigated the effect of extracellular topographies on tight junction formation 
in cells that were grown in form of a high density cell monolayer. The cells were seeded 
at 1500 cells/mm2 and expanded for 7 days in s-media. Figure 3.7(a) shows the confocal 
microscopy IF images of primary HCECs seeded at a high density onto FNC-coated 
patterned PS and stained for ZO1.  
 
Similar ZO1 expression was observed in primary HCECs grown on unpatterned PS, 
250 nm pillars and 1 µm wells. However, 1 µm pillar substrates showed enhanced 
Figure 3.7 (a) Confocal images of IF staining of primary HCECs ZO1 on PS substrates 
with FNC coating at high cell seeding density. (b) ZO1 fluorescence at cell boundaries 
for patterned and unpatterned PS substrates in arbitrary units. Scale bar=50 µm. (n=3) 
One-way. *P < 0.05 
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expression of ZO1. Discontinuity of the ZO1 pattern was observed in cells grown on 
unpatterned PS, 250 nm pillars and 1 µm wells. On 1 µm pillars, cells demonstrated 
enhanced ZO1 expression that was uniformly localized to cell-cell junctions. The ZO1 
fluorescence intensity at cell-cell junctions was quantified by using ImageJ software. 
Similar to the qualitative observations, the fluorescence intensity of ZO1 localized to 
cell-cell junctions was significantly higher in cells grown on 1 µm pillars than 
unpatterned PS, 250 nm pillars and 1 µm wells (P<0.05) (Figure 3.7(b)). 
3.3.4.3 Effect of dual-media and extracellular topography on primary HCECs 
cell shape and tight-junction formation 
Primary HCECs were seeded onto unpatterned PS and PS pillars, and expanded in p-
media and s-media before being analyzed by SEM.  The SEM images (Figure 3.8) 
present the effect of dual-media on HCEC tight junction formation and cell shape.  
  
Figure 3.8 Effect of media on tight junction formation and cell shape of primary 
HCECs. SEM images of primary HCECs on (a) FNC-coated unpatterned PS in p-media 
(b) FNC-coated 1 µm PS pillars in p-media (c) FNC-coated unpatterned PS in s-media 
(d) FNC-coated 1 µm PS pillars in s-media, 3 days after switching the media. High 
resolution images of primary HCECs to demonstrate the formation of cell-cell contacts 
on (e) unpatterned PS and (f) 1 µm PS pillars in s-media at day 3. Arrows indicate the 
filopodia stitching to form cell-cell tight junctions. scale bar=10 µm 
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In p-media, the cells had an elongated morphology and the cells were not fully confluent 
(Figure 3.8(a,b)). This was observed when cells were grown on either unpatterned PS 
or 1 µm PS pillars topography (Figure 3.8(a,b)).  When the media was changed from p-
media to s-media, which permitted the formation of confluent HCEC monolayer after 
culturing for 3 additional days, the cells appeared more polygonal in shape (Figure 
3.8(c,d)). It is also interesting to note that when cells were grown on patterned PS, 
extensive filopodia were detected during cell-cell junction formation in s-media (Figure 
3.8(d)). However, on unpatterned PS, such filopodia were not frequently detected in s-
media (Figure 3.8(c)). High resolution images of HCECs grown on unpatterned PS, 
showed cell-cell junctions, which had voids and almost no filopodia protruded. Similar 
images of HCECs on patterned PS, showed filopodia that appeared to be interlaced at 
cell boundaries to form tight junctions free of voids (Figure 3.8(e, f)). 
3.3.4.4 Effect of switching the biophysical cues on the primary HCEC 
monolayer formation 
HCECs were studied for their capacity to form monolayers and maintain characteristic 
morphology when topographic cues were removed. 1 µm PS pillars were selected as 
primary HCECs grown on this topography had demonstrated the most well-defined 
ZO1 expression in previous experiments in this chapter. Figure 3.9(a) shows a 
simplified schematic diagram of the experimental method followed to change the 
extracellular topography on which cells grew after the third passage. Figure 3.9(b) 
shows the ZO1 and Na+/K+-ATPase expression of primary HCECs that were seeded 
after the third passage (P3) onto new substrates (P4). In case-1, where HCECs were 
seeded from unpatterned PS to unpatterned PS, no ZO1 was expressed at tight junctions 
(Figure 3.9(a)). This is in line with previous findings that suggest that primary HCECs 
gradually lose functional markers that are typical of corneal endothelial cells beyond 
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passage 3 [95]. However, in case-2, when the primary HCECs that had been cultured 
on patterned PS at P3 were reseeded onto unpatterned PS at P4, the cells clearly 
expressed ZO1 at tight junctions (Figure 3.9(b)). Similarly, in case 3, when cells were 
Figure 3.9 (a) schematic representation of the experiment method to investigate the 
effect of changing the topographical cues on ZO1 expression. (b) Na+/K+-ATPase and 
ZO1 Expression of HCECs in case-1, when HCECs were passaged from unpatterned 
PS at P3 onto unpatterned PS at P4; case-2, when HCECs passaged from 1 µm PS 
pillars onto unpatterned PS; case-3, When HCECs passaged from 1 µm PS pillars onto 
1 µm PS pillars. (c) Quantification of ZO1 fluorescence at cell-cell boundaries for all 3 
cases in arbitrary units. Effect of switching the topographical cues on (d) HCEC cell 
area, (e) coefficient of variation of HCEC cell area, and (f) HCEC cell circularity. Scale 




cultured on patterned PS at P3 and re-seeded on patterned PS at P4, ZO1 was expressed 
at tight junctions. These cells produced a clearer profile of ZO1 than case-1(Figure 
3.9(c)).   
Quantitative analysis of ZO1 at tight junctions showed that case-2 (P<0.05) and 
case-3 (P<0.05) had significantly higher fluorescence of ZO1 at tight junctions than 
case-1 where no topographic cues were used during primary HCEC seeding. More gaps 
between cells were observed in case-1 than cases 2 and 3. As far as the Na+/K+-ATPase 
expression is considered, regardless of how cells were seeded, all cells showed same 
expression of Na+/K+-ATPase pumps.  
The effect of extracellular topographical cues on primary HCECs shape was also 
studied for all three cases. The primary HCECs cell area was similar in all three cases 
(Figure 3.9(d)). However, the CV was significantly higher and cell circularity was 
significantly lower in Case-1 than case-2 and case-3 (Figure 3.9(e, f)). A high CV and 
low cell circularity showed that the cells were unable to preserve polygonal cell shapes. 
3.4 Discussion 
This investigation demonstrates that the size of the patterned topographical cues in 
the micro- and nano-scale range influences several vital functions of primary HCECs 
including cell proliferation, morphology, and cell phenotype. Primary HCECs do not 
divide in vivo to compensate any loss of cells attributed to specific diseases, resulting 
in corneal edema [8]. The major issue in discovering alternative techniques for the 
treatment of unhealthy corneal endothelium, is the development of robust primary 
HCECs culture methods in vitro. Achieving this would enable the potential 
regeneration of corneal endothelium for applications such as tissue engineering, cell 
therapy, and drug testing. Few research groups have induced proliferation of primary 
HCECs through the use of biochemical cues in culture media [12]. However, additional 
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investigation is required to increase the rate of primary HCEC proliferation as well as 
the quality of the expanded cells. 
3.4.1 The effect of topography on proliferation and morphology of primary 
HCECs 
Biophysical cues as modulators for corneal endothelial cell behavior has not been 
investigated for primary HCECs. It is well known that unique properties of the 
extracellular microenvironment, such as substrate stiffness and extracellular 
topographies, provide cues that regulate the functions of various cell types [197]. 
Topographic cues that are within the nano- to micro-scale range of synthetic and natural 
materials have been identified and are known to modulate cell behavior [17, 130]. 
Isotropic cues such as wells and pillars were selected for this part of the thesis work 
due to the fact that the corneal Descemet membrane, which provides surface on which 
endothelial cells reside, also consists of isotropic structures [191]. I employed PS for 
the patterning of isotropic topographies for primary HCECs for this study. PS is 
commercially available widely-used material for in vitro cell culture. The capacity to 
integrate patterned topographies onto commercially available PS could accelerate the 
application of these results into existing cell culture material and techniques. 
Nearly a three-fold increase in the proliferation rate of primary HCECs was 
shown when the cells were seeded onto FNC-coated 1 µm pillars. The mechanism of 
the increased proliferation is not yet investigated. Previous studies have demonstrated 
that cell spreading is vital for the survival and growth of different mammalian cell types 
[198-200]. Here, I speculate that the enhanced cell spreading on PS pillars, as described 
earlier, could result in increased proliferation of HCECs. A 3-fold increase in the 
numbers of primary HCECs could lead to an increase in the number of cell therapy 
procedures and tissue-engineered constructs that can be produced from a single donor 
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cornea. This could further result in faster, and less expensive, production of cell therapy 
or tissue-engineered constructs [201].  The application of patterned topographical cues 
enhances the expansion of primary endothelial cells without inducing fibroblastic like 
changes in cell phenotype. Cell shape must also be considered in order to verify the 
quality of in vitro cultured primary HCECs. Primary HCECs have been widely studied 
in vivo, and cell areas, CV, and cell circularity were extensively illustrated [159, 202, 
203]. To summarize, high cell density (smaller cell areas), low CV (tighter distribution 
of cell areas), and high cell circularity (polygonal cells) were suggestive of a high 
quality primary HCEC monolayer.  The experiments conducted in this work reveal that 
the cell shape can also be controlled by the extracellular topography. I determined that 
the cell areas and CV were improved on FNC-coated 250 nm PS pillars. In this 
investigation, the primary HCEC cell size ranged from 3-10 times the size of cells in 
vivo [95] depending on the seeding density and extracellular  topography utilized. In 
conclusion, FNC-coated 250 nm pillars were found to be the ideal surface for enhancing 
the shape of the primary HCECs. 
The effect of dual media on the shape on cells was also studied.  The results 
revealed that the cells had different shapes and confluences in different media. In p-
media, the cells became elongated and were in a sub-confluent state at the end of the 
time point which could be due to low “packing” due to the elongated cell morphology. 
In s-media, the cells were polygonal in shape and fully confluent. It was concluded that 
the s-media played an important function in regulating the native-like polygonal cell 
shape and cell monolayer integrity [193]. A comparison of the confluent HCEC 
monolayer in s-media on unpatterned PS and patterned PS displayed that the filopodia 
of opposing cells showed to interdigitate to form cell-cell adhesions on patterned PS, 
which is not frequently seen for primary HCECs on unpatterned PS. These filopodia 
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like projections could aid in the formation of cohesive cell monolayer that are essential 
for the formation and the integrity of corneal endothelial monolayer [204]. 
3.4.2 The effect of topography on the expression of functional markers of 
primary HCECs 
Another important criterion to evaluate during in vitro regeneration of primary 
HCECs is the expression of functional markers of primary HCECs. Factors that enhance 
cell growth, but do not assist in maintaining or improving the expression of functional 
markers, are ineffective as the cells would de-differentiate and become unusable for 
potential tissue engineering, cell therapy or drug testing. I showed that the increased 
proliferation of primary HCECs was not at the expense of critical functional markers in 
topographical culture. In fact, functional markers of HCECs, such as ZO1, were 
improved during expansion with topographical cues. ZO1 is an important HCEC 
marker as it allows the cell layer to behave as a barrier to the free flow of liquid 
molecules through the corneal endothelium which would otherwise result in corneal 
edema. Amplified expression of ZO1 at cell-cell junctions would potentially improve 
the integrity of the cell layer and limit the cell loss during as well as after 
transplantation. This investigation establishes that, in relation to unpatterned surfaces 
and other topographies, the 1 µm PS pillars not only improve cell growth, but also 
enhance the expression of ZO1 at cell-cell tight junctions. It should be noted that 3 
different cell densities were used in these experiments for a variety of experimental 
objectives. For primary HCEC expansion and proliferation assay, lower cell seeding 
densities were used to reduce influence from contact inhibition on cell proliferation. 
Previous research using 30 cells/mm2 and 50 cells/mm2 for cell proliferation have 
determined to deliver more reliable results [95, 193]. For general cell propagation, 
optimized seeding density of at least 100 cells/mm2 was used as it generated the most 
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consistent cultures in terms of cellular morphology [205], and also allowed for cell 
growth before contact inhibition was established when the culture became confluent. 
For high-density primary HCEC monolayer studies, a seeding density of 1500 
cells/mm2 was used to simulate a functional primary HCEC monolayer [31-34]. 
IF staining was used to examine the functional marker expression, as other 
techniques such as western blotting require a large quantity of cells, which is difficult 
to obtain from a single donor cornea. Mixing cells from different donors was also not 
practical because donor cells may have different properties from each other [206]. In 
this work, IF staining is ideal as it not only demands less cells, but also offers 
information about the localization of the ZO-1 protein. Such information cannot be 
collected by using other methods. Understanding the localization of this functional 
marker is vital because ZO1 expression at cell-cell junctions is indicative of an intact 
monolayer, whereas ZO1 expression in the cytoplasm is not. 
3.4.3 The effect of topography on the passaging of primary HCECs 
Recent studies have demonstrated that cells can 'remember' past biophysical 
cues, and that this memory is tested when biophysical cues are altered or removed [160, 
168]. This work also aimed to verify if the primary HCECs could preserve the higher 
expression of their functional markers even after the topographies were removed. The 
results revealed that the topography-exposed cells sustained a greater amount of ZO-1 
expression at cell junctions when their adherent substrate was changed from patterned 
PS to unpatterned PS. The increased ZO1 expression was similar to the primary HCECs 
that continued to expose to the topographic cues, thus sensing the sustained 
topographical signal. Cell shape analysis also revealed that topography-exposed 
HCECs can maintain a high circularity and regular cell shape with lower CV in the 
newly formed monolayer. These results contain great potential for future cell therapy 
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methods [14] as it demonstrates that primary HCECs proliferated on and exposed to 
topography can maintain the enhanced functions and phenotype to facilitate the 
formation and stabilization of a functional corneal endothelial monolayer. In cell 
injection therapy, corneal endothelial cells are injected into the anterior chamber of the 
eye where, unlike in vitro culture, the surface will not be well-defined or the 
extracellular environment may lack appropriate topographical cues to enhance cell 
phenotype. However, HCECs could be cultured on topographic cues prior to injection 
to improve cell phenotype, and to form a cell layer with well-defined ZO1 expression 
at cell-cell junctions. Such characteristics may be retained during the formation of the 
in situ monolayer after injection. This study did not test the timescale on which 
topography induced memory of cells could last. Additionally, the mechanistic studies 
of how the cells gain topographic memory was also not carried out. Both of these 
aspects should be studied in detail to gain a better understanding of this effect for future 
uses in cell therapies.  
3.5 Conclusion 
This part of the thesis work demonstrates the application of extracellular 
topographical cues for the first time, to improve the in vitro growth of donor derived 
primary HCECs where critical primary HCECs functions were regulated by size of 
topographic cues in nano- to micron-scale range. this work established a robust process 
for the patterning of isotropic micro- and nano-structures, which was based on simple 
hot-embossing. By using this protocol, a patterned cell culture platform was developed 
from commonly used material tissue culture polystyrene that not only increased the 
proliferation of primary HCECs, but also improved the expression of functional 
markers. The cell shape parameters, such as cell area and CV, was also regulated and 
improved by growing HCECs on 250 nm PS pillars topography. The work also 
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demonstrated that even after primary HCECs were detached from the patterned 
substrate, they were able to memorize the topography-induced effects and sustain the 
topography-mediated cell behaviors.  This suggest that the primary HCECs cultured on 
topography would acquire epigenetic memory of the topography-induced functions, 
leading to formation of functionally enhanced in situ monolayer even upon 
transplantation onto a non-patterned cell-carrier or in vivo surfaces. The findings hold 
important implications and allow for the cultivation and regeneration of primary HCEC 
monolayers for cell therapy, tissue engineering and drug screening applications.  
The chapter 4 and chapter 5 will present the research work on the use of in vitro 
grown HCECs for cell regenerative therapies and corneal endothelial tissue 
engineering. Moreover, the studies on the fabrication and application of extracellular 
topographies in cell regenerative therapies and corneal endothelial tissue engineering 




Chapter 4. In-vitro topographical model of Fuchs 
dystrophy for evaluation of corneal endothelial cell 
monolayer formation 
Summary 
[Rizwan M, Peh GS, Adnan K, Naso SL, Mendez AR, Mehta JS, Yim EKF. In Vitro 
Topographical Model of Fuchs Dystrophy for Evaluation of Corneal Endothelial Cell 
Monolayer Formation, Adv. healthcare mater. 2016;5:2896-2910.] 
 
The most common indication for corneal transplantation is a dysfunctional corneal 
endothelium due to Fuchs’ endothelial dystrophy (FED). A diagnostic clinical sign of 
FED is the presence of excrescences on Descemet membrane (DM), called corneal 
guttata, in the shape of pillars or domes depending on the disease progression. 
Minimally invasive corneal endothelial cell regenerative procedures such as endothelial 
cell injection therapy and Rho-kinase inhibitor pharmacotherapy have been proposed 
as alternatives to conventional corneal transplantation for FED patients. However, the 
effect of guttata on cell migration and monolayer reformation is unknown. 
Investigations of endothelial monolayer formation on guttata are not possible in vivo, 
due to lack of suitable animal model. Based on the clinical observations of guttata 
structures, I fabricated an in vitro synthetic-guttata model to mimic the topographical 
micro-environment of FED patients and systematically investigated the migration of 
primary human corneal endothelial cells and monolayer regeneration on synthetic-
guttata. The monolayer formation, which would correlate to the recovery of the corneal 
endothelial, was significantly affected by the density, height and curvature of the 
guttata-like micro-pillar array.  The human corneal endothelial cells were unable to 
form a monolayer either following the cell injection model or the pharmacotherapy 
model, on densely-packed synthetic-guttata mimicking late stage FED. The Euclidean 
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distance and directness of cell migration were also significantly lower on densely-
packed synthetic-guttata as compared to guttata-free surface. However, the cells could 
form monolayer and express tight-junctional protein zona occuludin-1 on sparsely-
spaced synthetic-guttata of lower height and curved sidewalls, which mimicked the 
early stage FED. These results suggest that advanced stage FED guttata could hinder 
corneal endothelial monolayer formation. Hence surgical removal of the most densely-
formed corneal guttata combined with the cell regenerative therapy would improve the 




4.1  Introduction 
Corneal transparency is maintained by the corneal endothelium, which lies on the 
posterior surface of the cornea (Reviewed in section 2.2) [207]. Fuchs’ endothelial 
dystrophy (FED), a degenerative disorder, is a primary disease of the corneal 
endothelium, which, if left untreated, results in corneal blindness (Section 2.2.2.1). A 
diagnostic clinical sign, and hallmark of FED, is the presence of discrete abnormal 
collagen excrescences, called corneal guttata. These are found on the Descemet’s 
membrane (DM), on the posterior surface of the cornea [16, 36, 37]. The guttata appear 
centrally on the DM, at the onset of the disease. As the guttata become larger, they 
attenuate the cell cytoplasm on the apical side of the endothelium, which leads to cell 
death and progressive deterioration of endothelial function [1].  Eventually, the 
dynamic balance required for the maintenance of corneal hydration becomes disrupted 
as the dysfunctional endothelium fails to move excess fluid from the cornea [16]. The 
guttata density is highest in the central region of the cornea and gradually decreases 
towards the peripheral area [208]. Previous studies using transmission electron 
microscopy (TEM), have reported that guttata lesions appear as convex micro-dome 
like or micro-pillar like structures with different diameters, heights and spacing. These 
factors all depend on the stage to which the FED had progressed [1]. 
In view of the worldwide shortage of transplant grade tissue, minimal invasive cell 
regenerative medicine procedures have been proposed as possible alternatives for the 
treatment of patients with endothelial dysfunction (Section 2.5)[13, 102, 105, 110, 111, 
209]. However, the effect of guttata on primary HCEC monolayer regeneration is 
unknown and proper disease models to study this effect does not exist. In order to better 
understand the influence of corneal guttata in both these possible treatment modalities, 
I aimed to recapitulate the topographical micro-environment created by the presence of 
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guttata found in clinical cases of FED [210].  In this chapter, I used existing clinical 
data to develop a variety of synthetic guttata-like microstructures that would allow a 
better understanding of how different guttata dimensions affect migration, spreading 
and monolayer formation of primary cells [210]. Furthermore, I aimed to develop a 
better understanding of the physical micro-obstacles that could affect corneal 
endothelial recovery following these new endothelial cell regenerative approaches. 
4.2  Materials and methods 
4.2.1 Characterization of FED patient guttata 
A 36 years old patient affected by FED (Krachmer grading 3 [211]) was examined for 
guttata (Figure 4.4). The image was acquired after pupillary dilation, with the patient 
positioned on a slit lamp (SL-D8Z, Topcon corp., Tokyo, Japan) combined with a 
digital camera (D7000, Nikon Corp., Tokyo, Japan). Using ImageJ software, five 
guttata were manually selected at their higher reflection intensity signal and joined in a 
triangulation by means of a Delaunay algorithm. Using Pythagorean theorem, each side 
representing the spacing between guttata was calculated. Following IRB and ethics 
approval, a patient with FED gave consent for their DM to be used for research 
following excision during a corneal transplantation procedure. A section from the 
central DM was excised and fixed in a mixture of 2% paraformaldehyde and 2% 
glutaraldehyde (Electron Microscopy Sciences) at 4°C overnight. Post-fixation in 1% 
osmium tetroxide (Electron Microscopy Sciences) was then performed for 2 hrs at room 
temperature. After rinsing with copious amounts of distilled water, the sample was 
dehydrated through a series of graded ethanol, then embedded in Araldite resin 
(Electron Microscopy Sciences). Ultrathin sections of 80-100 nm thickness were 
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collected on nickel grids, stained with lead citrate for 8 minutes, and finally imaged 




4.2.2 B4G12 cell culture 
Human corneal endothelial cell line (B4G12) was cultured on flasks coated with 10 
µg/mL laminin (Gibco) and 10 mg/ml chondroitin sulfate (Sigma) in a culture media 
Figure 4.1 Examination of the guttata of a patient with Fuchs dystrophy. (A) 
Appearance of guttata in retroillumination photography. Guttata are densely packed in 
the central region of cornea, gradually decreasing in density towards the peripheral 
region. (b) Enlargement of the insert rectangle in (a) showing a representative affected 
region where the average of distances between five selected guttata is 38.4 μm (white 
lines forming a Delaunay triangulation). The arrow in the lower part of the image shows 
calescence of two guttata. (c) Appearance of a representative guttata in transmission 
electron microscopy (TEM). The guttata height is about 3.5 µm and the diameter is 
about 20 µm. Low height of guttata is potentially indicating that this particular guttata 
belong to an early stage of formation. 
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containing 10% Fetal Bovine Serum (FBS, Gibco) and 1% Penicillin-Streptomycin 
(Gibco) in High Glucose DMEM (HyClone®). The cells were cultured in a 5% CO2 
incubator at 37 °C with a medium change every other day until reaching confluence. 
The cells were then passaged using trypsin (Gibco) and seeded on PDMS and PS 
synthetic guttata (s-guttata) substrates for experiments. 
4.2.3 Primary HCECs isolation and culture 
Research-grade donor corneas not suitable for transplantation were obtained from the 
Lions Eye Institute for Transplant and Research (Miami, FL, USA). Primary HCECs 
were isolated from donor corneas as described previously [95]. The donor information 
is provided in Table S1. The protocols conformed to the tenets of the Declaration of 
Helsinki, and the study was approved by the institutional review board of the Singapore 
Eye Research Institute / Singapore National Eye Centre. A dual culture media system 
was used to cultivate the cells obtained from the donor corneas which was comprised 
of M5-Endo stabilization media (s-media) and M4-F99 proliferation media (p-media) 
as previously described [132, 193]. The s-media consisted of human endothelial-SFM 
supplemented with 5% fetal bovine serum (Gibco) and 1% penicillin-streptomycin 
(Gibco), and the p-media is made up of equal amounts of Ham’s F12 and M99 
supplemented with 5% fetal bovine serum (Gibco), 20 µg/ml of ascorbic acid (Sigma), 
Insulin, Transferrin, Selenium, Ethanolamine Solution (ITS-X, Gibco) diluted to a final 
concentration of 5 µg/ml of insulin, 2.75 µg/ml of transferrin, 2.5 ng/ml of selenium, 
1X antibiotic/antimycotic (Gibco), and 10 ng/ml of bFGF (Life Technologies). The 
media was changed every other day. The cells were maintained in an incubator with 
5% CO2 on tissue culture dishes with FNC Coating (proprietary coating mixture of 
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fibronectin and collagen, US Biological). For experiments, HCECs were passaged by 
using TrypLE™ Express (Gibco) for 10 minutes at 37 °C. 
4.2.4 Fabrication of PDMS micro-structures 
Based on the dimensions of patients’ guttata (Figure 4.4) and published literature [16, 
208, 212-217], synthetic guttata (s-guttata) micro-structures of similar dimensions were 
fabricated on silicon (Si) wafers by using standard photolithography tools (MBI 
Microfab Core). Polydimethylsiloxane (PDMS Sylgard 184, Dow Corning) stamps 
were prepared as mentioned in section 3.2.1. Two types of structures were prepared in 
PDMS: PDMS s-guttata pillars for B4G12 cell culture and experiments, and PDMS 
micro-wells as working stamps for fabrication of polystyrene (PS) s-guttata pillars and 
domes.  
Table 4.1 Donor information of the primary human corneal endothelial cells used in 
the current study. OD = Oculus Dexter, OS = Oculus Sinister. 
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4.2.5 Fabrication of polystyrene synthetic guttata (s-guttata) pillars and domes 
and coating of fluorescently-labelled fibronectin  
PDMS with micro-wells were used as stamps to fabricate micro-pillars by using hot-
embossing as described in section 3.2.1. 
 
For the fabrication of PS s-guttata with curved sidewalls (s-guttata domes), a simplified 
schematic of the fabrication concept is shown in Figure 4.1. Starting with a PDMS 
master with micro-wells (vertical sidewalls), a range of embossing parameters were 
used to transfer the patterns from PDMS to PS (PS-1, convex). For PDMS to PS-1 hot-
embossing, temperatures ranging from 150-200°C with a fixed pressure of 2 bar for 90 
sec followed by 30 sec air-cooling were used. For sample preparation for SEM analysis, 
PS-1 was used to transfer patterns to PDMS-2 (concave) by using PDMS molding. 
PDMS-2 was analyzed with SEM for pattern fidelity. The PDMS-2 with desired feature 
Figure 4.2 Experimental design. (a) Hot embossing of s-guttata pillars and domes by 
using the same mold by changing process parameters. (b) Micro-domes with curved 
sidewalls were fabricated by using a regular micro-well mold with vertical sidewalls 
by reducing the embossing pressure and temperature. 
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dimensions after optimization were used as a master stamp to transfer patterns to PS by 
using hot embossing at optimized parameters. The s-guttata feature types and 
dimensions are given in Table 1 along with the naming convention used to refer to 
various s-guttata features. 
S-guttata pillars of different heights and dimensions were cleaned with absolute ethanol 
and dried with N2 gas before exposure to 80% O2 plasma for 1 min at 80 W (FEMTO 
Science, Cute-B). After plasma treatment, the samples were incubated in 1 µg/ml of 
fluorescently-labeled fibronectin (HiLyte 488, Cytoskeleton) in DI water for 1 hr at 
37°C. Subsequently, the samples were washed 3 times with DI water and imaged with 
LSM 710 confocal microscope (Nikon). 
4.2.6 Preparation of PDMS films for cell attachment blocking 
 PDMS solution was prepared with 10:1 base to curing agent ratio. PDMS solution was 
introduced between two glass slide chambers with 150 µm spacers and allowed to 
crosslink for 4 h at 60°C. After crosslinking, the PDMS film was carefully harvested 
from the glass slides and cut into strips of 1 mm in width and about 7 mm in length. 
The strips were used to block cell attachment on PS s-guttata samples. 
4.2.7 B4G12 cell seeding on synthetic guttata 
 PDMS s-guttata pillars of different heights and dimensions were cleaned with absolute 
ethanol and dried with N2 gas before exposure to 80% O2 plasma for 1 min at 80 W 
(FEMTO Science, Cute-B). The samples were sterilized with UV exposure for 30 min. 
To simulate the cell injection therapy, B4G12 cells were seeded at a seeding density of 
100,000 cells/cm2 directly on top of PDMS s-guttata pillars between 5-20 µm in height, 
10-40 µm diameter and 10-80 µm spacing as given in Table 1. The cells were cultured 
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for 7 days to allow the formation of a monolayer. Subsequently, the cells were stained 
for zona occludin 1 (ZO1) as described in section 2.7 and imaged using an optical 
microscope to analyze the B4G12 monolayer. For cell monolayer formation from 
migrated cells, PS samples with s-guttata pillars for cell seeding were cleaned with 
absolute ethanol and dried with N2 gas before exposure to 80% O2 plasma for 1 min at 
80 W (FEMTO Science, Cute-B). PS samples and the PDMS strips were then irradiated 
with UV for 30 min for sterilization. PDMS strips were placed in the center of PS 
samples to block cell attachment (Figure 4.2). B4G12 cells were seeded at a density of 
100,000 cells/cm2 on PS samples in 24 well plates. After 4 h, the PDMS strips were 
carefully lifted from the samples and the samples were washed twice with media to 
remove any unattached cells. Time-lapse images of the cell migration were captured by 
using an IncuCyte ZOOM® microscope (Essen Bioscience) for 48 hrs. After live cell 
imaging, the same cells were cultured for 5 additional days to allow cells to form a 
monolayer. Subsequently, the cells were characterized by using confocal microscopy 




4.2.8 Primary cells seeding on synthetic guttata 
 Polystyrene (PS) samples with s-guttata micro-structures for studying cell migration 
were prepared similarly as described for B4G12 cells. FNC coating solution was added 
in the s-media at a ratio of 1:2 (1 part FNC solution to 2 parts s-media). The HCECs 
were detached from the culture flask by using TrypLE and seeded onto the PS samples 
with PDMS strip at a density of 100,000 cells/cm2 by using s-media with the FNC 
coating. After 4 h, the strips were removed and the cells were washed twice with the s-
media containing FNC solution. After washing, fresh s-media without FNC solution 
Figure 4.3 Schematic diagram of the experimental design for cell migration and 
imaging. The monolayer of migrated cells was imaged in the area which was initially 
covered with PDMS strip during cell seeding. The monolayer of the cells seeded 
directly on top of the s-guttata was imaged in the area which was not covered with 
PDMS strip during seeding. 
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was added into the wells. The imaging time points and method used was similar to the 
imaging of B4G12 cells. 
4.2.9 Cell migration analysis 
 Raw cell migration tracks of B4G12 cells and HCECs were plotted by using time-lapse 
images of the cell migration with the help of the manual tracking plugin in Fiji (NIH). 
Migration tracks were then analyzed with the Ibidi chemotaxis and migration tool for 
cell migration speed, distance, and direction of cell migration. Euclidean distance was 
defined as the straight line distance between two points while the accumulated distance 
was defined as the total distance travelled by the cells between two points. 
4.2.10 Immunofluorescence staining and imaging 
B4G12 cells and the primary HCECs on PS s-guttata microstructures at day 7 were 
stained for ZO1 as described in section 3.2.4. The monolayer imaging was performed 
with the samples in PBS without mounting to prevent disturbing the cells on top of s-
guttata. Confocal microscopy images were captured at an interval of 2 µm in the z-
direction starting from the basal plane of s-guttata micro-structures to the apical plane 
of the micro-structures where the cells were no longer visible. The z-stack was merged 
using the ‘maximum intensity projection’ option in Fiji to combine the details of the 
cell monolayer on the bottom and top of the micro-structures in one image (Figure 4.3). 
For the monolayer of migrated cells, the confocal imaging zone was restricted to the 
area which was initially covered by the PDMS strip so that only the migrated cells were 
imaged. The percentages of s-guttata pillars or domes with the ZO1 expression on top 
were calculated by using images of HCEC monolayer in a cell migration model. To 
determine the percentage of the s-guttata pillars or domes with ZO1 expression on top, 
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a binary scoring system (positive or negative for the cell-cell junctions ZO1 on top of 
guttata) was used. 
4.2.11 Scanning electron microscopy 
 B4G12 cells and the HCECs were seeded on PS samples with s-guttata and allowed to 
form a monolayer as mentioned in section 2.5. After 7 days of culture, the cells were 
prepared for SEM analysis as described in section 3.2.7. The images of single cell 
interaction with s-guttata were taken from the center of the area which was initially 
blocked with PDMS film, where the cells were less confluent at the time point of 7 
days. 
4.2.12 Statistical analysis 
One-way ANOVA with Tukey’s post hoc test was used to determine statistical 
significance of multiple comparisons. The statistical significance threshold was set at 
P ≤ 0.05. All data are presented as means ± SD. For the B4G12 cell migration analysis, 
20 cells per group were analyzed. For the primary HCECs migration analysis, 40 cells 
per group were analyzed. At least 50 s-guttata micro-structures were analyzed per group 
for ZO1 expression analysis on top of s-guttata.  
Figure 4.4 Confocal imaging method used for capturing the cell monolayer on s-
guttata. Due to the height of s-guttata (20 µm), capturing complete monolayer on basal 
and top planes of guttata was not possible in a single image. Stacks were captured along 
Z-direction and merged in Fiji software to merge the monolayers in one image. 
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4.3  Results 
4.3.1 Examination of guttata lesions on posterior cornea of FED patients 
The dimesons of corneal guttata from a patient’s cornea and in the published literature 
were examined to develop a clinically relevant FED disease model. Full field corneal 
DM image showed that the guttata were relatively more densely packed in the central 
portion of the cornea (Figure 4.4A). The density of the guttata decreased from center to 
the peripheral regions. The average guttata spacing between the five guttata was 38.4 ± 
5.7μm (Figure 4.4B). No region with spacing <20 microns could be identified. This 
could be due to the fact that as the spatial density increased, neighboring guttata 
eventually become confluent to give rise to guttata of larger diameter. In the TEM 
image, the guttata emerged on the posterior surface of the DM as an excrescent mass 
of material, resembling pillar-like structure with an irregularly curved sidewall, and 
without an obvious separation to the posterior non-banded zone of DM (Figure 4.4C, 
Courtesy of our collaborators Dr Jod Mehta, Gary Peh, and Sacha Naso from Singapore 
Eye Research Institute). The width of this particular guttata was about 20 µm, with a 
height of about 3.5 µm. The analysis of guttata images in the published literature 
showed guttata height ranging from 3-25 µm, guttata width from 6-70 µm and guttata 
spacing from 3-240 µm on FED affected corneas depending of the stage of the disease 
(Table 4.2). Based on the in vivo guttata examination, the s-guttata were designed to 
have spacing and widths from 20 µm to 40 µm and heights ranging from 5 µm to 20 





4.3.2 Fabrication of dome-like structures by using micro-well stamps 
 
In vivo, guttata could also appear as mushroom-like micro-structures with 
curved sidewalls [62], herein referred to as domes. Fabrication of the s-guttata domes 
was achieved using the same stamps used in the fabrication of s-guttata micro-pillars 
by controlling hot embossing parameters. The replication scheme was started with 20 
µm deep PDMS micro-wells. The results demonstrated that the sidewall curvature and 
the depth of the replicated patterns gradually increased as the time or temperature of 
the embossing was increased (Figure 4.5B). The depth of the replicated patterns peaked 
at about 5 µm for 20 µm diameter domes and 10 µm for 40 µm diameter domes (Figure 










1 NA 17-18 3-8 [214] 
2 6-33 9-17 NA [218] 
3 10-34 20-34 6-13 [219] 
5 30-240 40-70 10-25 [220] 
6 3-28 10-40 6 [221] 
7 3-45 6-15 6-12 [222] 




sidewalls) were obtained instead of the dome structures, indicating that a maximum 
aspect ratio (A.R.) of 0.25 of the domes could be achieved with this method. 
  
Figure 4.5 Dome-like microstructures (round edges) fabrication with micro-pillars 
(vertical edges). Effect of varying the temperature and time of embossing at fixed 
pressure on the depth of heat-embossed concave domes. Increasing the time and 
temperature increased the depth of domes. Ultimately, the micro-wells were obtained 
instead of micro-domes at 200°C temperature. Negative replica in PDMS (concave 





Table 4.3 Dimensions and types of s-guttata micro-structures used for studying cell 
monolayer formation. H refers to the height of the features (5 µm, 10 µm, 20 µm) 
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4.3.3 Interaction of B4G12 cells with synthetic guttata micro-structures 
4.3.3.1 B4G12 monolayer formation on s-guttata to evaluate cell injection 
therapy approach 
Cells were seeded directly on top of s-guttata to simulate a cell injection approach. The 
results demonstrated that B4G12 cells were able to attach to the base, as well as to the 
top of the s-guttata, and this was observed for all three different PDMS pillar heights 
(5 µm, 10 µm, 20 µm) (Figure 4.6).  
Depending on the pillar dimensions and spacing, the cell-cell junction protein ZO1 and 
cell nuclei could be observed on top of the pillars (Figure 4.6). The cells could not form 
a monolayer on top of 10 µm diameter pillars as the junctional ZO1 was not observed 
on top, and this was regardless of the pillar height or spacing (Figure 4.6). The cells 
were also elongated on 10x20x20 (10 µm diameter, 20 µm spacing, 20 µm height) pillar 
samples. In contrast, the cells could express cell-cell junction ZO1 on top of 20 µm 
pillars with the lower heights of 5 µm and 10 µm (Figure 4.6A and 4.6B). However, 




Figure 4.6 B4G12 monolayer formation on PDMS pillars of various dimensions. The 
cells were seeded on top of the pillars and stained and imaged after the monolayer was 
formed. (a) Immunofluorescence staining images of ZO1 expressed by B4G12 on 
H=5μm PDMS pillars. (b) Immunofluorescence staining images of ZO1 expressed by 
B4G12 on H=10μm PDMS pillars. (c) Immunofluorescence staining images of ZO1 
expressed by B4G12 on H=20μm PDMS pillars, 3 days after reaching confluence. 




s-guttata with an array of pillars of 20 µm height, and the cells were also elongated on 
s-guttata samples with 20x20x20 (20 µm diameter, 20 µm spacing, 20 µm height) 
pillars (Figure 4.6C).  
In the case of 40 µm diameter pillars, cells were also not able to form a monolayer on 
20 µm height pillars (40x40x20) (40 µm diameter, 40 µm spacing, 20 µm height) 
(Figure 4.6C). When the spacing between 40 µm diameter pillars was increased from 
40 µm to 80 µm (40x80x20 pillars), the monolayer formation was restored on the space 
between the micro-structures. With lower heights of 5 µm and 10 µm (40x40x5 and 
40x40x10), the cell-cell junction ZO1 was observed on top of pillars, and this was 
regardless of the pillar spacing (Figure 4.6C). 
The interaction between B4G12 cells and the PDMS s-guttata also served as a screening 
experiment to reduce the number of s-guttata sizes that would be used to study the 
migratory behavior of B4G12 and HCECs with relevance to the pharmacotherapy 
approach. The 20 µm s-guttata height was selected for migratory behavior experiments 
because the results of the above experiments suggested that the 20 µm tall pillars 
restricted monolayer formation. In terms of diameters, 20 µm and 40 µm wide pillars 
were selected for migratory behavior experiments. The 10 µm diameter pillars were 
excluded as those with a height of 20 µm would give rise to an aspect ratio of 2, which 
is not representative of in vivo guttata, where the aspect ratio is usually less than 2 as 
suggested by the guttata images [1, 16, 216]. 
4.3.3.2 B4G12 monolayer formation in a cell migration model to evaluate 
pharmacotherapy approach 
B4G12 cells were used in a cell migration model that allowed the formation of a 
monolayer composed exclusively of migrated cells. This model effectively excludes the 
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possibility of cells settling on top of the micro-structures during seeding. The data 
indicated that B4G12 cells were unable to migrate on the PDMS substrate. However, 
B4G12 cells and the primary HCECs demonstrated a capacity to migrate on the 
polystyrene (PS) substrate. Therefore, a PS substrate was used for subsequent 
experiments on cell migration and monolayer formation. Synthetic guttata on PS with 
a fixed 20 µm height and varying sizes (20-40 µm diameter and 20-80 µm spacing, 
Table 3) were used to study cell response and monolayer formation of B4G12 cells. 
The complete monolayer from the basal plane to the apical plane of the s-guttata micro-
structures was captured by merging z-stacks. 
The spacing of the s-guttata affected the monolayer formation. On s-guttata samples 
with 20 µm diameter pillars and 20 µm spacing (20x20x20), the cells could not form a 
monolayer at apical or basal plane of guttata (Figure 4.7A). When the spacing was 
increased from 20 µm to 40 µm (20x40x20), the junctional ZO1 was better expressed 
Figure 4.7 (a) B4G12 cell monolayer formation on polystyrene (PS) synthetic-guttata 
pillars of 20 µm diameter and on (b) 40 µm diameter. (height 20 µm for all). The s-
guttata were covered with PDMS strip during cell seeding. 
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at the base of pillars, whereas junctional ZO1 expression on the apical plane of the 
pillars was also observed on some pillars (Figure 4.7A). It appears that an increase in 
the spacing of s-guttata facilitated the climbing of the cells, which in turn improved the 
monolayer formation. In the case of s-guttata samples with 40 µm diameter pillars and 
40 µm spacing (40x40x20), the B4G12 monolayer was observed at the basal plane, as 
well as at the apical plane of all the pillars (Figure 4.7B). When the spacing was 
increased from 40 µm to 80 µm (40x80x20), no appreciable difference in the monolayer 
formation was observed (Figure 4.7B).  
The s-guttata pillar diameter also influenced the monolayer formation. On square array 
s-guttata samples with 20 µm diameter pillars (20x20x20), B4G12 cells could not form 
monolayer on top of the pillars. When the diameter was increased from 20 µm to 40 
µm (40x40x20), the cells formed monolayer on top of pillars.  No appreciable 
difference between hexagonal and square arrangement of pillars was found in terms of 
the coverage of pillars with junctional ZO1 except for 20x20x20 pillars where the cells 
could not form monolayer on square array pillars. DAPI staining observed on top of 
pillars indicated that multiple cells, including cell nuclei were able to migrate and climb 






4.3.3.3 SEM characterization of the interaction of B4G12 cells with s-guttata 
Scanning electron microscopy (SEM) was performed in order to confirm the responses 
of B4G12 cells. SEM images supported the observations made in confocal analysis. 
Cells were unable to form a monolayer on the basal plane of s-guttata 20x20x20 pillars, 
and they tended to be elongated (Figure 4.9A).  A cell monolayer with regular 
polygonal cell morphology was restored as the pillar spacing was increased, except at 
the pillar periphery where a discontinuity in the cell monolayer was noticed (Figure 
4.9A). The highest deviation from a monolayer was found on 20x20x20 pillars, 
regardless of the arrangement when compared with the s-guttata-free area (Figure 
4.9A). This appears to be a function of s-guttata pillar spacing (pillar density) since the 
height was same for all s-guttata features in this experiment. 
Figure 4.8 Distribution and morphology of B4G12 and HCEC nuclei on synthetic 
guttata. B4G12 nuclei were found on top of the pillars indicating that the nuclei can 
climb to the top of pillars. Primary cells nuclei were not found on top of pillars or 
domes. Nuclei around the pillar periphery deform to wrap the pillars. Deformation was 
higher when the pillar diameter is less. 
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Increasing the pillar diameter from 20 µm (20x20x20) to 40 µm (40x40x20) also 
improved the monolayer formation (Figure 4.9A & 4.9B).  When using 40 µm pillars 
spaced 80 µm apart, the cells formed a monolayer in the area between the pillars, which 
was similar to s-guttata-free surface (Figure 4.9B). Higher magnification images of the 
cell interaction revealed that cells ‘bridged’ two nearby pillars on the 20x20x20 pillars 
(Figure 4.9C). The cell cytoplasm was also observed on apical plane of the 20x20x20 
pillars. However, the cells were elongated (Figure 4.9C) and there were gaps between 
cells (Figure 4.9A), which could be due to the presence of high density s-guttata 
(20x20x20), which prevented the cells to assume a polygonal cell morphology and cell 
monolayer formation. Cells were also found to be ‘suspended’ between two pillars 





Figure 4.9 SEM characterization of the interaction of B4G12 cells with s-guttata. (a,b) 
Comparison of B4G12 cell monolayer formation on s-guttata pillars of various spacing 
and diameter (Height 20 µm for all) vs s-guttata-free area on polystyrene substrates. 
The images represent cell monolayer formed after the cell migration, excluding the 
possibility of any cells on top of s-guttata micro-structures during cell seeding. (c) High 
magnification SEM images of cells interacting with synthetic guttata. 
 95 
 
4.3.3.4 Analysis of cell migration on s-guttata 
Raw cell migration tracks suggested that the cells tend to migrate in a nearly straight 
path on s-guttata-free surfaces (Figure 4.10A). However, on s-guttata-laden surfaces, 
the migration paths were highly deviated due to the presence of s-guttata. The deviation 
decreased as the spacing of pillars increased. The Euclidean distance traveled by cells 
was significantly lower on s-guttata-laden substrates as compared to s-guttata-free 
substrates, which indicate that s-guttata hindered cell movement (Figure 4.10B). The 
Euclidean distance travelled by the cells was lowest on high density and tightly spaced 
20x20x20 pillars (Figure 4.10B). The Euclidean distance travelled by the cells 
increased when the pillars were spaced further apart. The accumulated distance covered 
by cells on all types of s-guttata samples did not significantly differ from the s-guttata-
free substrates. The accumulated distance was higher than the Euclidean distance for 
all types of s-guttata pillars. 
The spacing between s-guttata pillars also affected the direction in which cells migrated.  
The direction of cell migration deviated the most when the s-guttata pillars were spaced 
closer together (20x20x20) (Figure 4.10D). When the spacing was increased from 20 
µm to 40 µm for 20 µm diameter pillars (20x40x20), and from 40 µm to 80 µm for 40 
µm diameter pillars (40x80x20), the deviation in the direction of cell migration 
decreased (Figure 4.10D). The increased deviation in cell migration direction that was 
observed as the pillar spacing decreased, indicated a gradual increase in hindrance to 
cell movement presented by s-guttata (Figure 4.10D). The migration speed was similar 
on all types of surfaces (Figure 4.10E).  
Similar to confocal and SEM imaging data, no significant difference in the direction, 
speed and distance in which cells migrated was observed on square vs hexagonal 
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arrangement of s-guttata pillars. Overall, the results of B4G12 cell migration and 
monolayer formation on s-guttata structures showed that the small and densely packed 
pillars with 20 µm diameter and 20 µm spacing presented the most challenging surface 





Figure 4.10 Migratory behavior of B4G12 cells. (a) Raw cell migration tracks of 
B4G12 cells on polystyrene (PS) s-guttata pillars. (b) Euclidean distance (least distance 
from point A to point B) covered by cells in 48 hrs. (c) Accumulated distance (total 
distance) travelled by cells in 48 hrs. (d) Directness of cell migration showing the 
ability of cells to move in a straight line. (e) Speed of the B4G12 cell migration. Error 
bar represents the standard deviation of the mean. In total 20 cells were analyzed for 
the migration behavior (n=20). *shows statistical significance as compared to s-guttata-
free control. # shows statistical significance between groups connected by bracket. 




4.3.4 Interaction of primary HCECs with synthetic guttata micro-structures 
Based on the results observed using B4G12 cells, I then assessed the behavior of 
primary corneal endothelium on s-guttata. For these experiments, PS s-guttata pillar 
arrays with the highest density and smaller spacing (20 µm diameter pillars with 20 µm 
spacing that represent the highest number of s-guttata per given area (625 pillars/mm2)) 
and lowest density with larger spacing (40 µm diameter pillars with 80 µm spacing that 
represent the lowest number of s-guttata per given area (69 pillars/mm2)) with either 20 
µm or 10 µm in height were used.  
4.3.4.1 Primary HCEC monolayer formation on s-guttata to evaluate cell 
injection therapy approach 
The size of the s-guttata affected the ability of the primary HCECs to constitute a 
monolayer on top of the pillars. Almost no monolayer formation was observed on apical 
plane of 20 µm tall pillars, and this was the case for the 20 µm diameter pillars 
(20x20x20) and 40 µm diameter pillars (40x80x20) (Figure 4.11A). However, at 10 µm 
height, 20 µm diameter pillars (20x20x10) had better monolayer coverage on top of the 
pillars as compared to the 40 µm diameter pillars (40x80x10) (Figure 4.11A). Similarly, 
the 20 µm diameter domes (mushroom-like micro-structures with curved sidewalls) 
(20x20x5) were found to have more cell-cell junctions and monolayer on top of the 





Figure 4.11 Primary human corneal endothelial cells (HCECs) monolayer formation on 
s-guttata micro-structures. (a) Primary HCECs monolayer formation of the cells seeded 
directly on top of s-guttata pillars and domes to evaluate the cell injection therapy. (b) 
Primary HCECs monolayer formation of migrated cells on various s-guttata pillars and 
domes to evaluate cell migration in pharmacotherapy. (c) Quantification of the 
monolayer formation on top of s-guttata in terms of the number of pillars covered with 
cell-cell junction protein zona occludin 1 (ZO1) on top. At least 50 pillars per group 
were analyzed for the presence of ZO1 at cell-cell tight junctions on top of s-guttata. 
The results are presented as the %age s-guttata with ZO1 on top. Error bar represents 
the standard deviation of the mean (n=3). (d) An example comparison of the cell 
morphology and ZO1 expression on s-guttata pillars vs s-guttata-free area (e) SEM 
characterization of the interaction of primary HCECs with s-guttata pillars and domes. 




Junctional ZO1 was lacking on the vast majority of the 20 µm diameter pillars with 20 
µm height (20x20x20). When the height of pillars was reduced from 20 µm to 10 µm 
(20x20x10), the junctional ZO1 was clearly observed on top, indicating that primary 
HCECs are able to overcome some micro-structures at a height of 10 µm (Figure 
4.11A). However, with 40 µm diameter pillars, reducing the height from 20 µm 
(40x20x20) to 10 µm (40x20x10), did not induce monolayer formation on top of pillars. 
The s-guttata diameter seemed to have significant effect on the amount of cell 
monolayer that can form on the apical plane of s-guttata. 
The sidewall profile significantly affected cell monolayer formation on top of s-guttata. 
The number of cell-cell junctions on top of 20 µm diameter s-guttata domes, which had 
a 20 µm spacing and 5 µm height (20x20x5), increased as compared to that on 
20x20x20 pillars. Additionally, tri-cellular cell-cell junctions were also observed on top 
of the 20x20x5 domes (Figure 4.11A). However, the cells behaved differently on large 
diameter 40x40x10 domes (40 µm diameter) being unable to constitute cell-cell 
junctions (Figure 4.11A). There is a possibility of cells settling on apical plane of large 
40 µm diameter pillars during cell seeding however, the cell monolayer was still not 
observed on the apical plane which could be because the cells on apical plane could not 
establish cell-cell contacts with the cells at the basal plane. Overall, the amount of cell-
cell junction ZO1 expression in HCECs on top of s-guttata was dependent on the height, 
diameter and type of the s-guttata. Decreasing the height of pillars and making the 
sidewalls curved instead of vertical led to significantly increased ZO1 expression. 
 101 
 
4.3.4.2 Primary HCEC monolayer formation on s-guttata to evaluate 
pharmacotherapy approach 
The s-guttata size also affected the ability of the primary HCECs to constitute a 
monolayer on top of the pillars in a cell migration model. The cells had a better 
monolayer coverage on top of 10 µm tall and 20 µm diameter pillars (20x20x10), when 
compared to 40 µm diameter pillars (40x80x10) (Figure 4.11B). Similarly, 20 µm 
diameter domes (20x20x5) had more cell-cell junctions and monolayer on top of them 
as compared to 40 µm diameter domes (40x80x10) (Figure 4.11B). Overall, the 40 µm 
diameter s-guttata had lower cell-cell junctions and less monolayer coverage on top, 
irrespective of height and shape. The results suggested that the 40 µm diameter pillars 
being too large were difficult to overcome by the cells for monolayer formation. 
The height of the s-guttata also influenced the HCEC monolayer formation. Very few 
cell-cell junctions were found on top of 20x20x20 pillars (Figure 4.11B). Decreasing 
the height from 20 µm to 10 µm, increased the number of cell-cell junctions observed 
on top of the 20x20x10 pillars (Figure 4.11B). In the case of 20 µm and 40 µm diameter 
s-guttata, when the sidewall of the s-guttata changed from vertical (pillars) to curved 
(domes), an increase in the cell-cell junctions on top of the domes was observed (Figure 
4.11B).  
Next, I quantified the expression of the cell-cell junction ZO1 observed on top of the s-
guttata pillars and domes. Only 2% of the 20x20x20 pillars, had ZO1 expression on 
top. Decreasing the pillar height from 20 µm to 10 µm (20x20x10) increased ZO1 
expression on top of pillars from 2% to almost 60% (Figure 4.11C). On 20x20x5 s-
guttata domes, ZO1 was expressed in approximately 75% of the cell monolayer (Figure 
4.11C). Less ZO1 coverage was observed top of the 40x80x10 s-guttata domes, as 
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compared to the 20x20x5 domes. This indicated that the small s-guttata domes were 
more conducive to cell-cell junction formation and this in turn led to better monolayer 
coverage (Figure 4.11C). Overall, the results suggested that the taller, denser s-guttata 
pillar arrays (20x20x20) were the least favorable substrates for corneal endothelial 
monolayer formation. The endothelial monolayer formation was most efficient on 
smaller domes (20x20x5) compared to pillars, and this was regardless of pillar 
dimensions.  
Comparing the cell morphology and the ZO1 expression profile of the densely packed 
20x20x20 pillars with the s-guttata-free area clearly showed that ZO1 expression and 
cell morphology was disturbed by the presence of dense s-guttata (Figure 4.11D). The 
cells were polygonal and ZO1 was clearly expressed and located at cell-cell junctions 
on s-guttata-free area. However, the cells were elongated and ZO1 could not be 
expressed at cell-cell junctions when cells were on 20x20x20 s-guttata pillars (Figure 
4.11D). More strikingly, the primary cell nuclei were unable to climb the s-guttata 
regardless of the pillars height or structure, which clearly differed from the response of 
B4G12 cells (Figure 4.8). To confirm if the height or shape of the s-guttata affects the 
extracellular matrix (ECM) coating and thus the cell climbing, s-guttata micro-
structures were coated with fluorescently-labelled fibronectin. The results displayed 
that the fibronectin coating was conformal regardless of the height or shape of the s-
guttata (Figure 4.12). Therefore, the different behavior of HCECs is unlikely due to 
differential ECM coating. The primary cell nuclei clustered around the s-guttata, which 
was similar to rosette-type clustering of primary corneal endothelial cells in vivo [218]. 
The HCEC clustering also validated the developed disease model as it recapitulated the 




4.3.4.3 SEM analysis of the primary HCEC monolayer 
SEM analysis of the primary HCEC monolayer verified the observations made through 
confocal microscopy. The cell layer was highly irregular on 20x20x20 pillars and the 
cells were not in the form of a monolayer (Figure 4.13). Decreasing the height of the 
pillars lead to decreased spacing between cell boundaries and improved monolayer 
formation. On s-guttata domes, the cells were able to form a more intact monolayer 
without much disruption observed, and this was regardless of dome size. This is likely 
due to the curved sidewalls of the domes, which assisted the cell migration and or cell 
stretching, climbing over the dome-like micro-structure (Figure 4.13).  
Figure 4.12 Coating of fluorescently-labelled fibronectin on s-guttata micro-structures. 
The images showed a conformal fibronectin coating on the s-guttata regardless of 




4.3.4.4 Analysis of primary HCECs migration on s-guttata 
Raw cell migration tracks of primary HCECs displayed that the cell movement was 
most chaotic (cells often deviated from a straight direction) on high density 20x20x20 
pillars (Figure 4.14A). With primary HCECs, the accumulated as well as Euclidean 
distance travelled by the cells, as well as the cell migration speed, was significantly 
higher on s-guttata domes as compared to the high density 20 µm pillars (20x20x20) 
and low density 40 µm diameter pillars (40x80x20). This suggests that the sidewall 
profile significantly affected the cell migration. Migration speed, accumulated distance 
and Euclidean distance was slightly higher on 40x80x20 pillars as compared to 
20x20x20 pillars. Cells migrating on s-guttata domes (both the 20x20x5 and 40x80x10) 
behaved similarly as those on s-guttata-free controls in term of the migration speed and 
direction. Keeping the feature diameter the same and changing 
Figure 4.13 SEM characterization of the interaction of primary HCECs with s-guttata 




Figure 4.14 Migratory behavior of primary human corneal endothelial cells (HCECs). 
(a) Raw cell migration tracks of primary HCECs on polystyrene (PS) s-guttata pillars 
and domes. (b) Speed of the primary HCEC cell migration. (c) Accumulated distance 
travelled by primary HCECs in 48 hrs. (d) Euclidean distance covered by primary 
HCECs in 48 hrs. (e) Directness of cell migration showing the ability of primary 
HCECs to move in straight line. Error bar represents the standard deviation of the mean. 
In total 40 cells were analyzed for the migration behavior (n=40). *shows statistical 
significance as compared to s-guttata-free control. # shows statistical significance 
between groups connected by bracket. *P<0.05; **P<0.01; ***P<0.001; 
****P<0.0001. #P<0.05; ##P<0.01; ###P<0.001; ####P<0.0001 
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 the sidewalls from vertical to curved significantly improved the cell migration in terms 
of migration distance, speed, and directness (Figure 4.14B-D). Cells deviated regularly 
in the direction they migrated when on 20x20x20 pillars, indicating the increased 
interaction of migrating cells and the hindrance to cell movement presented by pillars 
(Figure 4.14E). This deviation in the direction of HCEC cell migration 20x20x20 pillars 
was 30.4 % higher as compared to s-guttata-free control, while the 40x80x20 pillars 
produced 20.6 % more deviation as compared to s-guttata-free control. 20x20x5 domes 
had only 5.8 % more deviation in the direction of migration and 40x80x10 domes had 
12.6 % more deviation as compared to the guttata-free control. The difference in 
directness between 20x20x5 and 40x80x10 domes was not significant (Figure 4.14E). 
4.4  Discussion 
Here, I developed a synthetic guttata (s-guttata) model to evaluate corneal endothelial 
monolayer formation following two approaches to regenerative tissue engineering. This 
model was based both on clinical observations (in collaboration with Dr. Jod Mehta in 
Singapore Eye Research Institute) and from published literature [16, 208, 212-217]. 
Studying the formation of corneal endothelial monolayers on the s-guttata framework 
significantly assists in understanding how corneal endothelium can be reconstructed 
through regenerative cell therapy. The s-guttata model presented in this work 
essentially allows varying design parameters to be controlled while allowing the 
examination of sparse and short guttata (representative of an early presentation) to 
confluent guttata of varying heights. 
Depending of the stage or progression of the FED, guttata can present in a wide range 
of dimensions. Hence, this model of s-guttata incorporated various parameters, 
including the arrangement, spacing, diameter and height of the guttata. The nature of 
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this work makes it difficult to conduct in another setting. Although there is an animal 
model of FED, it is less useful than the FED disease model presented here, since the 
various parameters cannot be controlled, as were achievable using a synthetic guttata 
framework. The design of the study also allowed us to evaluate two proposed methods 
of cell regenerative therapy; namely cell injection therapy and pharmacotherapy. Both 
of these approaches are currently being studied without the removal of guttata [13]. 
The isolation and propagation of primary HCECs is challenging, especially whilst 
maintaining functional characteristics and cell morphology [8, 95, 132]. Hence, for the 
initial screen of s-guttata parameters, which included their arrangement, spacing, 
diameter and height, B4G12 cells were used. Once the B4G12 cell data had been 
collated, the s-guttata parameters were refined, and the study was made clinically 
relevant with the use of primary HCECs.  The highest density pillars, which had the 
smallest spacing (20x20), as well as the lowest density pillars, which were spaced the 
furthest apart (40x80), were selected for primary cells. For each case pillar heights of 
20 µm and 10 µm heights were used as these could potentially present the most 
challenging surface, and relatively favorable surface respectively, for HCECS to form 
a cell monolayer. Additionally, s-guttata domes were included in the study to simulate 
the early onset of FED disease, where guttata begin to appear and have curved sidewalls 
[214, 217]. The s-guttata micro-structures used in this study are 3D in nature due to the 
feature dimensions in relation to the cell size, unlike submicron or nanometer-sized 
features which are used as biophysical cues to modulate cell functions, including cell 
migration [130, 133, 197]. 
Cell injection therapy has been advocated as a possible therapy for the delivery of 
corneal endothelial cells. The results of this research indicated that the capacity of 
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B4G12 cells to form a monolayer when injected on top of s-guttata was the lowest on 
20x20x20 pillars (high density pillars with 20 µm diameter, 20 µm spacing, and 20 µm 
height) and increased when shorter pillars were used.  The behavior of primary HCECs 
reciprocated the results of B4G12 cells on 20x20x20 pillars, indicating that the taller, 
high-density pillars, (20x20x20) were the most detrimental to cell monolayer 
formation. These high-density s-guttata pillars (20x20x20) are similar to the most 
densely populated guttata in the central cornea of patients, as shown both in FED patient 
examination and in the literature [16, 213]. It could be inferred then that the injection 
of primary cells into the anterior chamber of such FED patients, with these densities of 
guttata, may not be able to efficiently reform an intact corneal endothelial monolayer, 
which is essential for the functional integrity of the corneal endothelium. Hence 
removal of the highest area density of guttata should be considered prior to cell 
injection. The s-guttata domes of smaller diameter and lower height (20 µm diameter, 
20 µm spacing, 5 µm height), which simulates the early stages of FED disease, were 
the most favorable for monolayer formation of injected cells. The data suggests that 
primary corneal endothelial monolayer formation is dependent on guttata height and 
diameter. The 20x20x20 and 20x20x10 s-guttata pillars have the same diameter and 
spacing (density), but the monolayer on the 20x20x10 s-guttata was more complete in 
terms of the coverage of apical plane of pillars as compared to that on the 20x20x20 s-
guttata pillars. Similarly, 40 µm diameter pillars were the most detrimental for 
monolayer formation, and this was regardless of their height and sidewall profile. The 
current understanding of how cells behave when injected on a guttata-laden surface 
suggest that the progression or stage of corneal DM guttata is a significant factor when 
determining the success of cell monolayer formation, and hence the success of cell 
injection therapy.   
 109 
 
I also evaluated the pharmacotherapy approach in a cell migration model. 
Understanding the migratory behavior of cells on an s-guttata-laden surface could 
provide valuable insights into the processes of wound healing, and in vivo monolayer 
formation of native cells [109, 110, 223]. The results of this research work suggest that 
the s-guttata microstructure could strongly modulate the cell migratory behavior by 
causing cells to deviate from their cell migration paths. For faster wound healing it is 
desirable that cells migrate at faster speeds, for longer distances and in a more direct 
path [109]. B4G12 and primary HCEC migration analysis indicated that the cells were 
unable to migrate smoothly on higher density pillar arrays with smaller spacing between 
pillars, such as the 20x20x20 array.  Compared to the s-guttata-free control, the dense 
pillar array produced a 30 % lower directionality and 21% slower migration speed. 
However, both the directionality and speed of migrating primary HCECs improved on 
dome-like s-guttata (20x20x5). In this case a 5.8 % lower directionality and 3.2% faster 
migration speed was observed. These results have important implications for the 
pharmacotherapy approach, which is largely grounded on the ability of cells to migrate 
[108-110]. The migration results coupled with confocal and SEM imaging of cell 
monolayers validate that the higher density 20x20x20 s-guttata pillars, which simulate 
late stage FED, clearly hindered cell motility and formation of a cell monolayer. 
However, the 20x20x5 s-guttata domes of low height, allowed the formation of a 
monolayer.  
Overall, the results suggest that cell injection therapy or pharmacotherapy treatments 
may be plausible for early cases of FED cases, but will not be as effective for patients 
with high density guttata (i.e. late stage FED) unless combined with adjuvant guttata 
removal. By using pharmacotherapy treatment, a monolayer of corneal endothelium 
may be reformed, to some extent, on guttata-laden surfaces, which mimick an early 
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onset of the disease. However, FED patients that are treated with a pharmacotherapy 
regime are still likely to require a surgical intervention at a later stage since the patient’s 
own HCECs will continue to accumulate focal excrescences, which would result in the 
continuous growth of more densely packed, and taller guttata. As more guttata form, 
disease progression will continue, resulting in the gradual attenuation of the cellular 
cytoplasm, and eventually, apoptosis [214]. Surgical removal of the guttata from the 
DM prior to cell injection therapy or pharmacotherapy could increase the success rate 
of HCEC monolayer formation, which could potentially increase the chances of cell 
therapy success. However, cell adhesion and cell migration may be affected by the lack 
of a basement membrane [224]. Using the corneal cell regenerative therapies combined 
with surgical intervention or laser removal of the guttata lesion, will mean more people 
respond to the therapy. This would be more cost-effective, and less invasive way of 
treating patients with FED. A microscopic examination of the corneal surface of FED 
patients could also help clinicians tailor their therapy procedure to the specific needs of 
the patient. 
Current published studies on corneal cell regenerative therapies have used ROCK 
inhibitors to both improve cell adhesion during cell injection therapy [13, 102, 109], 
and stimulate cell migration during pharmacotherapy, which enhanced the reformation 
of the corneal endothelium [103, 108, 111]. However, this study was conducted without 
using a ROCK inhibitor, mainly because experiments were conducted in vitro with 
primary cells cultured in a growth media which promoted the adhesion and migration 
of cells; which are prerequisites to study the reformation of monolayer in the presence 
of synthetic guttata. As such, the inclusion of ROCK inhibitor in the growth media 
would merely have translated to a shortened time period of experiment due to increased 
cell migration rate [103, 108-110]. Future work will be conducted to examine the effect 
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of a ROCK inhibitor on the regeneration of human corneal endothelial monolayers with 
young and old donor cells in a cell injection therapy approach. This would potentially 
help to determine the donor-age at which corneal endothelium monolayers regenerate 
on synthetic guttata most efficiently. 
4.5  Conclusion 
A synthetic guttata FED disease model based on a patient’s guttata parameters was 
developed to evaluate the effect of cell injection therapy and pharmacotherapy on in 
vitro monolayer formation on guttata-laden surfaces. When primary HCECs were 
injected on top of high-density synthetic guttata pillars (20 µm diameter, spacing and 
height) or large diameter (40 µm) pillars of any height and spacing, a corneal 
endothelial monolayer failed to form. Although to a lesser extent, similar results were 
observed when using B4G12 cells. However, corneal endothelial monolayer formation 
from HCECs was significantly improved when the guttata height was reduced from 20 
µm to 10 µm (with the pillar diameter and spacing retained at 20 µm each). Similarly, 
cell monolayer formation improved on s-guttata domes with a diameter and spacing of 
20 µm and a height of 5 µm, which mimicked the early stage of FED diseases. The cell 
monolayer formation in a pharmacotherapy setting suggested that the densely packed 
synthetic guttata (20 µm diameter, spacing and height), which was akin to a mature 
diseased DM surface, were also the least conducive substrates for cell migration with 
respect to cellular directionality. The results indicate that pre-existing DM guttata could 
interfere with injected cells or with the migration of native primary corneal endothelial 
cells, thus hampering monolayer formation within the eye. The surgical removal of pre-
existing guttata before cell injection therapy or pharmacotherapy therapy could 
potentially increase the chance of successful cell therapy in advanced cases of FED 
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disease where the guttata height is closer to 20 µm and the guttata diameters is closer 




Chapter 5. Micro- and nano-patterned robust and 




[Rizwan M, Peh GSL, Ang H, Lwin NC, Adnan K, Mehta JS, Tan WS, Yim EKF. 
Sequentially-crosslinked bioactive hydrogels as nano-patterned substrates with 
customizable stiffness and degradation for corneal tissue engineering application, 
Biomaterials. 120 (2017) 139–154] 
Corneal endothelium dysfunction is a major source of permanent corneal blindness, 
which can potentially be treated by transplanting a tissue-engineered human corneal 
endothelial cell (HCECs) monolayer. Such a monolayer of cells can be obtained from 
donors, or by growing HCECs on a strong implantable bioactive material that can serve 
both as a tissue engineering scaffold and a cell carrier. The latter approach reduces 
patient dependence on donor tissue availability. Naturally-bioactive hydrogels lack 
mechanical strength and generally require complex fabrication methods or multi-
component additives, which enable improvements in material strength but could 
compromise other properties. In this chapter, I developed modified gelatin-
methacrylate (GelMA) materials and took advantage of sequential hybrid (physical + 
UV) crosslinking to achieve gelatin methacrylate gel material, GelMA+ with over 8-
fold increase in mechanical strength as compared to regular GelMA without the 
addition of any other chemical component. The presence of physical gelatin triple helix 
associations increased the subsequent UV covalent crosslinking efficiency, giving rise 
to gels with desirable properties: high strength that was thermally-stable and slow 
biodegradation kinetics. Moreover, a new oxygen impermeable stamp based approach 
was developed to pattern GelMA+ films with micro/nano-topographical cues for 
enhanced cellular morphology and functional markers.  The micro/nano-molding with 
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resolution down to nanoscale with this approach was not possible to achieve with 
PDMS-based molding. Studies of GelMA+ patterned surfaces show that primary 
HCEC monolayers grown on a square-array of 1 µm pillars of GelMA+ demonstrate 
improved zona-occludin-1 expression while monolayers on a hexagonal-array of 1 µm 
pillars of GelMA+ exhibit higher cell density and homogeneity of cell size, which are 
indications of functionally-superior monolayer. In conclusion, a novel material and 
fabrication approach was developed for implantable cell-carrier devices that not only 
provide the necessary mechanical support during implantation, but, more importantly, 
also offer excellent tailored properties that support in vitro culture of superior tissue-





An impaired human corneal endothelial cell (HCEC) monolayer due to endothelial 
dystrophy (ED) or bullous keratopathy is one of the major causes of corneal blindness 
[12, 16]. It is also the leading indication of corneal transplantations, which is the only 
solution for corneal blindness [2]. Due to donor cornea shortage, tissue-engineered 
HCEC monolayer on an implantable film is being investigated as an alternative tissue 
engineering approach for corneal endothelium dysfunction patients [12, 15]. Ideally, 
the implantable film should be biocompatible and support HCEC adhesion, be optically 
transparent, permit diffusion of aqueous humor nutrients and should be mechanically 
strong for easy handling. It should also be foldable to suit the surgical procedure and 
preferably demonstrate slow biodegradation after implantation. Previous research 
studies have utilized several synthetic and natural materials to fabricate a cell-carrier 
for HCEC monolayer transplantation [119, 120, 122, 123, 127, 225]. However, limited 
characterization was performed related to material properties necessary for the 
development of effective cell-carrier materials. An adequate nutrient transport rates 
through the cell-carrier, slow biodegradation kinetics, and effective maintenance of 
functional cell phenotype are the essential criteria of cell-carrier materials. The majority 
of cell-carriers in use today are “passive”. They act primarily as a transfer support for 
transplantation of monolayer and do not participate in enhancing the functional markers 
and phenotype of the regenerated HCEC monolayer. Corneal transplants often fail due 
to loss of the donor HCECs from the transplanted donor HCEC monolayer. Studies 
show that 30% HCECs are lost within the ﬁrst 6 months of transplantation [125, 126]. 
Improving the long term survival of the graft, by creating implantable cell-carriers that 
act as a transporter and enhances cell function and phenotype thus minimizes cell loss, 
is of leading importance to improve the long term success of corneal transplantation. 
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Gelatin methacrylate (GelMA) is increasingly being used in tissue engineering and 
regenerative medicine for applications such as cell encapsulation, cardiac and 
cardiovascular tissue engineering, bone tissue engineering, cartilage tissues 
engineering, muscle tissue engineering, and as bioink for 3D printing [160]. The rise in 
popularity of GelMA is due to its proven biocompatibility, physico-chemical 
tailorability and the possibilities it offers for patterning with spatio-temporal control of 
UV-crosslinkable hydrogels [160]. Topographically-patterned GelMA hydrogels could 
potentially provide a superior implantable cell-carrier for the formation and 
transplantation of HCEC monolayer. The topographical cues can improve the 
morphology and the expression of functional markers of HCECs [132, 192]. However, 
GelMA hydrogels in the form of hydrated thin films may not be mechanically strong to 
support surgical transplantation of the HCEC monolayer without rupture. Several 
strategies to improve the mechanical properties of gelatin methacrylate hydrogels have 
been reported. These include reinforcement with 3D printed microfibers [226], carbon 
nanotubes [196, 227], graphene oxide [228], PLEOF [229], polyacrylamide [230], and 
polyethylene glycol [200, 231]. Biopolymers such as gellan gum [232], hyaluronic acid 
[233], dextran [234], and silk fibroin [235] have also been incorporated to tune the 
mechanical properties and biodegradation of GelMA. The reported strategies have thus 
far focused on the addition of another component to the GelMA and involve complex 
and often expensive processes. A robust yet simple method to improve the strength and 
biodegradation properties of GelMA hydrogels without incorporating additional 
components remains an unmet challenge.  
Apart from the mechanical properties of the cell-culture substrate, the role of micro- 
and nano-scale surface topographical cues to direct the cellular processes is well 
documented and increasingly evident [132-135]. PDMS micro-molding and 
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photolithography are the two most commonly used techniques for topographical 
patterning of hydrogels [162-164]. Chemically crosslinked Hydrogels have been 
patterned with feature sizes of 10 µm to less than 500 nm (micro and nano-molding) by 
using PDMS master molds [165-167]. However, PDMS micro-molding of UV-
crosslinkable hydrogels including GelMA has faced limited success with minimum 
feature size achievable on the order of only 10s of micrometer [168-171]. The reason 
PDMS molds cannot achieve high resolution pattering of UV-crosslinkable hydrogels, 
is likely due to the high oxygen diffusion coefficient of PDMS, which inhibits UV 
crosslinking at the hydrogel-PDMS mold interface [172, 173]. UV-crosslinking with 
N2 purging [174] or expensive quartz and silicon stamp-based nanoimprint lithography 
of hydrogels have been used to improve the patterning resolution of UV-crosslinkable 
hydrogels [175, 176]. The literature have shown the importance of topographical cues 
at the sub-micron scale to control the cellular functions and stem cell differentiation 
[197]. The ability to pattern UV-crosslinkable GelMA with topographical cues in the 
range of 1 µm or lower with cost-effective and simple methods is useful to study the 
response of cellular functions to such cues.  Besides, the in vivo extracellular matrix 
also contains nanoscale topographical cues [130]. Using a PET master mold with low 
oxygen permeability, the pattering of nanoscale cues on hydrogel films in a simple and 




 Material and methods 
 Synthesis of gelatin methacrylate 
 Gelatin methacrylate (GelMA) was synthesized as described elsewhere [159] with 
modifications. Briefly, 5 g gelatin (Type A, Sigma Aldrich) was dissolved in 50 ml 
Phosphate Buffer Saline (PBS). Once fully dissolved, 10 ml methacrylic anhydride 
(Sigma Aldrich) was added dropwise to the gelatin solution at 60 ºC and the reaction 
was continued for 1 hour under magnetic stirring. Subsequently, the mixture was 
diluted with deionized (DI) water, filled in 12-14 kDa cut-off dialysis tubes and 
dialyzed in DI water for 5 days at 37 °C. After dialysis, the GelMA solution was frozen 
at -80 ºC and lyophilized to obtain white GelMA foam. The degree of methacrylation 
of gelatin was measured by using TNBSA assay, which was ca. 89% in this work. 
 Preparation of GelMA hydrogels 
Lyophilized GelMA was dissolved in PBS containing 0.5% w/v Irgacure 2959 (BASF) 
at 50 °C to prepare prepolymer solution. To prepare ‘regular’ GelMA hydrogel, the 
prepolymer solution at 37 °C was pipetted between glass slides separated by spacers 
(150-750 µm) and immediately crosslinked for 60 s by using UV irradiation (360-480 
nm) at an intensity of 32 mW/cm2 (UVACUBE 100, Honle) (Figure 5.1). To prepare 
hybrid crosslinked GelMA hydrogel (GelMA+), the prepolymer solution was pipetted 
between glass slides and the glass slide chamber was incubated at 4 °C for 1h. 
Immediately after incubation, the prepolymer was irradiated with UV light as described 
above (Figure 5.1). After crosslinking, the GelMA and GelMA+ hydrogels were 





Figure 5.1 Schematic diagram of the fabrication of regular GelMA and GelMA with 
hybrid crosslinking (GelMA+) 
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 Mechanical testing and FTIR analysis 
Hydrogel samples of 8 mm diameter and 1 mm thickness were prepared by crosslinking 
prepolymer solution as described above to prepare GelMA and GelMA+ hydrogels. 
The samples were incubated overnight in PBS at 37 °C.  The samples were tested on 
an Instron mechanical tester at a constant compression rate of 0.5 mm/min with 10 N 
load cell until failure. The data were plotted as compressive stress-strain curve and the 
compressive modulus was calculated as the slope of the linear region of the stress–
strain curve corresponding to 0%–15% strain. Fourier transform infrared spectroscopy 
(FTIR) was performed as described previously [232]. To determine the fraction of 
unreacted methacrylate double bonds in 30% GelMA and GelMA+ hydrogels with 
same methacrylation degree and UV exposure time. To prepare samples for FTIR, 
hydrogels were lyophilized, made into KBr pellets and the spectra were taken by a FTIR 
spectrometer (Shimadzu Scientific) with spectral data spacing of 6 cm-1. The FTIR 
spectra was corrected to remove peaks for water vapors and carbon dioxide (CO2). 
 Swelling analysis of hydrogels 
 GelMA and GelMA+ hydrogels with prepolymer concentration of 10 - 30 % and fixed 
degree of methacrylation were prepared in form of 1 mm thick films of 8 mm diameter 
and lyophilized to record the dry weight (Wd). Next, the hydrogels were re-hydrated in 
PBS buffer overnight at 37°C and the weight of the hydrogel in swollen state (Ws) was 
recorded. The percentage degree of swelling was measured as follows: 
Degree of swelling (%) =  
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To evaluate the effect of temperatures on degree of swelling, 30% GelMA and GelMA+ 
hydrogels were re-hydrated at 16°C and 40°C to obtain the Ws. Degree of swelling was 
measured as described above.  
 Rheological testing 
For rheological property measurements, GelMA and GelMA+ hydrogel disks of 20 mm 
diameter and 0.5 mm thickness were prepared and incubated overnight in PBS.  Parallel 
plate geometry (20 mm) was used for dynamical rheological measurements in a TA 
Instruments AR-G2 rheometer. The samples were loaded onto the bottom plate of the 
rheometer and the upper plate was lowered slowly while monitoring the normal force 
value. The upper plate was stopped when the normal force value started to increase, 
which indicated that the plate is touching the sample surface. The final gap was in the 
range of 480-500 µm depending on the sample height. The tests were carried out in the 
linear viscoelastic region (LVR). To determine the effect of temperature on elastic 
modulus (G’) of the hydrogels, temperature sweep rheometry was performed from 
16 °C to 40 °C at 1% strain and 1 Hz frequency. Few drops of water were added to the 
edges of the samples to avoid sample drying. 
 Fabrication of nanoimprinted PET masters 
Polydimethylsiloxane (PDMS) molds with micro- and nano-features were prepared 
from silicon mold by using soft lithography. The PDMS molds containing micro- and 
nano-pillar structures were used as masters to nanoimprint mirror-image patterns 
(wells) on polyethylene terephthalate (PET) film of 250 µm thickness (Goodfellow). 
The nanoimprinting of PET films was performed by using a desktop nanoimprint tool 
(NIL Technology) at a temperature of 175 °C under a pressure of 5 bar for 5 min. 
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 Patterning of hydrogel films 
Imprinted PET films were used as master mold to pattern GelMA and hydrogels. PET 
masters with micro- and nano-wells were bonded to the glass in the center of glass slide. 
The spacers of certain thickness were placed at either edges such that the gap between 
the PET master and the top glass slide was 150 µm. Another glass slide was placed on 
top and the warm (37 °C) GelMA prepolymer solution was pipetted between the glass 
slides and allowed to flow under capillary force to fill the chamber. Subsequently, the 
chamber was placed at 4 °C for 1 h. After incubation, the prepolymer was UV-
crosslinked as described above. After crosslinking, the GelMA and GelMA+ hydrogels 
with micro and nano-pillar patterns were detached from the chamber and incubated in 
PBS.  
 Characterization of PET and GelMA hydrogel patterns 
Patterned PET and hydrogel films were characterized in terms of pattern replication 
and fidelity by using scanning electron microscopy. Nanoimprinted PET films were 
sputter coated with gold prior to viewing. Hydrogel films were placed in 24-well plates 
and secured with PDMS rings to not allow contraction during sample preparation. The 
samples were fixed with 4% paraformaldehyde in PBS for 1 h. After fixing, the samples 
were serially dehydrated in ethanol gradient, followed by incubation in 
hexamethyldisilazane (Sigma Aldrich) twice for 5 min each. Finally, the samples were 
dried by evaporation of HMDS and sputter coated with gold. Sputter coated PET and 
GelMA samples were imaged with SEM. 
 Bio-degradation and optical transmission of hydrogels 
The GelMA and GelMA+ hydrogel films of 8 mm diameter and 140 µm thickness were 
incubated in collagenase II enzyme solution for 7 days to measure the degradation rate. 
 123 
 
The concentration of enzyme was 1 U/ml, 10 U/ml and 20 U/ml. The enzyme solution 
was replaced daily to maintain the activity of the enzyme. Small sample of the solution 
was taken at regular intervals and the bio-degradation rate was measured by using BCA 
assay in terms of the total protein liberated from the hydrogel films as a result of the 
degradation. Optical transmission of the hydrogels films of 140 µm thickness in visible 
UV spectrum was measured by using spectrophotometer (Tecan Infinite 200). 
 Cell culture and seeding on patterned hydrogel films 
Research-grade donor corneas were obtained from the Florida Lions Eye Bank (Miami, 
FL, USA). Primary HCECs were isolated from donor corneas as described previously 
[95]. Primary HCECs for this study were used from donors aged between 5-25 year 
(Table 1).  
Serial 
Number 
Age Sex Cell Count 
(OS) 
Cell Count  
(OD) 
Cause of death 
01   5 M 3534 3247 motor vehicle 
accident 
02 19 F 2890 3175 Craniocervial 
Dislocation 
03 24 F 2481 2457 Acute Cardiac 
Crisis 
04 25 M 3486 3559 Gun shot wound 
(head) 
 
Table 5.1  Donor information of the primary human corneal endothelial cells (HCECs) 
used in this study. 
  
The protocols conformed to the tenets of the Declaration of Helsinki and the study was 
approved by the institutional review board of the Singapore Eye Research Institute and 
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Singapore National Eye Centre. The HCECs were cultured as described previously 
[132]. HCECs at passage 3 were used to form monolayer in this study [12]. Unpatterned 
and patterned GelMA+ films of 6 mm diameter and 138±5 µm thickness were prepared 
and incubated in 4% amphotericin B (Sigma Aldrich) in PBS for 3 days at 37°C. 
Subsequently, the films were washed with PBS 3 times, sterilized with UV irradiation, 
and seeded with HCECs at a seeding density of 1500 cells/mm2. The cells were cultured 
on the films for 10 days in s-media, which consisted of human endothelial SFM 
supplemented with (Gibco) and 1% penicillin–streptomycin (Gibco) [132]. The media 
was changed every 2 days.  
 IF staining and analysis of functional markers and cell morphology 
Na+/K+-ATPase and zona occluding (ZO-1) were stained as described in section 3.2.1. 
To investigate the effect of surface topography on the expression of ZO-1, the images 
were captured at an interval of 2 µm in the z-direction and the z-stack was merged using 
the ‘maximum intensity projection’ option in ImageJ. The quantification of ZO-1 
ﬂuorescence at cell–cell junctions was performed by using ZO-1 stained images in 
ImageJ as reported previously [132]. Cell area, coefﬁcient of variation (CV) of cell 
area, and cell circularity of HCECs was analyzed as described in section 3.2.8.  
 Permeability analysis 
A custom-made chamber (Figure 5.2) was used to measure the permeability of the 30% 
GelMA+ film to ensure that there is no leakage and films are not cracked when the 
films are secured in the chamber. The permeability coefficient of the GelMA+ films 
was first measured without the cell monolayer by using BSA (65 kDa) and glucose 
(180.16 g/mol) as model molecules to establish a baseline. Then the HCECs were 
cultured on GelMA+ as described above to form monolayer on unpatterned and 1x6 
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µmpH patterned 30% GelMA+ and the permeability coefficient of the films containing 
the confluent monolayer was measured.  
 
Figure 5.2 Custom-built chamber for the measurement of permeability of GelMA+ and 
primary human corneal endothelial cell monolayer 
 
In a typical experiment, the chambers were briefly washed with 70% ethanol following 
by washing twice with PBS buffer. Subsequently, the chambers were sterilized by using 
UV irradiation for 30 min and the 10 mm diameter GelMA+ films (effective area for 
diffusion = 28 mm2) with or without the cells were placed between the two parts of the 
chamber, fastened with plastic screws and placed in the 6 well plate with each well 
filled with either 3 ml cell culture media or PBS buffer. For BSA permeation, the upper 
compartment was filled with 2 mg/ml BSA in 280 µl PBS buffer. For glucose 
permeation, the upper compartment was filled with 0.58 mg/ml glucose in 280 µl PBS 
buffer or cell culture media [237]. The liquid in the receptor compartment was stirred 
by using magnetic stirrer. BSA permeability was measured by using BCA assay 
(Thermo Fisher Scientific) while the glucose permeability was measured by using 
glucose assay kit (SIGMA) [127]. 
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 Statistical analysis 
Student’s t-test and One-way ANOVA with Tukey’s post hoc test was used to determine 
statistical significance of multiple comparisons. The statistical significance threshold was set 




 Results  
 Effect of hybrid crosslinking on mechanical strength and swelling of 
hydrogels 
Gelatin was methacrylated to obtain UV-crosslinkable gelatin methacrylate (GelMA). 
All GelMA studied had 89% methacrylation degree, as measured by using 2,4,6-
trinitrobenzene sulfonic acid (TNBSA) assay. To determine the effect of concentration 
and sequential crosslinking, Young’s compressive modulus was measured. Increasing 
the concentration of the prepolymer solution from 10% to 30% resulted in a significant 
increase in the compressive strength of regular GelMA (UV- crosslinking) (Figure 
5.3a).  In the case when GelMA was incubated at 4 °C prior to UV exposure to achieve 
hybrid GelMA+, the compressive strength also increased significantly with increasing 
prepolymer concentration from 10% to 30% (Figure 5.3a).  
The GelMA+ consistently demonstrated higher strength (4.9-fold higher at 10% 
concentration, 4.1-fold higher at 30% concentration) as compared to regular GelMA 
(Figure 5.3a). The 10% regular GelMA hydrogel demonstrated 5.8 kPa compressive 
modulus while the 30% regular GelMA hydrogel demonstrated 56.7 kPa compressive 
modulus. In comparison, the compressive modulus of GelMA+ hydrogel at 10% 
concentration was 28.8 kPa, which increased to 233.3 kPa at 30% concentration. 
Overall, by increasing the GelMA concentration from 10% to 30% and including a pre-
UV crosslinking 1 hr incubation at 4 °C, this method was able to increase the hydrogel 




Figure 5.3 Characterization of GelMA and GelMA+. The effect of prepolymer 
concentration and incubation of prepolymer solution at 4 °C prior to UV crosslinking 
on the (a) Young’s compressive modulus of hydrogels (b) The degree of swelling of 
the hydrogels (c) The microstructure (pore size) of the hydrogels. * P<0.05, ** P<0.01, 




Degree of swelling of the hydrogels is linked with the amount of the crosslinking, which 
affects the mechanical strength. In case of the regular GelMA hydrogel, the degree of 
swelling dropped from 778% to 336% as the concentration of the prepolymer solution 
increased from 10% to 30% (Figure 5.3b). In case of the GelMA+ hydrogel, the degree 
of swelling dropped from 462% to 276% as the concentration of the prepolymer 
solution increased from 10% to 30%. Interestingly, while the modulus of 30% GelMA+ 
was close to 5-fold higher than 30% GelMA, the degree of swelling of 30% GelMA+ 
was not drastically lower as compared to 30% GelMA. In fact, the difference in the 
degree of swelling of GelMA and GelMA+ gradually reduced, as the concentration of 
the prepolymer solution increased. 
To further analyze the difference in the GelMA and GelMA+ hydrogels, the 
microstructure (pore size) of both hydrogels was examined. The average pore size of 
the GelMA hydrogel was smaller as compared to GelMA+ hydrogel at 10%, 20% and 
30% prepolymer concentration (Figure 5.3c). GelMA hydrogels were inhomogeneous 
in nature comprising regions of higher and lower crosslink density, as reflected by large 
variations in pore sizes seen in the SEMs of the dried gel samples (Figure 5.3c). 
However, the GelMA+ hydrogels had more homogenous microstructures, particularly 
at higher prepolymer concentrations (Figure 5.3c). Therefore, the smaller and more 
uniform distribution of pores could be a key factor contributing to the superior 
mechanical properties of 30% GelMA+. 
 FTIR analysis of crosslinking in hydrogels 
Fourier transform infrared spectroscopy (FTIR) of the 30% GelMA and GelMA+ 
hydrogels was performed to compare the FTIR spectra in terms of the differences in the 
fraction of unreacted C=C double bonds of methacrylate groups after UV crosslinking 
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[232]. The FTIR spectra obtained from the GelMA and GelMA+ samples displayed the 
characteristic bands of gelatin backbone, namely the amide A, amide I, amide II, and 
Amide III (Figure 5.4) [238]. Additionally, the spectra between 1700-1600 cm−1 was 
analyzed in detail (Inset of Figure 5.4), which showed a peak at 1634 cm−1 in the case 
of GelMA. However, this peak was not observed in the case of GelMA+. The peak at 
1634 cm−1 is potentially showing the presence of unreacted C=C double bonds in 
GelMA, which points to the lower degree of crosslinking as compared to GelMA+ 
where the peak was not observed [232]. The absence of C=C peak in GelMA+ also 
indicate a more complete UV covalent crosslinking in GelMA+. 
 Effect of temperature on dynamic elastic modulus and swelling of 
hydrogels 
The effect of temperature on the strength of the hydrogels was analyzed by measuring 
the dynamic elastic modulus (G’) in temperature sweep rheometry from 16 °C - 40 °C. 
The upper temperature of the investigation was chosen as 40 °C to represent a slightly 
Figure 5.4 FTIR analysis of crosslinking in GelMA and GelMA+ hydrogels in terms 
of the presence of C=C bond. 
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higher temperature than the physiological temperature of the body, where the GelMA+ 
hydrogel films are intended to be used. Besides, this temperature range could also melt 
the gelatin triple helices if they are present in thermally-reversible state [239]. The 
rheological measurements were only conducted for 30% hydrogel since the highest 
strength was displayed by this hydrogel, which was one of the primary objectives to 
prepare cell-carrier films for corneal endothelial tissue engineering. The results 
revealed that the temperature sweep from 16 °C to 34 °C did not affect the G’ of the 
regular GelMA and GelMA+ hydrogels (Figure 5.5a). However, a small drop in G’ was 
observed at temperature beyond 34 °C, in GelMA+ probably due to the melting of some 
triple helices (Figure 5.5a) [239]. The drop in G’ was not observed for regular GelMA. 
Overall, the G’ of the GelMA+ hydrogel remained several folds higher as compared to 
GelMA hydrogel regardless of temperature (9.1-fold higher at 16 °C; 8.1-fold higher at 





The degree of swelling at 16 °C and 40 °C was also measured to determine if the change 
in temperature and the corresponding melting of triple helices (if any) could affect the 
swelling of hydrogels. The GelMA+ had significantly lower degree of swelling as 
compared to GelMA regardless of the temperature of measurement (Figure 5.5c). 
Figure 5.5 Effect of temperature on hydrogel elastic modulus G’ and swelling. (a) a 
representative cure showing the effect of temperature on the dynamic elastic modulus 
(G’) of GelMA and GelMA+. (b) The average G’ value of GelMA and GelMA+ at 1% 
strain at 16 °C and 40 °C. (c) The degree of swelling of the GelMA and GelMA+ at 16 
°C and 40 °C. * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001 (n=4 samples) 
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Degree of swelling of GelMA and GelMA+ was slightly lower at 40 °C as compared 
to 16 °C (Figure 5.5c). Dynamic elastic modulus as well as degree of swelling results 
indicate that the temperature did not drastically affect the properties of GelMA+ 
hydrogels at physiological temperatures. 
 High resolution micro- and nano-molding of UV-crosslinkable hydrogels 
To study the effect of topographical cues on the functional characteristics of human 
corneal endothelial cell (HCEC) monolayer formation, free-standing films of 30% 
GelMA+ with controlled thickness and micro- and nano-topographical patterns were 
fabricated. The thickness of the hydrogel cell carrier material was limited to 150 µm or 
less to accommodate the material in the limited space of anterior chamber of the eye 
and to ensure efficient nutrient transport across the cell-carrier. In this part of the thesis 
work, I developed a molding method to simultaneously control the thickness of the 
hydrogel film and pattern the hydrogel by taking advantage of capillary forces (Figure 
5.6a). The initial attempts to patterns the GelMA+ hydrogels by using micro-patterned 
PDMS master stamp failed for the feature sizes of 1 µm or less. Using poly terephthalate 
(PET) films as master stamps, this study was able to achieve high yield patterning of 
UV-crosslinkable GelMA+ hydrogels with 1 µm wells (Figure 5.6b). The freestanding 
GelMA+ films with thickness down to 10 µm patterned with 1 um pillars of aspect ratio 
of up to 3 or 1 µm wells were successfully fabricated using this method (Figure 5.6c). 
Figure 5.6d demonstrates the successful replication of 250 nm pillars by using PET-
stamp based nano-molding. The thickness of the patterned free-standing films could be 





To determine the effect of hydration in PBS buffer or cell culture media (swelling) on 
the dimensions of hydrogel topography, 40 µm gratings were fabricated and viewed 
with optical microscopy in cross section view (Figure 5.7). For comparison, 10% 
Figure 5.6 High resolution UV patterning of 30% GelMA+ films. (a) Schematic 
diagram of the micro and nano-molding method by using PET stamps to pattern 
hydrogel films. (b) Effect of stamp mold material (PDMS vs PET) on the replication of 
high resolution 1 µm features. (c) Fabrication of high aspect ratio pillars and wells on 
GelMA+ thin films. (d) Fabrication of nano patterns (250nm pillars) by using PET 
stamp based nano-molding. 
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GelMA+ hydrogels patterned with same topography were also included (Figure 5.7). 
The 10% GelMA+ topography demonstrated 12% increase in the grating height and 7% 
increase in the grating width (Figure 5.7). However, the dimensions of the topography 
for 30% GelMA+ did not change significantly (ca. 1% change), likely due to low degree 




Figure 5.7 The effect of hydration on the dimensions of surface topography of GelMA 
and GelMA+ hydrogels as measured in terms of the % change in the in dimensions of 
gratings height and width.  
% change in dimensions = [(dimensions after 1 day incubation in PBS buffer - 





Table 5.2 30% GelMA+ topographies and nominal dimensions used to study cell-
topography interaction 
 
 Effect of micro- and nano-topographical cues on the HCECs phenotype 
and morphology 
The functional characteristics of the primary human corneal endothelial cells cultured 
on patterned 30% GelMA+ hydrogels films (pattern details described in Table 5.2) were 
investigated.  The cells were able to form HCEC monolayer with polygonal cell shapes 
on unpatterned and patterned GelMA+ films, which was reminiscent of the corneal 
endothelium in native corneas (Figure 5.8a,b). The confocal images showed that the 
expression of cell-cell tight junctional protein Zona occuludin-1 (ZO1) (Figure 5.8a) 
and Na+/K+–ATPase (Figure 5.8b) was modulated by the underlying micro or nano-
topography. The Na+/K+–ATPase expression was lowest on unpatterned films. The 
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The amount of ZO1 expression at cell-cell junctions was also evaluated [132]. The expression 
of ZO1 was significantly higher on 1x6 µmpS as compared to 1x6 µmpH (Figure 5.9a). 
However, 1x6 µmpS pillars had significantly increased amount of ZO1 expression as compared 
to unpatterned films and 250 nm pillars.  
Figure 5.8 Effect of 30% GelMA+ topographical cues on (a) The expression of tight 




The morphology of the HCECs in the monolayer was also evaluated, since the morphology has 
been associated with the functional behavior and quality of cultivated corneal endothelial cells 
[95]. The HCEC monolayer had the highest cell density on the 1x6 µmpS (P<0.05) and the 1x6 
µmpH (P<0.001) as compared to unpatterned films (Figure 5.9b). The HCECs were 
significantly smaller on the 1x6 µmpH compared to unpatterned films (Figure 5.9c). Coefficient 
of variation of (CV) cell areas, was also lowest on 1x6 µmpH, which indicated homogenous 
cell sizes on these patterned films (Figure 5.9d). Overall, the results suggest that the GelMA+ 
films patterned with 1x6 µmpS topography could significantly increase the amount of ZO1, and 
Na+/K+–ATPase expression while 1x6 µmpH topography could induce favorable cell 
Figure 5.9 Effect of 30% GelMA+ topographical cues on HCEC monolayer. (a) The 
quantification of ZO1 expression on various topographies of GelMA+ (b) The effect 
of patterned GelMA+ topographical cues on (b) cell density (c) cell area (d) and 
coefficient of variation of cell area (CV) of the HCEC monolayer. * P<0.05, ** 
P<0.01, *** P<0.001, **** P<0.0001 (n=3 experiments) 
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morphometry such as high cell densities, low cell areas and homogenous cell size, thus 
improving the quality of the regenerated HCEC monolayer. 
 Biodegradation and optical transmittance of hydrogels 
Biodegradation of the 140 µm thick 30% GelMA and GelMA+ hydrogel films were 
measured in collagenase enzyme of different concentrations in terms of the gelatin 
protein liberated from the films (Figure 5.10a). Generally, increasing the collagenase 
concentration increased the biodegradation of the GelMA and GelMA+ hydrogels.  
 
Regular GelMA demonstrated higher biodegradation rate as compared to GelMA+ 
hydrogel at a given collagenase concentration. GelMA completely dissolved within one 
day in 20 U/ml and 10 U/ml collagenase. However, in 1 U/ml collagenase, 55% of the 
GelMA dissolved at the end of the time point (7 days). On the other hand, GelMA+ 
took two days to be completely dissolved in 20 U/ml and 7 days to completely dissolve 
in 10 U/ml. In 1 U/ml collagenase, only 10% of the GelMA+ dissolved at the end of 
the time point (7 days) as compared to 55% for GelMA at the same collagenase 
Figure 5.10 The biodegradation rates of the 30% GelMA and GelMA+ in collagenase 
enzyme of different concentrations. (b) The biodegradation rate of 30% GelMA+ in 
aqueous humour taken form rabbit eyes. (n=4 for biodegradation in collagenase, n=3 
for biodegradation in aqueous humor) 
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concentration. The data suggested that the incorporation of physical crosslinking prior 
to UV exposure (GelMA+) also influenced the biodegradation behavior of the hydrogel, 
which could now be tuned independently of prepolymer concentration, methacrylation 
degree, or UV crosslinking time. 
Next, the ex vivo biodegradation of 30% GelMA+ hydrogel films was assessed by 
measuring the biodegradation in the aqueous humor taken from rabbit eyes at various 
time points (Figure 5.10b). The degradation in aqueous humor was evaluated only the 
30% GelMA+ due to its possible use as implantable cell-carrier film. The GelMA+ 
films showed 22% degradation in aqueous humor after 7 days. The films were still 
intact after 7 days and could be handled with tweezers.  
An ideal material for corneal endothelial cell monolayer carrier should be transparent 
to visible light. The optical transparency of the 30% GelMA+ films of 140 µm thickness 
ranged between 90-92% in the visible range which was comparable to the optical 
transparency of the cornea (Figure 5.11) [3]. 
  




 Permeability of hydrogel films  
One of the important criteria for materials selection for corneal endothelial tissue 
engineering is the permeability, where the permeability of the cell carrier device should 
be higher than the corneal endothelial cell monolayer to allow nutrient transport. An 
acrylic-based custom-made system was designed to measure the permeably of hydrogel 
thin films, which prevented film rupture during film mounting and leakage during 
experiment (Figure 5.2). The permeability coefficient of the unpatterned 30% GelMA+ 
films was measured by using large (BSA) and small (glucose) model molecules. 
Glucose is a major source of nutrients in the aqueous humour [127, 237]. The films 
were found permeable to BSA as well as glucose molecules with permeability 
coefficient of 2.2x10-7 cm/s for BSA (PBSA) and 2.7x10
-5
 cm/s for  
glucose (PGlu)(Figure 5.12a,b). PGlu was ca. 123 times higher as compared to PBSA, 
probably due to small molecule size. The GelMA+ permeability for glucose in our study 
was higher than the permeability of the corneal endothelium to sucrose (similar 
molecular weight to that of glucose) [240] which ascertained that the GelMA+ film 
would not be a limit factor for the transport of nutrients to the cornea by HCEC 
monolayer. 
Next, corneal endothelial monolayer was cultivated on GelMA+ films patterned with 
1x6 µmpH topography and measurement of the effect of topography on the PGlu of 
corneal endothelial monolayer was carried out. The 1x6 µmpH topography was chosen 
as it significantly improved the functional characteristics of HCEC monolayer. The 
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HCEC monolayers on unpatterned as well as on patterned GelMA+ films were 
functionally active in terms of glucose diffusional permeability (Figure 5.12c). The PGlu 
of the HCEC monolayer on patterned GelMA+ films was 27% higher as compared 
Figure 5.12 Characterization of the permeability of GelMA+ films. (a) Permeability of 
GelMA+ films to (a) BSA molecules and (b) glucose molecules. (c) The permeability 
of the HCEC monolayer formed on unpatterned GelMA+ films and GelMA+ films 
patterned with hexagonal-array 1 µm pillars of 6 µm spacing (1x6 µmpH) to glucose 
molecules. (n=4 samples) 
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HCEC monolayer on unpatterned GelMA+ films, potentially due to the higher 
monolayer cell density. Overall, the results showed that the HCEC monolayer grown 
on a 30% GelMA+ films are fully functional in terms of the nutrient transport. 
 Implantability testing of GelMA+ in an implantation device 
The GelMA+ film was tested for its ‘implantability’ in terms of pliability as it is coiled 
by the device during passage, ability to withstand the forces when pulled through the 
device with tweezers and the damage to HCEC monolayer during the procedure. The 6 
mm diameter GelMA+ films with HCEC monolayer were passed through an Endoglide 
endothelium insertion system (Network Medical), which is an implantation device used 
by cornea surgeons for corneal endothelial keratoplasty [241, 242]. The tests 
demonstrated that the films were capable of withstanding the implantation procedure in 
the Endoglide device without any visible damage (Figure 5.13). Live/dead assay 
showed very few cells were killed by the process of passing the film through the device 
(Figure 5.13b,c). Importantly, the HCEC monolayer did not detach from the GelMA+ 





Figure 5.13 Implantability testing of cell carrier film loaded with HCEC monolayer in 
Endoglide cell monolayer insertion device. (a) The images of the GelMA films as it is 
loaded and pulled through the EndoGlide device. (b,c) The result of the live/dead assay 
showing the HCECs before and after testing the cell-carrier. Minimal cell damage was 
noticed after the testing. 
 
 Discussion 
This chapter presented a simple method of fabrication of robust gelatin methacrylate (GelMA) 
hydrogels with up to 9-fold improved strength by exploiting the hybrid (physical + covalent) 
crosslinking in gelatin. Furthermore, a generic and simple nano-molding method was developed 
to improve the patterning resolution of hydrogels, which was significantly better than existing 
methods for UV crosslinkable hydrogel patterning. The robust patterned films were presented 
as a superior biomaterial cell carrier device for corneal endothelial monolayer formation and 
implantation. 
 Effect of triple helices formation on the UV crosslinking efficiency and 
mechanical strength 
The increased strength of GelMA+ could be explained based on the effect of triple helices 
formation during the incubation at 4 °C prior to UV crosslinking. Cooling of gelatin solution 
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below 37 °C is known to induce folding of the protein strands into triple helices, which gives 
rise to physical crosslinks as the triple helices associate to form a 3D physical network. Gelatin 
modified with methacrylate groups has also been shown to retain its ability to form triple helices 
[159]. The formation of a physical gel network prior to UV-crosslinking clearly resulted in 
marked increase in the final modulus of the gels. Previous studies have demonstrated that 
formation of gelatin triple helices prior to covalent crosslinking result in a higher crosslink 
density, particularly given the proximity of the chains brought together by the formation of 
triple helices [243]. In our study, this is evidenced by the FTIR data, which showed higher 
crosslinking in GelMA+ hydrogels with almost no unreacted C=C bonds of methacrylate 
groups. Overall, another factor that potentially contributed to the increased strength of the 
gelatin is the more homogenous pore size produced as a result of hybrid crosslinking. The 
formation of a physical gel at 4 °C prior to UV crosslinking resulted not only in increased 
crosslinking density but also the gels with significantly homogenous microstructure. The 
combined effects of a more homogeneous microstructure gel with higher covalent crosslink 
density were likely key factors that contributed to the improved mechanical properties of the 
GelMA+ hydrogels.  
 Thermal stability of the strength of GelMA+ at physiological temperature 
and biodegradation of GelMA+ 
The increment in modulus, if it arose solely from additional physical crosslinking that may be 
lost when being exposed to physiological temperature, would be concerning for the application 
of GelMA+ at physiological temperature. Interestingly, in a previous study, enzymatically 
crosslinked gelatin hydrogels with pre-formed physical networks exhibited reduced strength at 
temperatures above 37 °C, which was linked to the melting of triple helices [239, 244]. 
However, this study shows that the GelMA+ hydrogels did not exhibit significant loss of 
mechanical stiffness with temperature increasing form 10 °C to 40 °C. As opposed to UV 
crosslinking where chain proximity could enhance the chances for reaction, in the case of 
enzyme based crosslinking, the formation of triple helices could instead limit the access of the 
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enzyme to crosslinking sites. While physical crosslinks in the enzymatically crosslinked gels 
came apart above 37 °C temperature, in our case, the physical crosslinks seem to be stabilized 
by the covalent crosslinks formed during UV exposure, such that the mechanical properties 
remained stable up to 40 °C.  This shows that the strength of the GelMA+ will not be adversely 
affected when used at physiological temperatures. However, the higher temperatures beyond 
the physiological temperature range may affect the mechanical properties of GelMA+, which 
needs to be studied in future. 
Besides strength, the enzymatic biodegradation data showed that the GelMA+ degraded more 
slowly as compared to the GelMA hydrogels at a given concentration. Rate of biodegradation 
is generally associated with the prepolymer concentration and degree of crosslinking. The 
slower degradation kinetics of the GelMA+ also points towards increased crosslinking within 
the network.  Previously, it was postulated that the biodegradation rate of GelMA can only be 
modified by altering the concentration of GelMA [200]. This study shows that the 
biodegradation rate can be modulated without altering the concentration of hydrogel. 
Here, this study demonstrated that degradation kinetics can be modified by incorporating the 
hybrid crosslinking in GelMA. Slow degrading GelMA+ could potentially find applications in 
tissue engineering where these could perform better as compared to fast degrading scaffolds for 
superior tissue regeneration [245, 246].  
 PET stamp based nano-molding of UV-crosslinkable GelMA+ 
A wide range of polymeric cell culture substrates as well as some metallic and non-UV 
crosslinkable hydrogels substrates have been patterned with high resolution micro- and 
nano-topographical cues to direct the essential cellular processes of seeded cells such 
as proliferation, contact guidance, morphology, and stem cell differentiation [18, 130, 
133, 247]. However, the patterning of UV-crosslinkable hydrogel surfaces at submicron 
and nanometer scale remains challenging, where only the low resolution molding has 
been demonstrated so far [160, 168-171]. One of the drawbacks of UV crosslinking is 
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its inhibition by the presence of oxygen molecules which inhibit free-radical 
polymerization, and thus resulting in under-cured tacky surfaces, and loss of surface 
properties [248]. PDMS is highly permeable to oxygen and other gases [249, 250]. The 
permeation of oxygen through PDMS inhibits UV-crosslinking near the PDMS surface. 
The oxygen permeation through PDMS affects UV crosslinking where the effect has 
been estimated that of a 4-5 µm in depth. However, the top 1 µm layer in contact with 
the stamp is seriously affected by the oxygen inhibition [251]. While the inhibition of 
a 1 µm layer for patterning low resolution features of tens of µm in size is not damaging, 
the effects of oxygen inhibition is prohibitive for the formation of submicron features. 
This study demonstrated that high resolution micro- and nano-molding of UV 
crosslinkable GelMA can be achieved by overcoming oxygen permeability related 
limitations of PDMS using material with low oxygen permeability (PET) as stamp 
material.  PET has several order of magnitude lower permeability for oxygen as 
compared to PDMS [252] and enabled successful high resolution micro- and nano-
molding. The use of PET as a stamp material could offer unique advantages over 
traditional PDMS based stamps as PET can be thermally imprinted with much smaller 
feature sizes as compared to PDMS [253]. Silicon and quartz are also oxygen 
impermeable, and thus can be used as a stamp for patterning UV hydrogels. However, 
high costs associated with the production of Si or quartz stamp prohibit their use 
directly as a stamp material for cell substrate patterning. The wear of the master stamp 
features and the clogging of the features due to residual hydrogel limits the use of the 
master stamp to only 10-15 times. Thus, the use of the Si or quartz master stamp directly 
for hydrogels increases the fabrication cost significantly. Therefore, they are only used 
to produce inexpensive copies of master molds. PET is in a relatively inexpensive 
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material. Besides, several hundred copies of PET stamps can be prepared from one Si 
or quartz mold, which significantly lowers the overall cost. 
 Benefits of using topographically patterned and permeable GelMA+ films 
as cell carrier for corneal endothelial tissue engineering 
Majority of corneal transplants are performed due to dysfunctional corneal 
endothelium. Tissue engineering and regenerative medicine aim to develop an 
alternative solution by using cultivated HCECs to generate transplantable monolayer, 
which could ultimately decrease the dependence on donor corneas. The advent of 
advanced surgical procedures of transplanting HCEC monolayers such as endothelial 
keratoplasty have stimulated the efforts to find suitable thin film implantable materials, 
which could be used to grow and transplant the HCEC monolayer for endothelial 
dysfunction patients [254]. Improvement in the strength of the thin films in the hydrated 
state while keeping the thickness as low as possible for improved nutrient transport 
after surgery could be the key to develop successful cell carrier materials. The other 
key properties required for a successful cell carrier device include cell adhesive ligands, 
optical transparency and nutrient permeability. GelMA+ hydrogel contains naturally 
present cell adhesion ligands. Therefore, it can support the cellular adhesion without 
the use of ECM coatings. Rationally designed materials not only could provide 
mechanical support for HCEC monolayer delivery, but could also improve the 
functionality of the monolayer. Chapter 3 demonstrated the extracellular matrix (ECM) 
micro- and nano-topography induced improvement in the functional markers of the 
human corneal endothelial cells (HCECs) on polystyrene cell culture substrates [132]. 
However, PS cannot be used as cell-carrier device due to lack of biodegradation and 
permeability. This chapter shows the development of hydrogel that is robust in hydrated 
state when fabricated into thin films and patterned it with same pillars as were used in 
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chapter 3 [132]. Additionally, the pillars with hexagonal array were added to study the 
effect of arrangement of topographical cues on the cellular behavior.  Square array 1 
µm pillars of 6 µm spacing, which were shown to improve the tight cell-cell junctional 
protein expression of HCECs on polystyrene [132] also improved the ZO1 expression 
of the HCECs on GelMA+ films. Changing the arrangement of the pillars from square 
to hexagonal lead to homogenous cell sizes and smaller cell areas, which are critical 
parameters to assess the quality of the cultivated HCECs [95]. The inclusion of ECM 
surface topography on cell-carrier device provides a way not only to provide a substrate 
and mechanical support for the HCEC monolayer transplantation, but also to provide 
the micro-environment to improve the functional markers of HCECs simultaneously. 
Degradation of the cell carrier film for HCEC monolayer transplantation is not well 
studied, especially in the aqueous humor environment. The degradation rates could 
affect the stability of the transplanted monolayer, where fast degradation could 
potentially cause failure of the graft due to insufficient development of the HCECs 
contacts with posterior corneal surface as the carrier film degrades. Slower degradation, 
on the other hand, could provide sufficient time for the transplanted HCEC monolayer 
to adapt to the environment and establish strong contact with the posterior corneal 
surface. The 30% GelMA+ degradation rates in collagenase and in extracted aqueous 
humor suggest slow degradation kinetics where it could take weeks to dissolve, thus 
provide time to the HCEC monolayer. As the GelMA+ film is optically transparent and 
permeable, the slower degradation reduces the risk of deleterious effects to the 
functioning of the HCEC monolayer in terms of nutrient delivery to the cornea.  
 Conclusion 
This chapter described a simple method, which demonstrated that the gelatin methacrylate 
fabrication process can be tweaked to exploit sequential hybrid (physical + UV) crosslinking 
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to achieve excellent mechanical strength in modified GelMA (GelMA+) as compared to regular 
GelMA. The presence of physical network of gelatin triple helices improved the subsequent 
UV covalent crosslinking efficiency, which imparted excellent strength to hydrogels. The 
resulting GelMA+ was close to 5-fold stronger in terms of Young’s compressive modulus and 
close to 9-fold stronger in terms of dynamic elastic modulus. The increased strength was shown 
to be thermally-stable at physiological temperatures. The GelMA+ had slower biodegradation 
kinetics as compared to regular GelMA. A new micro- and nano-molding method was 
developed for the pattering of UV-crosslinkable hydrogels based on the oxygen impermeable 
imprinted PET stamps to study topographically patterned hydrogel substrate-cell interactions. 
The primary HCEC monolayers grown on 1 µm pillars of square-array GelMA+ demonstrated 
improved zona-occludin-1 expression while monolayers on 1 µm pillar of hexagonal-array 
GelMA+ exhibited higher cell density and homogeneity of cell size, which are indications of 
functionally-superior monolayer. Implantability of the GelMA+ films with HCEC monolayer 
were tested in corneal endothelial transplantation device and the results indicated minimal 
damage to cell layer and no damage to cell-carrier film during the procedure.  The GelMA+ 
films did not hinder the nutrient transport process measured in terms of glucose permeability. 
The study presents GelMA+ films as an implantable cell-carrier device, which not only acts as 
a mechanical support, but contain tailored properties to tissue-engineer superior transplantable 




Chapter 6. Conclusions and recommendations 
 
This thesis was set out to probe the role of extracellular topographical cues in the field 
of corneal endothelial tissue engineering and regenerative medicine and sought to 
answer the following questions. 
- How does the extracellular topography affect the proliferation and functional 
markers of primary HCECs? 
- How do extracellular guttata micro-features affect HCEC monolayer 
regeneration? Which are the important parameters of guttata that affect the 
monolayer regeneration? 
- How does a hybrid crosslinking affect the mechanical properties of hydrogel 
films?  What are the design considerations of nano-molding method that affect 
the high resolution pattering of hydrogels? How does the extracellular 
topography affect the monolayer formation on hydrogel films? 
The aims were designed and research program was laid out to answer the above 
questions.  This chapter highlights the important findings of the research work and 
conclusions drawn thereafter. The aims of the thesis, as described in the chapter one, 
are reviewed and the research achievements are addressed in relation to the aims. 
Additionally, recommendations for future work are also presented as indicated by this 
research. 
6.1  Conclusions 
The first aim of the study was to identify the optimal micro/nano features for enhancing 
the proliferation, morphology and functional markers of primary human corneal 
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endothelial cells. The results of the study demonstrated that the 1 µm pillars on PS cell 
culture substrates improved the proliferation rate and the expression of ZO1 of primary 
HCECs. This lead to the in vitro formation of a high quality cell layer with enhanced 
tight-junction formation, as determined by the expression and localization of ZO-1. The 
250 nm TCPS pillars showed the most significant change when quantified by 
morphometry such as cell area and CV of HCECs. Importantly, the results showed that 
even after the primary HCECs were detached from the topographically patterned PS, 
they were able to maintain the topography-mediated cell functions. This suggests that 
the primary HCECs cultured on topography would acquire epigenetic memory of the 
topography-induced functions, leading to formation of functionally enhanced in situ 
monolayer even upon transplantation to a non-patterned cell-carrier or in vivo surfaces. 
Moreover, the hot embossed PS could potentially be developed to the commercially 
available PS-based cell culture vessels, which are tailored by incorporating 1 µm 
extracellular pillar topographies, for faster primary HCECs cultivation. Overall, this 
work undoubtedly allowed the cultivation of large quantities of high quality primary 
HCECs for the purpose of research and development of tissue engineering, cell therapy 
and drug screening applications. Additionally, the topographical cues studied in this 
part not only were of significant importance for HCECs proliferation, they were also 
critical in designing an improved cell carrier film for HCEC monolayer, which was 
discussed in chapter 5 and will be discussed shortly. 
The corneal endothelial cell therapies offer minimally invasive appealing options for 
the treatment of FED; however, no adequate in vitro or in vivo model is available for 
understanding FED. The second aim of the thesis was to develop an in vitro disease 
model simulating the topographical microenvironment of FED-affected corneal 
surface, which could be used to study the effectiveness of regenerative therapies. By 
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using microfabrication techniques, an in vitro FED disease model was engineered by 
recapitulating the guttata-like surfaces from clinical data and analysis of data from 
published literature, which mimic the topographical micro-environment of FED. The 
key findings suggested that the guttata dimensions, density and spacing significantly 
affect the migratory behavior and HCEC monolayer reformation. The primary HCECs 
were unable to form a monolayer in cell injection approach or in pharmacotherapy 
approach on densely-packed synthetic guttata, which mimicked the late stage FED. 
Primary HCECs morphology and alignment around larger 40 µm as well as dense 20 
µm synthetic guttata pillars resembled with the clinical observation of corneal 
endothelial cell rosette-type clustering on FED corneas, which authenticated the micro-
fabricated disease model. The Euclidean distance and directness of cell migration was 
also significantly lower on densely-packed synthetic guttata as compared to guttata-free 
surface. However, the cells could form a monolayer and express ZO1 on sparsely-
spaced synthetic guttata micro-structures of a lower height, mimicking the early stage 
FED. Similarly, cell monolayer formation improved on curved dome-like s-guttata with 
diameter and spacing of 20 µm and a height of 5 µm, which also mimicked the early 
stage FED. Overall, the findings suggest that the presence of the guttata and the stage 
of the progression of disease must be considered when considering cell regenerative 
therapies as a treatment for the FED patients. The severity of the FED, as determined 
by height and density of existing guttata, can potentially attenuate corneal endothelial 
monolayer formation of cell injection therapy and pharmacotherapy. The cell therapy 
can be considered for patients in the initial stages of the diseases, however, the guttata 
would keep on growing for these patients as well. Therefore, the surgical removal of 
the corneal guttata combined with the cell regenerative therapy could improve the 
efficacy of the treatment. 
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While cell regenerative therapy is promising for FED with initial stage disease 
progression, transplantation of tissue-engineered monolayer is another avenue for 
advanced FED and other endothelial dysfunction patients. Therefore, the third aim was 
to design a patterned implantable hydrogel cell carrier film for the tissue-engineered 
functionally-enhanced primary HCEC monolayer. In this work, I explored hybrid 
(physical + UV) crosslinking of GelMA. The presence of physical network of gelatin 
triple helices improved the subsequent UV covalent crosslinking efficiency, which 
imparted excellent strength to hydrogels. GelMA+ was sufficiently strong to not rupture 
when it was passed through the corneal endothelial transplantation device, which 
showed good implantability of the GelMA+ films. I also developed a new micro- and 
nano-molding method for the pattering of UV-crosslinkable hydrogels by using oxygen 
impermeable imprinted PET stamps. This opens up new opportunities to study the 
effect of hydrogel extracellular topographical cues of high resolution on cellular 
functions. Based on the findings of chapter 3 on the effect of isotropic cues on 
functional markers of primary HCECs, the cell carrier film was patterned with similar 
topographical features to investigate if they could improve the HCEC monolayer 
functions. The primary HCEC monolayers grown on 1 µm pillars of square-array 
GelMA+ demonstrated improved ZO1 expression, while monolayers on 1 µm pillar of 
hexagonal-array GelMA+ exhibited higher cell density and homogeneity of cell size, 
which are indications of functionally-superior monolayer. The GelMA+ films were 
porous and did not hinder the nutrient transport process across the membrane. Overall, 
the study presents GelMA+ films as an implantable cell-carrier device, which not only 
acts as a mechanical support, but contain tailored properties to tissue-engineer superior 
transplantable monolayers for corneal endothelial dysfunction patients.  
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In spite of the significant contributions and impact of extracellular topography cues on 
tissue engineering and regenerative medicine, the use of such techniques have not 
received much attention in the field of corneal endothelial tissue engineering. This PhD 
thesis has tried to take a holistic approach to look at this field and showed how the use 
of topographical cues can benefit the corneal endothelial tissue engineering and 
regenerative medicine field. 
6.2  Recommendations  
Based on the research work performed, recommendations for future work, which could 
benefit the field of primary HCECs proliferation and regenerative medicine, are 
presented in the following section. The limitations of the current work will be 
considered along with the future work which could improve upon the current work.  
6.2.1 The interplay between the origin of primary HCECs, ROCK inhibitor and 
the topographical cues 
The research work in chapter 3 presents convincing evidences of the enhanced 
proliferation of primary HCECs by the use of isotropic extracellular topography. 
However, insights into the mechanistic pathways and the molecular mechanisms 
underlying the HCECs - topography interaction are unclear. In chapter 3, I speculated 
that the topography improved the cell spreading, which in turn affected the cell 
proliferation, as suggested by previous studies as well [255].  Future studies should be 
performed to understand the effect of micro- or nano- topography on the expression of 
ZO1 and sustaining of ZO1 expression when HCECs are passaged from 
topographically-patterned substrates to unpatterned substrates. The study of the 
synergetic effect of soluble cues such as ROCK-inhibitor in combination with 
extracellular topography is an another exciting direction for new research, which could 
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direct the cellular functions of HCECs during in vitro culture. Previous studies have 
shown that the proliferation of primary HCECs depends on the donor age and the 
location of the donor corneal endothelial cells within the corneal endothelium (cells 
from central vs peripheral regions of donor cornea) [207]. The primary HCECs used in 
the research work performed in chapter 3 were harvested from whole donor corneal 
endothelium without segregating the cells based on the region of cells. Moreover, the 
cells were mostly from donor corneas obtained from younger donors.  As such, 
differential effect of extracellular topography on the donor age and the origin of primary 
HCECs is unclear. Extracellular topographies could activate different pathways in 
younger vs older donor cells and donor cells of different locations, which could offer 
interesting insights into the cell proliferation mechanisms. Lastly, I would like to 
emphasize that any methods to proliferate HCECs in vitro should only improve the 
proliferation response transiently and in a controlled fashion. The cells must retain the 
capacity to stop the cell division once the monolayer is formed. The uncontrolled 
proliferation could lead to complications as discussed in chapter 2. 
6.2.2 The effectiveness of cell regenerative therapies and the role of ROCK 
inhibitor 
The influence of guttata dimensions on the monolayer regeneration of HCECs is clearly 
evident from the work presented in chapter 4. However, it also opens up new directions 
for further research. Current published studies on corneal cell regenerative therapies 
have used ROCK inhibitor to improve the cell adhesion for cell injection therapy [13, 
102, 109] and to stimulate the cell migration for reformation of corneal endothelium for 
pharmacotherapy [103, 108, 111]. By using the disease model developed through this 
work, future studies could be performed to examine the effect of ROCK inhibitor and 
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its dosage on the regeneration of human corneal endothelial monolayer. Further, a 
comparison of the ability of primary HCECs of young and older donor cells in cell 
injection therapy could also be an interesting topic of research. This would potentially 
help to determine the donor-age window for the best possible regeneration of corneal 
endothelium monolayer on synthetic guttata. 
6.2.3 Effect of the removal of FED affected DM on cell regenerative therapies 
Chapter 3 showed that the cell regeneration therapy or pharmacotherapy is not a viable 
option for patients with late stage FED disease due to the dense and taller guttata 
microstructures. However, the disease affected DM can be removed by using surgical 
procedures. The combination of surgical method of the removal of DM with the cell 
injection therapy could provide improved outcome for cell therapy approach. Further 
studies are need on this topic to investigate the cell survival, attachment, migration and 
monolayer regeneration of the injected cells on the corneal surfaces devoid of DM.  
6.2.4 Long term studies of the transplantation of cell carrier films: The effect of 
biodegradation on cell attachment to posterior cornea, cell loss and the graft 
survival 
In vitro regenerated HCEC monolayer on an implantable cell carrier film is a promising 
approach for FED patients. An intelligently designed cell carrier further improved the 
chances of success a controlled delivery of tissue engineered monolayer in anterior 
chamber.  However, what happens after the implantation of the cell carrier film is not 
yet clearly understood. Firstly, it is not clear how the cell carrier degradation will affect 
the cellular attachment with the posterior cornea. As the scaffold degrades, cell 
monolayer should be able establish contacts with the posterior cornea for long term 
survival and functioning. This need to be studied in an in vivo environment. Secondly, 
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a long term study should be carried out to quantify the maintenance of the tissue-
engineered monolayer in anterior chamber environment. Chapter 5 showed the 
monolayers grown on a cell carrier film with patterned topographies have improved 
cell morphology and ZO1 expression. A long term study should be conducted to 
quantify the beneficial effect of growing monolayers on patterned cell carrier films by 
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